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INTRODUCTION 
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CHAPTER 1  INTRODUCTION: 
1.1  BIOSTATISTICS: 
• Biostatistics is the applcation of static’s to biology. It is frequently 
associated with applications to medicine and to agriculture. Biostatics may 
be defined as the application of the statically methods to the problem of 
boilogy, including human biology, medicine and public health. It is also 
known as biometry. Biostatistics is the branch of statistics applied to 
biological or medical sciences. Biostatistics is also called biometry. The 
Greek roots are bios and Merton measured, hence biometry means 
measurement of life. It may be stated as the application of statistical 
methods to the solution of biological problems. Biostatistics. Covers 
applications and contributions not only from health, medicine and nutrition 
but also epidemiology, anthropology and many others. Biostatistics of 
applications. Biostatistics is an applied scientific discipline rather then a 
basic or fundamental study. Its roots lie in mathematics, but its branches 
touch all areas of biology, medicine, nutrition and public health. 
Biostatistics: when the data is being analyzed or derived from the 
biological sciences and medicine, we use the term ‘bio-statistics’ to 
distinguish this particular application of statistical tools and concept.” 
“Medical statistics or biostatistics can be called quantitative medicine.” 
“Active participation and involvement of statisticians is extremely essential 
for the formulation of research programmers not only in the field, but also 
in the clinic and the laboratory and for the interpretation of data. It is also 
important that research scientists get adequate training at least in elements 
of biostatistics. By the same taken, it is also important that biostatisticans 
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who are involved in health and nutrition research acquire basic knowledge 
with respect to health and nutrition science.” 
Biostatistics can be divided into two subcategories: descriptive biostatistics 
and inferential biostatistics: 
1. Descriptive Biostatistics: It is the study of biostatistical procedures 
which deal with the collection, representation, calculation and processing, 
i.e., the summarization of data to make it more informative and 
comprehensible. It involves graphical and tabular approaches to describe, 
summarize and analyze the data. The primary function of descriptive 
statistics is to provide meaningful and convenient technique for describing 
features of data that are of interest. The failure to choose appropriate 
descriptive statistics often leads to faulty scientific inferences. The field of 
descriptive statistics is not concerned with implications or conclusions that 
can be drawn from the sets of data. It is basically a device for organizing 
data and bringing into focus their essential characteristics for the purpose of 
conclusion. 
2. Inferential Biostatistics: It constitutes the procedures which serve to 
make generalizations or drawing conclusions on the basis of the studies of 
a sample. This is also known as sampling biostatistics. Statistical 
inference is most often limited to the quantitative aspects of the 
generalization but more often a biostatistician is asked to contribute to the 
process of reaching substantive conclusions as well. The study of the 
quantitative aspects of the inferential process provides a solid basis. On 
which the more general substantive process of inference can be founded. 
By virtue of experience, a biostatistician can frequently be in a position to 
make contributions to a substantive inference.   
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SAMPLE AND TEST BIOSTATISTICS:  
In biological studies, two types of statistics are used. These are: 
1. Sample Statistics: Sample statistics are generated from data used to 
estimate population parameters like mean, standard deviation, etc. 
Sample statistics are used to define the nature and distribution of the 
data. These are calculated immediately to give the biologist a first 
approximation look at his results. Sample statistics often provide 
information as to whether the results are significant or not. 
2. Test Statistics: Test statistics are used to test hypothesis about one 
or more samples of data. The statistical test chosen for analysis 
depends to a great extent on the experimental design and the type of 
the analysis when designing the data collection format. In such 
cases, the experimental design usually does not dictate the statistical 
test or vice-versa, but they remain coordinates, e.g., chi square test.  
Biostatistics focuses on the development and application of statistical 
Techniques to address problems in health-related fields, including 
epidemiology, medicine, and public health. Biostatisticians are 
indispensable team members for any research study. They help 
formulate the scientific questions to be answered, determine the 
appropriate sampling techniques, coordinate data collection procedures, 
conduct statical analyes to answer the scientific questions, and help write 
up the final results. Often, to fully address the scientific questions of 
interest, the biostatistician will develop new statistical methodology 
interests of the current faculty in the division include (incomplete) 
longitudinal data, causal inference, survival analysis, statistical genetics, 
and Bayesian inference. Within the University of Florida’s Division of 
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Biostatics, the research problems are as diverse as studying the impact of 
educational programs on obesity, developing new stem cell therapy to 
repair brain damage associated with oxygen deprivation at birth, 
assessing the impact of the environment on human health, testing of new 
drugs to control asthma, identifying genes realated to recovery from 
traumatic brain injury, determining the mechanism of the effect of 
exercise on smoking cessation, developing new approaches to assess 
vaccine efficacy based on validation samples, and assessing 
interventions to prevent lower back pain industry. 
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(1.2) BIOMEDICAL STATISTICS: 
Biostatistics is the applicaton of statistical techniques to scientific research 
in health related fields, including medicine, biology, and public health, and 
the development of new tools tostudy these areas. Since the beginning of 
the twentieth century, the field of biostatistics has become an indispensable 
tool in improving health and reducing illness. [1] Biostatisticians play 
essential roles in designing studies, analyzing data and creating methods to 
attack research problems as diverse as 
 The determination of major risk factors for heartdisease, lung disease and 
Cancer.  
 The testing of new drugs to combat AIDS. 
  The evaluation of potential environmental factors harmful to human 
health. 
  such as tobacco smoke, asbestos or pollutants [1]  
 Survival Analysis: 
Survival analysis concerns the statistical modeling of time-to-outcome data, 
I.e. data where the variable of primary interest is the time interval between 
some specified origin and the event of interest occurring. The event of 
interst susually referred to as the outcome or endpoint (other terms Include 
terminating or target event, or failure). 
Survival data may also be referred to as time-to-event data, lifetime data, 
failure time data, reliability data, and durationdata or event history data. It 
arises commonly in applicationsin Medicine, Social Sciences and 
enengnineering. 
 Clinical Trial: 
A clinical trial is a research study to answer specific questions about 
Vaccines or new therapies or new ways of using known treatments. 
Clinical trials (also called medical research and research studies) are used 
to determine whether new drugs or treatments are both safe and effective. 
Carefully conducted clinical trials are the fastest and safest way to find 
Treatments that work. 
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 Resources in Vital and Health Statistics: Finding and Using 
Statistics 
Identifying sources of relevant health-related statistics can be a challenge. 
Statistics are kept by groups as diverse as the World Health Organization, 
The Government of India various department. Unfortunately, due to the 
Complexity of the information available, there is no single way to start 
Looking. Outlined below are several points to consider when doing your 
Search? 
 
 Government or Private agency concerned search area : 
All levels of government, from the Union Government down to individual 
Cities produce statistics in the course of fulfilling their individual 
missions.Often these statistics are then made available either in print form 
or on the Internet. There are also many private foundations and 
organizations that Make information they collect and produce available to 
the public. We can identify an appropriate agency, can search their web site 
and print Publications, or contact the agency directly. Examples of this 
search Method is: -visiting the Centers for Disease Control statistics –
contacting The (Association of Physicians) to find the number of currently 
 
 Current (Within the last few year) Statistics:  
The time frame of this research will also affect where we find statistics. 
There is generally a lead time of at least one year before most statistics are 
published.  Need of more current information, try looking in journal and 
newspaper articles or press releases.  
 
 Type of statistics (Vital, demographic, health, etc.): 
Vital statistics are records of births, marriages/divorces and deaths. Example: 
The number of women over40who gave birth in the Gujarat Demographics 
 Describe a specific population group; often this group is defined by geographic. 
Example: the number of people who live in the Gujarat. 
Health statistics, also called mortality and/or morbidity statistics, detail the 
incidence of certain diseases and conditions. 
Example: the number of deaths related to illegal drugs (note: this 
information may also be found both in vital statistics and in mortality and 
morbidity reports). 
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 Level of statistics: 
 
Locating statistics on a national or international level is very different from 
locating statistics on a local level. Generally, it is good ideas to use a 
source as close (in approximation) to the area are researching as possible.  
 
 Alpha: 
Alpha is the probability of rejecting a true null hypothesis. It is the 
probability that the investigator will conclude that a relationship exists 
between independent and dependent variables when no such relationship 
exists. It is represented by the lowercase Greek letter alpha. 
 Beta: 
Beta is the probability of accepting or retaining a false null hypothesis. It is 
the probability that the investigator will conclude that no relationship exists 
between independent and dependent variables when such relationship does 
exist. It is represented by the lowercase Greek letter beta. 
 Binomial Distribution:  
 
The family of binomial distributions is a category of discrete frequency 
distributions showing distributions of events having two possible outcomes, 
like success or failure. Consequently, if you know the probability of 
success on any given trial, binomial distributions can be used to predict 
probabilities of given numbers of successes in given numbers of trials. This 
means that a researcher can determine whether an empiricaldistribution 
deviates significantly from what would typically be expected.  
Binomial distributions are important to the clinician because they can be 
used to represent many situations which have two possible outcomes (e.g., 
success/failure, life/death, improved/not improved, pregnant/not pregnant, 
etc.).  
 
 Box Plot: 
 
A box plot or box and whiskers plot is a graphical way of representing the 
salient features of a distribution. It can be used with either Gaussian or non-
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Gaussian distributions. The box plot shows a rectangle stretching from the 
first to the third quartile of the distribution, these quartiles, the edges of the 
box, are called "hinges". The box displays in a pictorial fashion the 
variability in the data. A line inside the box shows the approximate 
positionof the median. If the median is not in the middle of the box the 
distribution is skewed. The further the median is from the middle, the more 
skewed is the distribution. The box contains 50% of the data in the 
distribution. The box and whisker plot has lines extending from the box 
showing the approximate regions occupied by outliers and extreme values. 
 Causal Relationship: 
 
A causal relationship among variables is a relationship among variables in 
which changes in one variable produce changes in another variable. 
Changes in one variable affect another variable. Changes in one variable 
depend on changes in another variable. 
 Central Tendency: 
 
Measures of central tendency are summary statistics or descriptive statistics 
used to indicate the central location of a group of data values. The three 
most commonly used measures of central tendency are the mean, the 
median, and the mode. 
 Chi_Square Tests: 
Chi-Square tests are frequently used to dected significant relationships 
between two variables measured on norminal scales, or to determine 
whether a distribution differs significantly from the class of statistical 
inferential procedures known as nonparameteric or distribution free tests. 
 Correlation: 
Correlation referes to the degree of relationship among variables. 
Correlation coefficients are a measure of the degree of relationship among 
variables. There are many correlation coefficients. Two of the most 
important measures are the Pearson product moment correlation coefficient 
(Often used with ordinal measures and or non-Gaussian variables). The 
Pearson is parametric and the Spearman is a nonparametric measure of 
relationship. 
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 Dependent Variable: 
In an experimental setting, dependent variable refers to the variables 
which are observed by the experimenter.More generally dependent 
variables values depend upon the values of independent variables. 
 Distribution: 
A distribution or, more formally, a frequency distribution is simply a table, 
chart or graph, which pairs each different value obtained from a sample or 
population with the number or proportion of time it occurs. So, any time a 
set of values is obtained from a sample, each value may be plottes against 
the number or proportion of times it occurs using a graph having the values 
on the horizional axis and the counts or proportions on the vertical axis. 
Such a graph is a very conveninent way to represent a frequency 
distribution. 
 Effect size: 
Effect size refers to the size of the effect produced by the independent 
variable on the dependent variable in a research study. For example, if the 
study compares the effectiveness of two treatments on the dependent 
variable, the difference between the mean is the effect size. Medical before 
conducting a research study because the size of the effect plays an 
important role in determining the statistical power, and thus the optimal 
sample size for conducting the research. 
 Empiricial: 
An empirical effort or process is one which is data-based. The fundamental 
difference between scientific research and other methods of inquiry is that 
scientific research is data based. A fundamental tenet of the scientific 
method is that an outcome or result is not regarded as valid until there is a 
substantial body of hard evidence or data to support it. Another way to say 
this is that empirical studies are ones which make use of hypothesis testing 
or reality-testing to determine whether assertions, hypothesis, or theoretical 
frameworks will be regarded as valid. 
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 Exploratory Data Analysis: 
Exploratory Data Analysis (EDA) provides a simple way to obtain a big 
picture look at the data, and a quick way to check data for mistakes to 
prevent contamination of subsequent analyses. Exploratory data analysis 
can be thought of as preliminary to more in depth statistical data 
analysis. Box plots are a primary tool in exploratory data analysis. 
 Gaussian distribution: 
The family of Gaussian or normal distributions is a category of frequency 
distributions fitting a precise mathematical model. When plotted on a 
graph, they are characterized by continuous, symmetrical, bell-shaped 
curves. These curves represent the mathematical law of errors. The curves 
precisely describe the phenomenon that measurements often include small 
errors, and that as errors become larger they decreases in number. Gaussian 
distributions are important to the clinician because they represent many 
situations where a condition is the result of a variety of factors summing 
together. 
 Independent Variable: 
In an experimental setting, independent variable refers to the variables that 
are manipulated by the investigator; more generally, Independent variables 
are the causes or causal factors in medical research studies. 
 Inferential Statistics: 
Inferential statistics concern that branch of statistics that has as its primary 
focus generalizing from samples to populations with knows degree of 
accuracy and probabilities. Inferential statistical methods allow us to 
compare small random samples and then to make statements about the 
much large populations they represent with known probabilities of 
truth.Inferential methods typically take the form of statistical tests. 
Examples: Chi-square tests, t-tests, Analysis of variance, Kreskas-Wallis 
test, z-tests, etc. 
 Instuctions: 
Biostatistics for the clinician accepts input from either the mouse or 
keyboard and is designed to be displayed using netscape navigator 3.x or a 
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compatible web browser in the standard fashion. It uses the standard point 
and click interface of the netspace browser and so is quite intuitive and 
easy to use. Use the mouse or arrow and Enter keys to make selections 
from the menus or move though the document, or navigate using the scroll 
bars. 
Use the left mouse buttion to click on arrow icons or scroll bars to 
navigate.Move the mouse cursor to the location of your choice, and then 
click the left mouse button to activate that selection.Hyperlinks appear 
underlined. Click on any hyperlink to activate the link and navigate to the 
location address by the link.Tables of contents contain hyperlinks to the 
various sections. Whithin the bodies of the text many substantive terms 
appear as hyperlinks. These are typically linked to the hypertext 
Glossary.Any time you seek further information about one of these 
coccepts, simply click on the link to go directly to that term in the 
glossary.To return to your previous positions press the “Back” button on 
the netscape toolbar. 
 Interquartile Range: 
The Interquartile Range of a distribution is one of the measures of 
variability of a distribution. It is the difference between the value at the 3rd 
quartile (75th percentile) and the value at the 1st quartile (25th percentile) of 
a distribution. 
 Interval Variables: 
Interval Variables, the third level of measurement, have all the properties of 
ordinal variables, but in addition have the property that equal differences 
between measures represent equal differences in the values of the variable. 
A variable must be at least interval to be able to compute a meaningful 
average. 
 Lesson: 
Each Main Menu Option from the represents a self-instuctional lesson that 
can be chosen and used to learn, present, practice or review statistics 
concepts and skills. Use the arrow keys or mouse to select the desired 
lesson. Lessons typically have a number of sections also accessed from 
menu. The browser interface is quite intuitive and consistent with typical 
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graphical user interface standards. Click on the “Back” button to return to 
previous documents or higher level menus. 
 Level of Measurement: 
“Level of Measurement” rerers to the four different (nomial, ordinal, 
interval, ratio) hierarchically ordered types of variables. 
 Mean: 
The mean refers to the average. It is one of the most useful measures of 
central tendency. The mean is calculated by finding the sum of the 
measures and dividing by the number of measures. 
 Measurement: 
Measurement is a systematic process of assigning names, labels, or 
numbers to the different values of a variable. 
 Median: 
The median is one of the three most commonly used measures of central 
tendency. It is the middle value or 50th percentile in a distribution. It is 
often used in nonparametric statistical procedures. It also appears in box 
plots. The median is often preferable to the mean as a measure of central 
tendency when distributions are skewed. 
 Mode: 
The mode is summary statistics and is one of the three most commonly 
used measures of central tendency. It is the most frequent value in a 
distribution. The mode may be preferable to the mean as a measure of 
central tendency, particularly with multimodal (many modes) distributions. 
 Nomial Variables: 
Nomial Variables are the lowest level qualitative variable and the lowest 
level of measurement Nominal measures simply name, group, type, classify 
or categorize values of a variable. 
 
 
 13
 Nonparametric Tests: 
Nonparametric statistical procedures are sometimes referred to as 
distribution free procedures. In general these procedures can be used with 
nominal or ordinal measures and do not have assumptions requiring that 
distributions of variables be of certain shapes (in contrast to parametric 
procedures which invariably require normal distributions and interval or 
ratio measures). Examples of nonparametric procedures include the Chi-
square tests, and the spearman rank Correlation Coefficient. 
 Null Hypothesis: 
The Null Hypothesis is a statement inferring there is no difference between 
population parameters. That is, there is no relationship between 
independent and dependent variables in the population under study. 
Typically, this is not the anticipated outcome of an experiment. Usually the 
investing-gator conducts an experiment becauses he/she has reason to 
belive manipulation of the independent variable will influence the 
dependent variable. So, rejection of the null hypothesis is interpreted as a 
significant finding. 
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(1.3) BIOMEDICAL STATISTICAL INFERENCE: 
Given the distributions of the variable in a population we obtained results 
about the distributions of various quantities, such as mean and variance, 
calculated from sample observations. These results are of direct interest in 
the planning of sampling enquires, as they enable the investigator to 
estimate the precision attainable with a biomedical sample of a given size 
and hence to decide how large a sample should be taken. 
When the biomedical sample has been taken, what sort of inferences can be 
drawn about the population on the basis of the sample? The argument here 
must in the opposite direction to that previously used. We do not know the 
characteristics of the population. We have taken the one random 
sampleWhatever inference can be made about the population. One 
fundamental difficulty usually arises. The expressions of sampling 
variation given by the various formulas. If we are attempting to make an 
inference about a normal distribution on the basis of one random sample. 
We shall continue to suppose that the data at our disposal from a random 
sample from and wish to use our biomedical knowledge of sample theory 
to make some population. In some sampling enquires this is known to be 
true by virtue of the design of the investigation. A more serious conceptual 
difficulty is that in many statistical investigations difficulty is that in many 
statistical investigations there is no formal process of sampling from well-
defined population. For instance the prevalence of the certain disease may 
be calculated for all the inhabitants of a village and compared with that for 
another area. A clinical, trial may be conducted in a clinical, with the 
participation of all patients seen at the clinic during a given period. A 
doctor may report the mean duration of symptom amongst a consecutive 
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series of patients with a certain form of illness. Individual readings very 
haphazardly whether they from a random sample or whether they are 
collected in a loss formal way, and it will often be desirable to assess the 
effect which this basic variability has on any statistical calculation that are 
performed. 
 It can be done by arguing that the observations are subject to random, 
unsystemic variations, which makes them appear very much like observations 
on random variables. The population formed by the whole distribution is not a 
real, well-defined entity, but it may be helpful to think of it as a hypothetical 
population which would be generated if an indefinitely large number of 
observations showing the same sort of random variation as those at our 
disposal could be made. This concept seems satisfactory when the 
observations vary in a pattern less way, putting forward a model or conceptual 
framework, for the random variation and propose to make whatever statement 
we can about the relevant features of the model. Just as wish to make 
statements about the relevant features of a population in strict sampling 
situation. The supposition that the data behave like a random sample is 
blatantly unrealistic. There may be a systematically tendency for the earliest 
observations to be greater in magnitude then those made later. When such 
modifications have been made, there will still remains some degree of 
apparently random variation, the underlying probability distribution of which 
is a legitimate object of study. 
It will be of considerable importance to compare two or more groups of 
observations made on units receiving different treatments, and to assess the 
extent to which such contrasts are affected by random variation. In most 
experiments the whole collection of units not selected by strictly random 
sampling in the clinical trial. Never the loss, because of random allocation 
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the differences between groups behave like differences random samples- 
from the sample population of all treatments differ in their effects. The 
sampling theory of differences is therefore directly relevant. 
The methods of statistical inference provide a largely objective means of 
drawing conclusion from the data about the issues under biomedical 
research. Jeffrey 1965, Good 1950, Sewage 1954, Lindley 1965 have 
advocated subjective probability method as the basis of statistical 
inference. 
Parameter estimates obtained from samples are usually meant to be used to 
estimate the true population parameters. The sample mean and variance are 
typical estimators or predictors of the true mean and variance, and are often 
called point estimates. In addition, an interval that is apt to contain the true 
parameter often accompanies and complements the point estimates. These 
intervals, known as confidence interval, can be constructed with a know a 
priori probability of bracketing the true parameters. Confidence intervals 
play an important role in the evaluation of drug and drug products. 
         The question of statistical significance pervades much of the statistics 
commonly used in pharmaceutical and clinical studies. Adverting, 
Competitive claims, and submissions of supporting data for drug efficacy 
to the fda usually require evidence of superiority, effectiveness, and/or 
safety based on the traditional use of statistical hypothesis of testing. This 
is the technique that leads to the familiar statement, The Difference is 
statistically significant Many scientists and statisticians feel that too much 
is made of testing for statistical significance is one of backbones of 
standard statistical methodology and the properties and application of such 
test are well understood and familiar in many experimental situations. This 
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aspect of statistical is not only important to the pharmaceutical scientist in 
terms of applications to data analysis and interpretation, but is critical to an 
understanding of the statistical process. 
Biomedical Statistical inference: 
A conclusion about a population or universe on the basis of information 
contained in a sample, a statement about a parameter based on the observed 
value of the Corresponding statistic. If our sample of Indian women aged 
40 to 49 was selected in a particular way (involving probability and 
randomness) , we may be able to conclude on the basis of an observed 
average resting heart rate of the population is likely to lie between 70.13 
and 72.13 (values of the parameter). Note that we never know population 
values exactly, since we have studied only a part of the population, i.e. a 
sample. Statistical inferences utilize the laws of probability.  
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(1.4) IMPORTANCE OF BIOMEDICAL STATISTICS: 
  
The role of clinical research is vital in establishing a standard of care such 
research is best performed using an interdisciplinary approach that 
combines efforts of the clinician and statistician from the conception of the 
study through data analyses and interpretation. The choice of the study 
design depends upon the research questions to be answered, the population 
available, the resources and effort to be extended. If the findings of a study 
reveal a statistical association, the validity of this association may be 
accepted after carefully ruling out alternate explanation such as chance, 
bias, and confounding. Further, the association may be more credible. If it 
is a consistent finding in other biomedical studies as well. 
The analysis of the data collected systematically in biomedical studies 
includes the determination of whether a statistical association exists 
between presence and absence of a factor and observation problems. If a 
statistical association is observed it is important to rule out alternate 
explanations such as the luck of the draw systematic errors in collecting or 
interpreting the data(bias), or the effects of other associated 
variables(Confounding).  Generally, in a biomedical statistical studies the 
researcher selects a study population that has a high risk of developing the 
outcome or response variable. Eligibility criteria for inclusion in the study 
must be clearly defined of the beginning of the study. Data from base line 
and subsequent visits must be collected in a systematic proceeding. The 
response or outcome variable that is to be measured must also be clearly 
defined. 
 19
Sample size calculations must be performed in the initial development 
phase of all analytic studies, but they are particular important in a 
biomedical studies. The studies must have a sufficiently large sample size 
to have adequate statistical power to detect difference between groups 
considered to be of biomedical interest. The proportion of individuals in 
each study are that develop the predetermined outcome is calculated and 
effects of the intervention are compared, monitoring of non-compliance 
and adverse side effects is an important aspect of study. 
Branches of science depends precision for its development and medical 
science is no exception with the scientific advances in modern medicine, 
including public health, there has been felt an increasing need for 
objectively, so that data may be properly processed and correctly 
interpreted with inferences, leading to conclusions that may stand the tests 
of significance, Even before the observations are made and data collected, 
experiments have to be designed and surveys planned keeping in mind the 
subsequent statistical analysis data that is why it is very important for 
Biomedical statistical studies. 
“The Importance of Statistics in Medical Science”  
  
When  considering  the  topic  of  this  article  many  will  think  only  of  
The application of statistical methods to the analysis of data arising in the 
Medical sciences. Some would also include“…and to the Interpretation 
of the results.” It is true that the proper application of statistical methods to 
the analysis of data arising in the medical sciences and the interpretation of 
the results are crucial to the understanding of the underlying medical 
scientific phenomena and to advancing knowledge and practice, but 
knowledge and practice are not advanced in the absence of appropriate 
attention to the design of medical experiments at the outset. No amount of 
statistical methodological gymnastics can salvage a poorly designed 
experiment.  
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There simply is no statistical fix at the analysis stage for a poorly designed 
or poorly conducted experiment (1). All experiments in the medical 
Science should begin with a medically important question that can only 
be answered by conducting an experimentalin. In my 30 plus years of 
working in and consulting to the pharmaceutical industry engaged in the 
discovery, research and clinical development of drugs, biologics or medical 
devices, I consider helping to define the objective of the investigation and 
contributing to developing a quality investigational plan (protocol) – 
including the most appropriate experimental design, to be of far greater 
importance than statistical analyses of data collected during the conduct of 
the investigation (1, 2). In 1974, I recall hearing Dr. Clyde Kramer, who 
made his mark by developing a statistical consultation function for 
Scientists engaged in Agricultural Research at the Virginia Polytechnic 
Institute and State University in Blacksburg, Virginia, USA, and who 
published an excellent primer on multivariate analyses lamenting his early 
experience. He said that when he begandeveloping the statistical consulting 
function, that Agricultural Scientists would bring their data to him for 
statistical analysis. He coined PARC as the acronym to describe this 
process: Plan after Research Completed. 
 He further stated that by commuting the letters in the acronym one 
produced a word that most often described the worth of the experiment. I 
experienced this same phenomenon early in my career – declining to 
analyze data from experiments which were flawed to the extent of having 
no basis for valid statistical inference.statistical or biostatistical input to 
medical science experiments should occur at all stages: Planning, 
development of the protocol [defining the question, identifyingthe data or 
endpoints reflecting the question, choosing the most appropriate 
experimental design, determining the needed number of participants, and 
developing the statistical analysis section (3)], during the conduct of the 
experiment, computerizing the data, statistical analysis and interpretation of 
results and report development. Medical scientific experiments are more 
likely to be successful and reflect greater quality if overseen by a Medical 
Scientific Team. The nucleus of this team is the medical scientific 
researcher and the biostatistician, but other professionals: database 
management expert, head of the monitoring staff, an expert on regulatory 
aspects of the experiment, head of the quality assurance department, and 
medical writer, contribute in a major way to the success of the experiment.  
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In my next column, I will address “Requirements for the Validity of 
Statistical Inferences from Medical Scientific Experiments.” Then 
succeeding columns will highlight real examples from my own 
experiencein the clinical development of 1. Fixed combination drugs; 2. 
Drugs to treat or prevent ulcers; 3. Drugs to treat angina; 4. Drugs to reduce 
CHD risk; 5. Drugs to treat panic attacks; and 6. Drugs to treat Alzheimer’s 
disease.  
  
 Analysis and interpretation of results and report development. Medical 
scientific experiments are more likely to be successful and reflect greater 
quality if overseen by a Medical Scientific Team. The nucleus of this team 
is the medical scientific researcher and the biostatistician, but other 
professionals: database management expert, head of the monitoring staff, 
an expert on regulatory aspects of the experiment, head of the quality 
assurance department, and medical writer, contribute in a major way to the 
success of the experiment.  
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(1.5) USE OF BIOSTATISTICS: 
1. In Physiology and Anatomy: 
Biostatistics is used for the purpose of study of a normal and a healthy 
population and for imposing limits for abnormality. It is also used in 
physiology and anatomy. For example: in studying the mean pulse rate, 
mean and variance of height and weight and their correlation in a healthy 
person. 
2. In Pharmacology: 
To find the action of a drug, biostatistics is used in pharmacology. For 
example if drug is given to certain population the changes produced in the 
health due to drug effect can be studied. It can be used for comparing the 
action of two different drugs two successive dosages of the same drug or to 
assess the relative potency of the drug. 
3. In Medicine: 
Biostatistics is used to compare the efficacy of a popular drug. It is also 
used in operation or in a line of treatment. It can be used to find an 
association between two attributes such as cancer and smoking or filariasis 
and social class or to identify the symptoms of a disease or a syndrome 
cough. 
4. In a surgery: 
Biostatistics is used in surgery to find the measurement of bile duct or 
intestine or organ to be transplanted or where certain statistical 
measurements and characteristic are required to be ascertained before 
performing operations. 
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5. In community medicine and public health: 
Biostatistics is used extensively in community and public to find the 
usefulness of sera and vaccines in the field, percentage of attacks or deaths 
among vaccinated. It is also compared with that among the unvaccinated to 
find whether the difference observed is statistically significant. It can also 
be used for epidemiologically studies to find the role of causative factors. 
For example: deficiency in calcium in iodized salt. In public health, the 
measures adopted are assessed. Also it is helpful for finding whether the 
lowering of morbidity rate in typhoid after pasteurization of milk may be 
attributed to clean supply of milk if it is statistically proved. Fall in birth 
rate may be the result of family planning or higher age of marriage or due 
to rise in living standards. 
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(1.6) APPLICATIONS OF BIOSTATISICS: 
Application of biostatistics is not restricted to certain experiments but is 
used in a wide variety or contexts. Some of these applications are as 
follows: 
1. Genetical Statistics:  
     In Classical or Mendel Ian genetics the focus of interest is centered on  
     The inheritance of qualitative characters. The statistical methods               
     Generally applied are binomial or chi square tests. For example,  
     With the use of chi-square test which deals with observed and  
     Expected frequencies we can test whether or not the new generations  
     Follow the Mendalian ratios. We can also study the Testing the  
     Agreement of observed frequency data with those expected or derived        
     By hypothesis of Mendelian segregation was the major task and this     
     Include problems such as detection and estimation of linkage. This falls     
     In the preview of Genetical statistics. 
Population genetics is concerned with studying genetic structure of 
populations and changes occurring in it over generations. The evolutionary 
changes that occur in a population are due to forces of evolution such as 
mutation, migration, isolation and selection. The frequencies of different 
genes and their changes due to the effect of these forces can be estimated 
with the application of different statistical methods. There are also effects 
related to small population size and consequent inbreeding. The 
applications of statistical methods have made it possible to trace the 
consequences of these effects in a population through abstract models. 
To study the behavior of genes in a population which is concerned with 
changes in the frequency of genes in the population statistical methods are 
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applied, e.g., the relationship between allelic and genotypic frequencies is 
justified by applying binomial equation. 
Population and Applied Genetic: The traits exhibiting continuous 
variation, which are often controlled by two or more genes are termed as 
polygenic and where several genes, make additive contribution to the 
phenotype, the trait is know as quantitative or continuous variation. To 
study such traits various statistical methods are used by the geneticists, like 
in twin studies, Weinberg’s differential method is used to estimate the 
frequencies of monozygotic or dizygotic twins. 
2. Numerical Taxonomy:  
     Numerical Taxonomy deals with grouping of taxonomic units into taxa 
by numerical methods on the basis of their characteristics. The term 
includes the drawing of phylogenetic inferences from the data by statistical 
methods. The major advantage of using numerical methods for 
classification is repeatability and objectivity. After having chosen the 
organisms and contrasting taxa based upon these resemblances are worked 
out. Generalizations are then made about taxa such as phylogeny, choice of 
discriminatory characters, etc. 
Apart from classification, the problems of identification are important 
facets of taxonomic studies. The problem of identification is that of placing 
an unknown operational taxonomic unit (OUT) 
Into one pre-established taxon based on the character-set observed in the 
specimen at hand.Numerical taxonomic methods are also used in fields 
outside systemic biology. Major applications have been recorded in 
ecology, biogeography, social and earth sciences. 
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3 Statistical Ecology: 
           Most of the statistical applications in ecology deal with the study of  
           Temporal and spatial patterns of populations of organisms. The          
           Ormer is described as population dynamics and the latter as       
           Statistical ecology. 
            Ecologists frequently measure the environmental variables along   
           With the observations on the organisms in their habitats. Studies on           
           Vegetation/animal versus environment is amendable to such  
           Analysis. An extension of canonical correlation analysis is called  
           Multiple discriminant analysis. 
It operates on several sets of qualitatively similar variates When the 
units for observations are discrete a simple test for association of two 
species or groups within the sample is provide by chi square value 
computed out of the contingency table. When more than two species 
are studied together, the results are not straight forward and need 
appropriate grouping of the frequency classes. 
 Two major aspects of interest with many species populations are 
species abundance relations and measurement of directivity. The 
species abundance relations are studied through distributions like 
lognormal, negative binomial and geometric distribution. These 
functions determine approximations to relationship between a 
number of species and a number of individuals and make it possible 
to predict the total number of species in the whole population from 
the observed number of species in the sample. 
3. Statistical Ecology: 
    Behavioral studies in the usual cases yield time series data. Data is         
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     Either collected from complete records of the events or from  
     Observations at fixed intervals of time or on the sequence of   
      Activities on local animals or their groups without a time base. 
Duration, interval and latency of behavioural acts are of ethologists. 
If the events in a time series are independent of one another there 
will be no significant correlation among the time of their 
occurrences. Auto-correlation coefficient may be used to determine 
the existence of such correlations. 
Cluster analysis is particularly preferred for ethological work. 
Cluster analysis proceeds by computing similarity measures between 
behaviors and grouping the entities by application of one of several 
algorithms available for this purpose. Cluster analysis is helpful in 
identifying common casual factors in behavior of different 
organisms or groups. But this needs to be applied with caution. 
 Many significant results may be gained from multivariate data 
through principle component and factor analysis for the purpose of 
examining variations within a population. Multivariate analysis of 
variance and discriminant analysis Technique provides powerful 
qualitative tools to examine the pattern in inter-group behavioural 
phenomena. 
4. Forest Mensuration: 
In forestry measurement of tree length, area or volume and weight 
are measured in some cases but it is different to be measure these 
attributes in many other cases. The prediction of those attributes 
which are difficult to be measured directly in terms of easily 
measurable characteristics is the crux of mensuration problem. Since 
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the prediction is probabilistic in nature, the science of statistics plays 
a major role in this field. 
5. Forest and Agricultural Yield Table: 
Yield table is a tabular statement which gives an idea of the 
developing crop, forest product or animal production. Yield tables 
have multiple uses in the management of crop, forest production, 
animal husbandry, fish production, etc. The standard regression 
techniques have gained wide acceptance for the construction of yield 
equations. 
Volume yield of a tree is the output of a regression function with tree 
volume as the dependent variable and diameter and/or height as 
independent variable(s). In practice the best suited function of a set 
of polynomial or exponential models selected is based on some 
goodness of fit criteria. 
 To test the effect of different types of manures, levels of irrigation, 
varieties of crops, etc. and to provide an analytical data, a thorough 
statistical knowledge is required. 
6. Biomass Estimation: 
      Biomass refers to the total mass of living material in a given locality          
or a given area.The estimation of biomass has assumed considerable 
importance in recent years. The common procedure of estimation is 
through the use of regression equations and standard tables. In biomass 
estimation many theoretical refinements like generalized test squares, 
stepwise regression, non-linear regression, etc. are used extensively. 
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7. Statistical Environmental Management: 
The use of statistical methods is a powerful tool to understand the 
complex relationship and processes in the environmental biology and 
its management. Now days, no field of environmental biology is left 
untouched by statistical technique. 
8. Cell Function, Endocrinology, Physiology and Biochemistry: 
When we deal with the cell functions or biochemical aspects of cell 
functions or endocrinology, statistical techniques have made enough 
contribution to these fields of biology. Many workers have used 
correlation and regression analysis system as basic determinants of 
cell physiology. Chi-square test has much been used in cell 
population studies in the physiological and endocrinological 
experiments. Some multivariate analysis is also useful to estimate 
resultant effect of different variable factors on a particular cell or 
endocrine gland. 
9. Demography: 
Demography is defined as the study of measurement of human 
population. It is the quantitative study of human population with 
respect to events such as birth, death, marriage, morbidity, migration 
etc. various statistical methods are used for these studies such as 
vital statistics, life table technique, population growth. 
10. Medical Sciences: 
Health is a sensitive issue. Health managers are expected to take 
sound decisions on the basis of whatever bit of in available. These 
decisions are taken under clouds of uncertainty. Here statistics plays 
a major role. 
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11. Biological Variation and Uncertainties: 
One of the out standing features of all living beings is that no two 
individuals are exactly alike. Variations are present not only between 
individuals but also within individuals from time to time. e.g. diurnal 
variations in body temperature. A large part of statistical efforts are 
devoted to devising and implementing strategies to keep variations 
under check. Control of variations is obtained by choosing an 
appropriate design of study. 
Very often it is found that statistical techniques are misused. 
Inadequate attention is given to the assumptions involved in many of 
the statistical tests and estimation procedures. Statistical systems 
have tremendous potential as an educational tool and practical aid 
for the biologist in choosing the specific techniques that are needed 
in their research. 
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(1.7) FOURIER'S SERIES: 
 In mathematics, those series which proceed according to sines and 
cosines of multiples of a variable, the various multiples being in the ratio of 
the natural numbers; they are used for the representation of a function of 
theVariable for values of the variable which lie between prescribed finite 
limits. Although the importance of such series, especially in the theory 
ofvibrations, had been recognized by D. Bernoulli, Lagrange and other 
mathematicians, and had led to some discussion of their properties, J. B. J. 
Fourier (see above) was the first clearly to recognize the arbitrary character 
Of the functions which the series can represent, and to make any serious 
attempt to prove the validity of such representation; the series are 
consequently usually associated with the name of Fourier. More general 
cases of trigonometrically series, in which the multiples are given as the 
roots of certain transcendental equations were also considered by Fourier. 
Before proceeding to the consideration of the special class of series to be 
discussed, it is necessary to define with some precision what is to be 
understood by the representative of an arbitrary function by an infinite 
series. Suppose a function of a variable x to be arbitrarily given for values 
of x between two fixed values a and b; this means that, corresponding to 
every value of x such that aGx-fib, a definite arithmetical value of the 
Function is assigned by means of some prescribed set of rules. A function So 
defined may be denoted by f (x); the rules by which the values of the Function 
are determined may be embodied in a single explicit analytical Formula, or in 
several such formulae applicable to different portions of the Interval, but it 
would be an undue restriction of the nature of an arbitrarily Given function to 
assume a priori that it is necessarily given in this manner, the possibility of 
the representation of such a function by means of a single analytical 
expression being the very point which we have to discuss. The Variable x 
may be represented by a point at the extremity of an interval measured 
along a straight line from a fixed origin; thus we may speak of the point c 
as synonymous with the value x = c of the variable, and of f(c) as the value 
of the function assigned to the point c. For any number of points between a 
and b the function may be discontinuous, i.e. it may at such points undergo 
abrupt changes of value; it will here be assumed that the number of such 
points is finite. The only discontinuities here considered will be those 
known as ordinary discontinuities. Such a discontinuity exists at the point c 
if f(c+e), f(c - e) have distinct but definite limiting values as e is 
indefinitely diminished; these limiting values are known as the limits on the 
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right and on the left respectively of the functionat c, and may be denoted by 
f(c+o), f(c - o). The discontinuity consists therefore of a sudden change of 
value of the function from f(c - o) to f(c+o), as x increases through the 
value c. If there is such a discontinuity at the point x=o, we may denote the 
limits on the right and on the left respectively by f (+o), f (- o). Suppose we 
have an infinite series u 1 (x) +u2(x) + ... +un(x) + ... in which each term is 
a function of x, of known analytical form; let any value x = c (a = c =b) be 
substituted in the terms of the series, and suppose the sum of n terms of the 
arithmetical series so obtained approaches a definite limit as n is 
indefinitely increased; this limit is known as the sum of the series. If for 
every value of c such that a .c b the sum exists and agrees with the value of 
f(c), the series Eu n (x) is said to represent the function (fx) between the 
values a, b of the variable. If this is the case for all points within the given 
interval with the exception of a finite number, at any one of which either 
the series has no sum, or has a sum which does not agree with the value of 
the function, the series is said to represent “in general " the function for the 
given interval. If the sum of n terms of the series be denoted by S n (c), the 
condition that S n (c) converges to the value f(c) is that, corresponding to 
any finite positive number as small as we please, a value n 1 of n can be 
found such that if n? n 1, I f(c) - Sn(c) I<S.  
Functions have also been considered which for an infinite number of points 
within the given interval have no definite value, and series have also been 
discussed which at an infinite number of points in the interval cease either 
to have a sum, or to have one which agrees with the value of the function? 
The narrower conception above will however be retained in the treatment 
of the subject in this article,. Reference to the wider class of cases being 
made only in connation with the history of the theory of Fourier's Series.  
Uniform Convergence of Series: 
If the series u l(x) +u2(x) + ...+ u2(x) + ...converge for every value of x in a 
given interval a to b, and its sum be denoted by S(x), then if, corresponding 
to a finite positive number S, as small as we please, a finite number n 1 can 
be found such that the arithmetical value of S(x) - S n (x), where n is 
lessthan S, for every value of x in the given interval, the series is said to 
converge uniformly in that interval. It may however happen that as x 
approaches a particular value the number of terms of the series which must 
be taken so that I S(x) - S n (x) I may be <S, increases indefinitely; the 
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convergence of the series is then infinitely slow in the neighborhood of 
such a point, and the series is not uniformly convergent throughout the 
given interval, although it converges at each point of the interval. If the 
number of such points in the neighborhood of which the series ceases to 
converge uniformly be finite, they may be excluded by taking intervals of 
finite magnitude as small as we please containing such points, 
andconsidering the convergence of the series in the given interval with such 
sub-intervals excluded; the convergence of the series is now uniform 
throughout the remainder of the interval. The series is said to be in general 
uniformly convergent within the given interval a to b if it can be made 
uniformly convergent by the exclusion of a finite number of portions of the 
interval, each such portion being arbitrarily small. It is known that the sum 
of an infinite series of continuous terms can be discontinuous only at points 
in the neighborhood of which the convergence of the series is not uniform, 
but non-uniformity of convergence of the series does not necessarily 
implydiscontinuity in the sum.  
Form of Fourier's Series: 
If it be assumed that a function f(x) arbitrarily given for values of x such 
that o <x <l is capable of being represented in general by an infinite series 
of the form A 1 sin l x +A2 sin 21x+ ...+A n sin n i x + ..., and if it be fui £ 
ther assumed that the series is in general uniformly convergent 
throughoutthe interval o to 1, the form of the coefficients A can be 
determined.  
Multiply each term of the series by sin n l x, and integrate the product 
between the limits o and 1, then in virtue of the property f o sin l x sin ni l x 
dx = 0, or Zl, according as n' is not, or is, equal to n, we have 2/A 0 = f i f 
(x) Sin e x dx, and? Thus the series is of the form l I sin n l x f of(x) sin ex... 
(I) this method of determining the coefficients in the series would not be 
valid without the assumption that the series is in general uniformly 
convergent, for in accordance with a known theorem the sum of the 
integrals of the separate terms of the series is otherwise not necessarily 
equal to the integral of the sum. This assumption being made, it is further 
assumed that f(x) is such that f of (x) sin n l x has a definite meaning for 
every value of n. Before we proceed to examine the justification for the 
assumptions made, it is desirable to examine the result obtained, and to 
deduce other series from it. In order to obtain a series of the form Bob--
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BI.cos l +Bo cos-1 - + ... +B 0 cos n i x + ... for the representation of f(x)in 
the interval o to 1, let us apply the series (I) to represent the function f(x) 
sin 7 - T x; we thus find 2° E sin n l xx f O f(x) sin l x sin 117X x, or l sin n 
l xJ o f cos (n1 ') rx cos (n + 1 1)7x on rearrangement of the terms this 
becomes 1 -rx l 2 7rx nirx l l sin l f '+- / E sin l cos l f f(x) cos -- T hence 
f(x) is represented for the interval o to 1 by the series of cosines if f E cos n 
x J f (x) cos n 1 x dx. .. (2) We have thus seen, that with the assumptions 
made, the arbitrary function f(x) may be represented, for the given interval, 
either by a series of sine’s, as in (I), or by a series of cosines, as in (2).  
Some important differences between the two series must, however, be 
noticed. In the first place, the series of sine’s has a vanishing sum when x 
=o or x =1; it therefore does not represent the function at the point x = o, 
unless f (0) =0, or at the point x =1, unless f (1) =o, whereas the series (2) 
Of cosines may represent the function at both these points. Again, let us 
consider what is represented by (1) and (2) for values of x which do not lie 
between o and 1. As f(x) is given only for values of x between o and 1, the 
series at points beyond these limits have no necessary connation with f(x) 
unless we suppose that f(x) is also given for such general values of x in 
such a way that the series continue to represent that function. If in (1) 
wechange x into - x, leaving the coefficients unaltered, the series changes 
sign, and if x be changed into x+21, the series is unaltered; we infer that the 
series (1) represents an odd function of x and is periodic of period 21; thus 
(1) will represent f(x) in general for values of x between too, only if f(x) is 
odd and has a period 2l. If in (2) we change x into - x, the series is 
unaltered, and it is also unaltered by changing x into x+21; from this we see 
that the series (2) represents f (x) for values of x between too, only if is an 
even function, and is periodic of period 2l. In general a function f(x) 
arbitrarily given for express by (I) the function 2 { f (x) - f (- x) } which is 
an odd function, and thus this function is represented for the interval - 1 to 
+1 by Z E sin n f1 t f(x) - f(- x)I 'sinn lx dx; we can also express z { f (x) +f 
(- x)}, which is an even function, by means of (2), thus for the interval – 1 
to +1 this function is represented by TT oz{f(x)+f(- x) }dx+ Z E cos n i x f 
O 2{f(x) +f (- x)} cosn ix dx. It must be observed that f (- x) is absolutely 
independent of f(x) the former being not necessarily deducible arbitrarily 
and independently for the interval o to 1. On adding the expressions 
together we obtain a series of sines and cosines which represents f(x) for 
the interval - 1 to 1. The integrals nrx f of (- x) cos - dx, f of (- x) sin nlx 
are equivalent to - f o l f (x) cos - 7 - dx, x dx, + o f(x) (x) sin n l xdx, thus 
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the series is ilf I l Ic" n? rx l n? rx n? rxff(x) s i n d x, l nrx E l _i cos l 
which may be written zlf if (x ') dx -?? f f(x') cos n ' r(l x') dx'.. . (3) The 
series (3), which represents a function f(x) arbitrarily given for the interval 
1 to 1, is what is known as Fourier's Series; the expressions (I) and (2) 
being regarded as the particular forms which (3) takes in the two cases, in 
which f (- x) = - f (x), or f (- x) = f (x) respectively. The expression (3) 
doesnot represent f(x) at points beyond the interval - 1 to 1, unless f(x) has a 
period 2l. For a value of x within the interval, at which f(x) is 
discontinuous, the sum of the series may cease to represent f(x), but, as will 
be seen hereafter, all values of x between =oo is neither periodic nor odd, 
nor even, and is therefore not represented by either (I) or (2) except for the 
interval o to 1.  
From (I) and (2) we can deduce a series containing both sines and cosines, 
which will represent a function f(x) arbitrarily given in the interval - 1 to 1, 
for that interval. We can has the value z {f (x+ from the latter by putting x 
for x in a formula; both f (x) and f (- x) are functions given o) -}-f (x – 
o)}, the mean of the limits at the points on the right and the left. The 
seriesrepresents the function at x = o, unless the function is there 
discontinuous, in which case the series is 2 {f (+o) -1-f (-0)}; the series 
does not necessarily represent the function at the points 1 and - 1, unless f 
(1) =f (-1). Its sum at either of these points is II f (l) +f (- l)}. Fourier's 
Series. - (a) Let be given from o to by f(x) =c, when o <x < 4l, and by f(x) 
= - c from Zl to 1; it is required to find a sine series, and also a cosine 
series; which shall represent the function in the interval.  
We have f l n7rx IL nirx 'n7rx o' sin 1 dx = c f sin l dx - c f #1 s i n - 1 - dx 
C _ - l (cos nir-2 cos 2nx+1). n7r this vanishes if n is odd, and if n=4m, but 
if n=4m +2 it is equal to 4c1/nlr; the series is therefore 4c - (1.27rx 1 61rx 
1 107rx +l r 2 1 Sn +3 1 s i n +5 s i n l, for unrestricted values of x, this 
series represents the ordinates of the series of straight lines in fig. I, except 
that it vanishes at the points o, zl, 1, 21 .. .  
Dirichlet's Integral: 
The method indicated by Fourier, but first carried out rigorously by 
Dirichrlet, of proving that, with certain restrictions as to the nature of the 
function f(x), that function is in general represented by the series (3), 
consists in finding the sum of n+i terms of that series, and then 
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investigating the limiting value of the sum, when n is increased 
indefinitely. It thus appears that the series is convergent and that the value 
towards which its sum converges is 2 {f (x+o) +f (x-o)}, which is in 
general equal to f(x). It will be convenient throughout to take -7r to 7r as 
the given interval; any interval -1 to 1 may be reduced to this by changing x 
into lx/7r, and thus there is no loss of generality.  
We find by an elementary process that 1-1-cos (x-x') + cos 2 (x-x') + ... + 
cos n(x-x') Sln 2n 2 2 sin 1(x' -x) Hence, with the new notation, the sum of 
the first n+I terms of (3) is I f f(X) 51n2fl 2 + (x x) r 1 2 sin a If we suppose 
f(x) to be continued beyond the interval -7r to 7r, in such a way that f(x) 
=f(x+27r), we may replace the limits in this integral by x+7r, x -7r 
respectively; if we then put = 2z, and let f(x') =F(z), the expression 
becomes ?f I n F(z) s s i n n z z dz, where m = 2n+I; this expression may 
bewritten in the form 1 f 2F (z) sin mz dz+ l f; F(-z) sin. Mz dz (4) 7r o sin 
n z 7r o s i n z we require therefore to find the limiting value, when m is 
indefinitely increased, off oF (z) s s z z dz; the form of the second integral 
being essentially the same. This integral, or rather the slightly more general 
one f hF (z) sinmz d, z, si z when 0< h<27r, is known as Dirichlet's 
integral. If we write X(z) =F(z) z the integral sin z becomes f o X(z) si 'mz' 
dz, which is the form in which the integral is frequently considered.  
The Second Mean-Value Theorem: 
The limiting value of Dirichlet's integral may be conveniently investigated 
by means of a theorem in the integral calculus known as the second mean-
value theorem. Let a, b be two fixed finite numbers such that a<b, and 
suppose f(x), 4(x) are two functions which have finite and determinate 
values everywhere in the interval except for a finite number of points; 
suppose further that the functions f(x), 4(x) are integrable throughout the 
interval, and that as x increases from a to b the function f(x) is monotone, 
i.e. either never diminishes or never increases; the theorem is that jbf()d 
=f(a +0) f ¢43 (x)dx+f(b -0) f 41(x)dx when t is some point between a and 
b, and f(a), f(b) may be written for f(a+o), f(b-o) unless a or b is a point of 
discontinuity of the function f(x).  
To prove this theorem, we observe that, since the product of two integrable 
functions is an integrable function, f b f(x)4(x)dx exists, and may be 
regarded as the limit of the sum of a series f(xo)0(xo) (xi-xo) +f(xi)4(xi) 
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(x2-xi)+ ... +f(xn_i)0(x,_i) (xn x„__1) where xo = a, n = b and xi, x 2 ... 
x,t_1 are n-I intermediate points. We can express c/, (xr) (x, +l -x,) in 
theform Yr. +l -Y,., by K=r ng Y,.=? P (xK-1) (xK - xK-1), Y0 = o. Putting 
K=r Writing X r for f(x,.), the series becomes Xo (Y1-Yo) +X1 (Y2-Y1) +. 
. +X„-1(Yn-Yn.-1) or Yi (X0X 1) +Y2 (X 1X 2) +. +Yn (Xn-1-X.) +YnXn.  
Now, by supposition, all the numbers Y 1, Y2. .. Y n are finite, and all the 
numbers Xr_i-X, are of the same sign, hence by a known algebraically 
theorem the series is equal to M (X0 -Xn) -}-YnXn where M is a number 
intermediate between the greatest and the least of the numbers Y1, Y2,. 
Yn.This remains true however many partial intervals are taken, and 
therefore, when their number is increased indefinitely, and their breadths 
are diminished indefinitely according to any law, we have f b f (d) = {f (a)-f 
(b)} M+f (b) J when M is intermediate between the greatest and least 
values which f ¢4 (x) dx can have, when x is in the given integral. Now this 
integral is a continuous function of its upper limit x, and there fore there is 
a value of x in the interval, for which it takes any particular value between 
the greatest and least values that it has. There is therefore a value t between 
a and b, such that M = f! 4(x) dx, a hence fbf0 dx =If (a) -f (b)} f e (x) dx 
(b) f6? (x) dx =f (a) f Q 4 +f (b) b (x) dx. If the interval contains any finite 
numbers of points of discontinuity of f(x) or cp(x), the method of proof still 
holds good, provided these points are avoided in making the subdivisions; 
in particular if either of the ends be a point of discontinuity of f(x), we 
write f (a+o) or f (b-o), for f (a) or f (b), it being assumed that these limits 
exist.  
Functions, with Limited Variation: 
The condition that f (x), in the mean-value theorem, either never increases 
or never diminishes as x increases from a to b, places a restriction upon 
theapplications of the theorem. We can, however, show that a function f(x) 
which is finite and continuous between a and b, except for a finite number 
of ordinary discontinuities, and which only changes from increasing to 
diminishing or vice versa, a finite number of times, as x increases from a to 
b, may be expressed as the difference of two functions f i (x), f 2 (x),neither 
of which ever diminishes as x passes from a to b, and that these functions 
are finite and continuous, except that one or both of them are discontinuous 
at the points where the given function is discontinuous. Let a, S be two 
consecutive points at which f(x) is discontinuous, consider any point x1, 
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such that a< x1-0, and suppose that at the points M 1, M 2. M r between a 
and xi, f(x) is a maximum, and at m1, m 2. m, it is a minimum; we will 
suppose, for example, that the ascending order of values is a, M 1, m1, M2 
i m2 Mr., M r, x1; it will make no essential difference in the argument if m 
i comes before M 11 or if M r immediately precedes xi, M r _ i being then 
the last minimum.  
Let (xi) =[.f(M1)-f(a+o)]+[f(M2)-f(m1) ] + .. +[f (Mr)- f(mr-1)] +[f(x1)- f 
(mr)]; now let x 1 increase until it reaches the value M r+1 at which f(x) is 
again a maximum, then let 1P(x1) [f( Mi)-f(a+)]±[f (M2)-f(mi)l+ + ... M r 
m r-1 Mr +1)f (m r)]; and suppose as x increases beyond the value M r+i, t ' 
(x i) remains constant until the next minimum m,.+1 is reached, when it 
again becomes variable; we see that 1P(x 1) is essentially positive and 
never diminishes as x increases.  
Let x(xi)= [f(M1)-f(m1)l+[f(M2)f(mi)]+ + [f (Mr) f (mr)1; then let x i 
increase until it is beyond the next maximum Mr+i, and Mr+i,  and then let 
x(x i) = [f (Mi) f (mi)] + [f (M2) f (mi)]  + [f (M r) f (mr)] + [f (Mr+1) f 
(xi)] thus x (xi) never diminishes, and is alternately constant and variable. 
We see that '(x1)-x(xi) is continuous as x i increases from a to 0, and that 
>L(xi)-x(xi) =f (x1) f (a+o), and when x i reaches a, we have tP(g)-x(xi) 
=f(a-o) f(a+o). Hence it is seen that between a and / 3, f(x) =[1G(x) 
+f(a+o)]-x(x), where 1'(x)+f(a+o), x(x) are cntinuous and never diminish as 
x increases; the same reasoning applies to every continuous portion of f(x), 
for which the functions 'i(x), x(x) are formed in the same manner; we now 
take f i (x) = (x) f (a+o) +C, f 2 (x) = x(x) +C, where C is constant between 
consecutive discontinuities, but mayhave different values in the next 
interval between discontinuities; the C an be so chosen that neither fi(x) nor 
f 2 (x) diminishes as x increases through a value for which f(x) is 
discontinuous. We thus see that f(x) =fi(x)-f2(x), where f i (x), f2(x) never 
diminish as x increases from a to b, and are discontinuous only where f(x) is 
so. The function f(x) is a particular case of a class of functions defined and 
discussed by Jordan, under the name “functions with limited variation " 
(functions a variation borne); in generalsuch functions have not necessarily 
only a finite number of maxima and minima.  
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Proof of the Convergence of Fourier's Series: 
It will now be assumed that a function f(x) arbitrarily given between the 
values 7r and +7r has the following properties: (a) the function is holds 
however large the odd integer m may be.  
2. Ifo<a<0<2, sifl mzdz snmz dz-I f s sin mz dz sin z sin a a sin i y where a 
< y < 0, hence I f g sin. Mz 2 / 1 J dz < - a Sn z m sin a precisely similar 
proof shows that hence the integrals JP si z z dz, 'a' sin mz dz, converge to 
the limit s zero, as m is indefinitely increased.  
Everywhere numerically less than some fixed positive number, and 
continuous except for a finite number of values of the variable, for which it 
may be ordinarily discontinuous. (b) The function only changes from 
increasing to diminishing or vice versa, a finite number of times within the 
interval; this is usually expressed by saying that the number of maxima and 
minima is finite. These limitations on the nature of the function are known 
as Dirichlet's conditions; it follows from them that the function is integrable 
throughout the interval. On these assumptions, we can investigate the 
limiting value of Dirichlet's  
integral; it will be necessary to consider only the case of a function F (z) 
which does not diminish as z increases from o to 27r, since it has been 
shown that in the general case the difference of two such functions may be 
taken. The following lemmas will be required: I. since sin dz..._ O 3 {1+2 
Cos 2z+2 cos 4z+... +2 cos 2nz} dz = 2 J this result  
To find the limit of fF (z) sin mz dz, written in the form sin z.  
3. If a > o, f! ° dо cannot exceed a value theorem f'` si? J a hence I Lh = J s 
0 1 d0 <-2; in particular if a 7r, f s' e ° d01- < 2. a Again sin B dg = sina 
g da a B a, a> 0, therefore f a sl B B d0 increases as a diminishes, when a 
°° sin B 7r sin B 7r but lim a-of a o de = 2, hence 6 de < 2, a where a <7r, 
and <3 where a L 7r. It follows that s i n mz dz+ f {F(z)-F(0)} in. nzzdz +f 
µ {F(z) -F(0)} s sin z z dz where p. is a fixed number as small as we 
please; hence if we use lemma (t), and apply the second mean-value 
theorem, oF(z) si nyzzdz 2F(0) z = f' {F(z) -F(0)} sin zsin mzdz +{F(µ+o)-
F(o)} rµ ls s z dz+{F(17 o)-F(o)} feiss mz when 1 lies between ? p. and fr. 
When m is indefinitely increased, the two last integrals have the limit zero 
in virtue of lemma (2). To evaluate the first integral on the right-hand side, 
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let G(z) = {F(z)-F(o)} z, and observe that G(z) increases as z increases 
from o to 7 .i, hence if we apply the mean-value theorem G) sin mz dz = 
G(A) f"` sin mz dz ' n µ sin °d0 <7rG(p), where o < < A, since G(z) has the 
limit zero when z =o. If e be an arbitrarily chosen positive number, a fixed 
value of may be so chosen that 7rG (u) < 2e, and thus that f G (z) sinmz dz 
< 2. When has been so fixed, m may now be so chosen that 1rF vd - 2 s F (o) 
<e.  
It has now been shown that when m is indefinitely increased f F (z) s i zzdz 
- 2 F (0) ha s the limit o sin Returning to the form (4), we now 1 (F(z) sin m 
y dz -11 1 F(- z) 70 0 sin z 7r o hence the sum of n+z terms of the series 2l 
j tf (x) dx + 7 2; _f(x i ') nir(x-x1) ax converges to the value 2{ f (x+o) +f 
(x-o) }, or to f(x) at a point where f(x) is continuous, provided f(x) satisfies 
Dirichlet's conditions for the interval from -1 to 1. Proof that Fourier's 
Series is in General Uniformly Convergent. - To prove that Fourier's Series 
converges uniformly to its sum for all values of x, provided that the 
immediate neighborhoods of the points of discontinuity of f(x) are 
excluded, we have IJ " F(z)s in z 2 LZdz F(o) <7rG(A) + m s n {F(?, +o) –
F(0)} s + m sin 1 [F(17-o)-F(o)} < siri %{f (x+2A) - f(x) } +m sin 
{f(x+2p.)-f(x)} 1 {f(x +, r) - f(x)}. m Using this inequality and the 
corresponding one for F(-z), we have IS2.+1(x) f(X) I <72 cosec u [ 
If(x+2u) -f(x) I + If(x - 2 µ) - f(x) +A I m cosec µ, where A is some fixed 
number independent of m. In any interval (a, b) in which f(x) is continuous, 
a value Al of can be chosen such that, for every value of x in (a, b), I f 
(x+2, u) f(x) I, f (x - 2 p.) - f(x) I are less than an arbitrarily prescribed 
positive number provided µ= A1. Also a value of µ can be so chosen that 4/ 
2 cosec /2 where n are an arbitrarily assigned positive number. Take for µ 
the lesser of the numbers then S - f(x) (< n+AI m cosec u for every value of 
x in (a, b). It follows that, since n and m are independent of x, I S2. + 1 –
f(x) I <2e, provided n is greater than some fixed value n i dependent only 
on e. Therefore S 2 7, +1 converges to f(x) uniformly in the interval (a, b). 
 Case of a Function with Infinities. - The limitation that f(x) must be 
numerically less than a fixed positive number throughout the interval may, 
under a certain restriction, be removed. Suppose F(z) is indefinitely great in 
the neighborhood of the point z=c, and is such that the limits of the two 
integrals f c±E F(z)dz are both zero, as is indefinitely diminished, then F(z) 
sin mz dz denotes the limit when o of sin z fcE F(z) sin mz dz {- f 1 F(z) 
sin mz d z, both these limits existing; the sin z c+E sin z first of these 
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integrals has 27rF(+o) for its limiting value when m is 
indefinitelyincreased, and the second has zero for its limit. The theorem 
therefore holds if F(z) has an infinity up to which it is absolutely 
integrable;' this will, for example, be the case if F(z) near the point C is of 
the form x(z) (z-c)'µ+ (z), where x(c), , ' (c) are finite, and o <u <1. It is 
thus seen that f(x) may have a finite number of infinities within the given 
interval, provided the function is integrable through any one of these 
points; the function is in that case still represent able by Fourier's Series.  
The Ultimate Values of the Coefficients in Fourier's Series: 
If f(x) is everywhere finite within the given interval 7r to +7r, it can be 
shown that an, b. n, the coefficients of cos nx, sin nx in the series which 
represent the function, are such that Na n, nbn, however F (0) f + a sin m 
Sn a' f R sin mz 4 a dz <ma' 17. For by the mean 0<a<7r; zero.  
See that the limiting value of sin mz dz is2 {F (+0) +F (-0)}; sin z great n 
is, are each less than a fixed finite quantity. For writing f(x) =fi(x)-f2(x), we 
have f ir 7r f i (x) cos = f i (-7r +0) f cos i (? r-0) f cos nxdx E hence J J J-? r 
with a similar expression, with f 2 (x) for f i (x), being between r and –7r; 
the result then follows at once, and is obtained similarly for the other 
coefficient.  
If f(x) is infinite at x=c, and is of the form ¢(x) K near the point (x-c) c, 
where o< K <1, the integral J f(x)? Cos nxdx contains portions of the form f 
xc J () x cos nxdx x-c) (¢(x) f -E x cos nxdx; consider the first of these, and 
put x = c+u, c it thus J becomes. e 4)(c u) cos n(c+u)du, which is of the 
form o E cos n(c+u) ¢(c fuK du; now let nu =v, the integral becomes o 
¢(+) cos nc ( n€ cos v sin nc nE sin v c 9e n ix U vK dv - nix f o 7T-
dv;hence n'-- K f f(x) cos nxdx becomes, as n is definitely increased, J ir of 
the form ¢(c) cos nc f o - -j V dv-sin nc j o svp Vdv which is finite, both the 
integrals being convergent and of known value. The other integral has a 
similar property, and we infer that n'-Ka n, n i -Kb n are less than fixed 
finite numbers.  
The Differentiation of Fourier's Series: 
If we assume that the differential coefficient of a function f(x) represented 
by a Fourier's Series exists, that function f'(x) is not necessarily represent 
able by the series obtained by differentiating the terms of the Fourier's 
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Series, such derived series being in fact not necessarily convergent. Stokes 
has obtained general formulae for finding the series which represent f'(x), 
f"(x) - the successive differential coefficients of a limited function f(x). As 
an example of such formulae, consider the sine series (I); f(x) is 
representedby 2 I sin - f o f(x) sinnl xdx; on integration by parts we have f 
(x) sin n x dx = n ? [f (+o) t f (l-0) +I cos n i a {f(a + 0) f (a-0) }] + Nom f 
o f’) n i x (x) cos - dx where a represent the points where f(x) is 
discontinuous. Hence if f(x) is represented by the series Fla n sin nlx, and 
f'(x) by the series 1bn cos rtl xx ,we have the relation b n = l 'r an l [f+o) =f 
(l-0) + E cos n a { f (a +0)f(a-0) }] hence only when the function is 
everywhere continuous, and f(+o), f (l-o) are both zero, is the series which 
represents f'(x) obtained at once by differentiating that which represents 
f(x). The form of the coefficient an discloses the discontinuities of the 
function and of its differential coefficients, for on continuing the 
integration by parts we find a n = n [f+o f(l-O) + cosna {f(a +0) f(a-0)}] 1 
22 [f'(+0) f'(l - 0) - I - sin n T – { f' + (0+0) f' (13-0))] +&c.Where l3 are 
the points at which f'(x) is discontinuous.  
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(1.8) WEIGHTED FOURIER SERIES: 
 
We present a novel weighted Fourier series (WFS) representation for 
cortical surfaces. The WFS representation is a data smoothing technique 
that provides the explicit smooth functional estimation of unknown cortical 
boundary as a linear combination of basis functions. The basic properties of  
The representations are investigated in connection swith a self-adjoint 
partial differential equation and the traditional spherical harmonic 
(SPHARM) representation. To reduce steep computational requirements, a 
new iterative  
Residual fitting (IRF) algorithm is developed. Its computational and 
numerical implementation issues are discussed in detail. The computer 
codes are also available at. As an illustration, the WFS is applied in 
quantifying the amount of grayMatter in a group of high functioning 
autistic subjects Within the WFS framework, cortical thickness and gray 
matter density are computed and compared. 
IndexTerms—Cortical thickness, diffusion smoothing gray matter density, 
iterative residual fitting, SPHARM, spherical we have presented a unified 
theoretical framework for WFS and the detailed numerical implementation 
issues. WFS are used as a smooth global parametrization of cortical 
surfaces. It is a very flexible functional estimation technique for scalar and 
vector data projected onto a unit sphere.  
 
WFS is shown to be a solution of a Cauchy problem in PDE, and for a 
specific weights, it becomes diffusion smoothing [10].As a special case of 
WFS when the bandwidth vanishes, the traditional SPHARM can be 
incorporated into this more general framework. However, WFS was shown 
to perform better than SPHARM when data are more noisy and 
discontinuous by not having the significant ringing artifacts. As 
anapplication of this novel approach, we used WFS as a tool for comparing 
the gray matter and the cortical thickness in a single mathematical 
framework. Using the WFS representation as the ground truth, cortical 
thickness and gray matter density are constructed and compared. In 
thecortical thickness analysis, the thickness is defined using the WFS-
correspondence. Afterwards, the SPM of thickness and gray matter density 
 
 Are compared to show the statistically significant regions do not overlap. 
This surprising result is caused by the negative correlation between 
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densities and thickness. Increased folding increases the gray matter density 
while decreasing thickness. This should serve as a spring board for more 
thorough investigation on comparing cortical thickness and density based 
morphometric techniques such as VBM. 
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(1.9) WEIGHTED FOURIER SERIES APPROXIMATION:  
For a continuous-time, T-periodic signal x (t), The N-harmonic Fourier  
series approximation can be written as 
x(t) = a0 + a1 cos (wot + Ə 1) + a2 cos (2wot + Ə 2) 
 + ... + aN cos (Nwot + Ə N)  
Where the fundamental frequency wo is 2Π /T rad/sec, the amplitude 
 Coefficients a1,..., aN are non-negative, and the radian phase angles satisfy 
0 ≤ Ə1 , ..., ƏN < 2 Π. To explore the Fourier series approximation, select a 
labeled signal, use the mouse to sketch one period of a signal, or use the 
Mouse to modify a selected signal. Specify the number of harmonics, N, 
and click "Calculate." The approximation will be shown in red. In 
Addition, the magnitude spectrum (a plot of an vs. n) and phase spectrum (a 
Plot of   Ən vs. n) are shown. (If the dc-component is negative, a0 < 0, then 
|a0| is shown in the magnitude spectrum and an angle of Π radians is shown 
in the phase spectrum.) To see a table of the coefficients, click "Table."  
The Importance of Proper Weighting Methods: 
The importance of good weighting methods in information retrieval - - 
methods that stress the most useful features of a document or query 
representative - - is examined. Evidence is presented that good weighting  
Methods are more important than the feature selection process and it is  
Suggested that the two need to go hand-in-hand in order to be effective. 
The Paper concludes with a method for learning a good weight for a term 
based upon the characteristics of that term. 
Other than experimental results, the first part of this chapter contains little 
new material. Instead, it's an attempt to demonstrate the relative importance  
And difficulties involved in the common information retrieval task of 
forming documents and query representatives and weighting features. This 
is the sort of thing that tendsTo get passed by word of mouth if at all and 
never gets published. 
 However, there is a tremendous revival of interest in information retrieval;  
Thus this attempts to helpAll those new people just starting in experimental 
information retrieval. 
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A common approach in many areas of natural language processing is to 
 
1. Find "features" of a natural language excerpt. 
2. Determine the relative importance of those features within the excerpt. 
3. Submit the weighted features to some task- appropriate decision 
procedure. 
This presentation focuses on the second sub: task above: the process of 
weighting features of a natural language representation. Features here could 
Be things like single word occurrences, phrase occurrences, other 
relationships between words, and occurrence of a word in a title, part-of-
speech of a word, automatically or manually assigned categories of a 
document, citations of a document, and so on. The particular overall task 
addressed here is that of information retrieval - finding textual documents 
(from a large set of documents) those are relevant to a user's information 
need. Weighting features is something that many information retrieval 
systems seem to regard as being of minor importance as compared 
forfinding the features in the first place; but the experiments described here 
suggest that weighting is considerably more important than additional 
feature selection. This is not an argument that feature selection is 
unimportant, but that development of feature selection and methods of 
weighting those features need to precede hand-in-hand if there is to be hope 
of improving performance. There have been many papers (and innumerable 
unpublished negative result experiments) where authors have devoted 
tremendous resources and intellectual insights into finding good features to 
help represent a document, but then weighted those features in a haphazard 
fashion and ended up with little or no improvement. This makes it 
extremely difficult for a reader to judge the worthiness of a feature 
approach, especially since the weighting methods are very often not 
described in detail. Long term, the best weighting methods will obviously 
be those that can adapt weights as more information becomes available. 
Unfortunately, in information retrieval it is very difficult to learn anything 
useful from one query that will be applicable to the next. In the routing or 
relevance feedback environments, weights can be learned for a query and 
then applied to that same query. But in general there is not enough overlap 
in vocabulary (and uses of vocabulary) between queries to learn much 
about the usefulness of particular words. The second half of this chapter 
discusses an approach that learns the importantCharactericstics of a good 
term. Those characteristics can then be used to properly weight all terms. 
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 Several sets of experiments are described, with each set using different 
types of information to determine the weights of features. All experiments 
were done with the SMART information retrieval system, most using the 
TREC/TIPSTER collections of documents queries, and Relevance 
judgments. Each run is evaluated using the "ll-point recall-precision 
average" evaluation method that was standard at the TREC 1 conference. 
 
 The basic SMART approach is a completely automatic indexing of the full  
Text of both queries and documents. Common meaningless words (like 
'the' or 'about') are removed, and all remaining words are stemmed to a root 
form. Term weights are assigned to each unique word (or other feature) in a 
vector by the statistical/learningProcesses described below. The final form 
of a representative for a document (or query) is a vector D~ = (w~, l, w~, 
2... wi, ~) where D~ represents a document (or query) text and w~, k is a 
term weight of term Tk attached to document Di. The similarity betweena 
query and document is set to the inner product of the query vector and 
document vector; the information retrieval systems as a whole will re-Turn 
those documents with the highest similarity to the query. 
 
 AD-HOC WEIGHTS: 
 
Remains that they are used because they work well, rather than 
anytheoretical reason. Table 1 presents the evaluation results of running a 
number of t f*I d f variants for query weighting against a number of 
variants for document weighting (the runs presented here are only a 
Document or query weights can be based on any number of factors; two 
would be statistical occurrence information and a history of how well this 
features (or other similar features) have performed in the past. In many 
situations, it's impossible to obtain history information and thus initial 
weights are often based purely on statistical information. A major class of 
statistical weighting schemes is examined below, showing that there is an 
enormous performance range within the class. Then the process of adding 
additional features to a document or query representative is examined in the  
Context of these weighting schemes. These are issues that are somewhat 
subtle and are often overlooked. 
 
 
 
 
 48
T f * I d f Weights: 
 
Over the past 25 years, one class of term weights has proven itself to be 
useful over a wide variety of collections. This is the class of t f*I d f (term 
frequency times inverse document frequency) weights [1, 6, 7], that assigns 
weight wik to term T k in document/)i in proportion to the frequency of 
occurrence of the term in D~, and in inverse proportion to the number of 
documents to which the term is assigned. The weights in the document are 
then normalized by the length of the document, so that long documents are 
not automatically favored over short documents. While there have been 
some post-facto theoretical justifications for some of the t f*I d f weight 
variants, the fact small subset of the variants actually run). 
 
 All of these runs use the same set of features (single terms), the only 
differences are in the term weights. The exact variants used aren't 
important; what is important is the range of results. Disregarding one 
extremely poor document weighting, the range of results is from 0.1057 to 
0.2249. Thus a good choice of weights may gain a system over 100%. As 
points of comparison, the best official TREC run was 0.2171 (a system 
incorporating a very large amount of user knowledge to determine features) 
and the median TREC run in this category was 0.1595. The best run 
(DOCWT = l n c, QWT = l t c), is about 24% better than the most generally 
used t f*I d f run (DOCWT = QWT = n t c). 24%is a substantial difference 
in performance, in a field where historically an improvement of 10% is 
considered quite well. The magnitude of performance improvement due to 
considering additional features such as syntactic phrases, titles and parts of 
speech is generally quite small (0 - 10%). Adding features and using good 
weights can of course be done at the same time; but the fact that somewhat 
subtle differences in weighting strategy can overwhelm the effect due to 
additional features is worrisome. This means the experimenter must be very 
careful when adding features that they do not change the appropriateness of 
the weighting strategy. 
 
Adding New Features: 
 
Suppose an experimenter has determined a good weighting strategy for a 
basic set of features used to describe a query or document and now wishes 
to extend the set of features. In the standard t f* I d f, cosine-normalized 
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class of weights, it is not as simple as it may first appear. The obvious first 
step, making sure the weights before normalization of the new set of 
features and the old set are commensurate, is normally straightforward. But 
then problems occur because of the cosine normalization. ForExample, 
suppose there were two documents in a collection, one of them much 
longer then the other: 
 
• Di = (w1,1, wl,2, wl,3) • D2 = (w2,1,w~,2,...w2,100) 
Now suppose the new approach adds a reasonably constant five features 
onto each document representative. (Examples of such features might be 
title words, or categories the document is in.) If the new features are just 
added on to the list of old features, and then the weights of the features are 
normalized by the total length of the document, then there are definite 
problems. Not only does the weight of the added features vary according to 
the length of the document (that could very well be what is wanted), but the 
weights of the old features have 350 changed. A query that does not take 
advantage of the new features will suddenly find it much more difficult to 
retrieve short documents like D1. D1 is now much longer than it was, and 
therefore the values of WL, k has all decreased because of normalization. 
 
Similarly, if the number of new added features tends to be much more for 
longer documents than short (for example, a very loose definition of 
phrase), a query composed of only old features will tend to favor short 
documents more than long (at least, more than it did originally). Since the 
original weighting scheme was a supposedly good one, these added 
features will hurt performance on the original feature portion of the 
similarity. The similarity on the added feature portion might help, but it 
will be difficult to judge how much. These normalization effects can be 
very major effects. Using a loose definition of phrase on CACM (a 
smalltest collection), adding phrases in the natural fashion above will hurt 
performance by 12~0. However, if the phrases are added in such a way that 
the weights of the original single terms are not affected by normalization, 
then the addition of phrases improves performance by 9%. 
 
One standard approach when investigating the usefulness of adding 
features is to ensure that the weights of the old features remain unchanged 
throughout the investigation. In this way, the contribution of the new 
features can be isolated and studied separately at the similarity level. [Note  
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That if this is done, the addition of new features may mean the re-addition 
of old features, if the weights of some old features are supposed to be 
modified.] This is the approach we've taken, for instance with the 
weighting of phrases in TREC. The single term information and the phrase 
information are kept separate within a document vector. Each of the 
separate sub vectors is normalized by the length of the single term sub 
vector. In this way, the weights of all terms are kept commensurate with 
each other, and the similarity due to the original single terms is kept 
unchanged. The investigation of weighting strategies for additional features 
is not a simple task, even if separation of old features and a new feature is 
done. For example, JoelFagan in his excellent study of syntactic and 
statistical phrases [2] spent over 8 months looking at weighting strategies. 
 But if it's not designed into the experiment from the beginning, it will be 
almost impossible. 
 
Relevance Feedback: 
 
One opportunity for good term weighting occurs in the routing 
environment. Here, a query is assumed to represent a continuing 
information need, and there have been a number of documents already seen 
for each query, some subset of which has been judged relevant. With this 
wealth of document features and information available, the official TREC 
routing run that proved to be the most effective was one that took the 
original query terms and assigned weights based on probability of 
occurrence in relevant and non-relevant documents.  Once again, 
weighting, rather than feature selection, worked very well. (However, in 
this case the feature selection process did not directly adversely affect the 
weighting process. Instead, it was mostly the case that the additional 
features from relevant documents were simply not chosen or weighted 
optimally.) In this run, using the RPI feedback model developed. 
Relevance feedback information was used for computing the feedback 
query term weight q~ of a term as p~ (1 –ri)/ [ri (1 -Pi)] - 1 Here Pi is the 
average document term weight for relevant documents, and ri is the 
corresponding factor for no relevant items. Only the terms occurring in the 
query was considered here, so no query expansion took place. Having 
derived these query term weights, the query was run against the document 
set. Let di denote the document term weight, then the similarity of a query 
to a document is computed by S (q, d) = ~] (log (qi * di + 1)) 
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LEARNING WEIGHTS BY TERMFEATURES: 
 
The ad-hoc t f*I d f weights above use only collection statistics to 
determine weights. However, if previous queries have been run on this 
collection, the results from those queries can be used to determine what 
term weighting factors are important for this collection. The final term 
weight is set to a linear combination of term weight factors, where the 
coincident of each factor is set to minimize the squared error for the 
previous queries [4, 5]. The official TREC runs using this approach were 
nearly the top result; which was somewhat surprising given the very limited 
and inaccurate training information which was available. This approach to 
earning solves the major problem of learning in an ad-hoc environment: the 
fact that there is insufficient information about individual terms to learn 
reasonable weights. Most document terms have not occurred in previous 
queries, and therefore there is no evidence that can be directly applied.  
 
Instead, the known relevance information determines the importance of 
features of each term. The particular features used tires 1 were 
combinations of the following term factor’s f: within-document frequency 
of the term 351 log I d f: log ((N + l) / n), where N is the number of 
documents in the collection and n is the number of documents containing 
the term lignum terms: log (number of different terms of the document) i m 
a x t f: 1 / (maximum within-document frequency of a term in the 
document). 
 
After using the relevance information, the final weight for a term in a 
TREC 1 document was W (t,) = 0.00042293 +0.00150083 * t f* log I d f* 
imaxtf +-0.00150665 • t f* imaxtf +0.00010465 * log i d f +-0.00122627 * 
lignum terms • imaxtf.There is no reason why the choice of factors used in 
TREC 1 is optimal; slight variations had been used forum earlier 
experimentationisprogressingon the choice of factors, especially when 
dealing with both single terms and phrases. However, even so, the TREC 1 
evaluation results were very good. If the minimal learning information used 
by this approach is available, the results suggest it should be preferred to 
the ad-hoc weighting schemes discussed earlier. 
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Tile sets of experiments described above focus on feature weighting and 
emphasize that feature weighting seems to be more important than feature 
selection. This is not to say that good feature selection is not needed for 
optimal performance, but these experiments suggest that good weighting is 
of equal importance. Feature selection is sexy and weighting isn't, but 
optimal performance seems to demand that weighting schemes and feature 
selection need to be developed simultaneously. 
Weighted sum of FS approximations variablesA statistic involving a 
weighted sum of random variables is frequently used in Statistical 
inference. When independence between the random variables is a 
reasonable assumption, weighted sums have several desirable properties. 
For instance, calculations of distribution characteristics [e.g., i h t and 
second order moments, various generating functions) wiU be greatly 
simple Med if independence of the variables in the sum may be assumed. 
The key statistical functional that w i l I be explored in detail in the next 
chapter is linear combinations of independent random variables. 
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(1.10) PARAMETRE ESTIMATION – W F S A: 
New morph metric frame work called the weighted Fourier series 
representation through approximation. The WFS is both a global high 
hierarchical parameterization and explicit data smoothing techniques 
formulated as a Fourier series approximation. WFS approximation 
generalized the traditional spherical harmonic representation with 
additional exponential weights. 
Unlike spherical harmonic, WFS approximation can be formulated as 
Kernel smoothing when the self ad joint operator becomes the Lap lace 
Beltrami Operator. The Similar Kernel smoothing, the random field theory 
can be used for statistical inference on localizing abnormal shape variation 
in a clinical population. Many basic theoretical properties of WFS 
approximation and its numerical implementation issues are considered in 
great depth. WFS approximation and its umbilical implementation issues 
are considered in great depth. WFS approximation requires estimating good 
numbers of unknown Fourier coefficients on a high resolution sample. This 
requires a specialized linear solver with fairly steep computational 
resources. 
To address this issue, we have to develop a new estimator technique called 
the iterative residual fitting algorithm. The correctness of the algorithm will 
be proved and its accuracy is numerically evaluated.  
The development of the underlying theory of the WFS approximation and 
its numerical implementation using the irruptive residual fitting algorithm. 
In following details, I will review the literature that is directly related to 
research methodology and address what specific hypothesis are in the 
context of the previous literature. 
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Smoothing process weighted Fourier series Approximation. 
I will investigate the properties of the finite expansion of linear operator L, 
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The expansion will be called as the weighted Fourier series approximation. 
By rearranging the inner product, the WFS approximation can be rewritten 
as kernel smoothing 
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Various theorems developed and tested. 
Numerical implementation- In constructing WFS approximation, aii I need 
is essential Fourier coefficients. There are three major techniques for 
computing the Fourier coefficients. 
Normal equation in statistical literatures, 
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The normal equation usually solved via a matrix inversion. 
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Rationale: 
 
In 1822, the French mathematician J.B. Fourier, Showed that any arbitrary 
periodic function could be represented by an infinite sum of sinusoids of 
harmonically related frequencies in terms of series , Several words in this 
sentence need clarification at this point. A continuous function f(t) is said 
to be periodic with period T if f(t) = f (t +T) for any T. Of special interest to 
us are the sinusoids  
 
 
 
1 0
2 0
2          cos  cos    
2   sin  sin    
nf t t n w t
T
nand f t t n w t
T


    
    
 
 
Where n is any integer (or Zero). Each frequency of the sinusoids 
0
2  nn w
T
  is said to be the nth harmonic of the fundamental w thus a 
periodic wave will be described in terms of its fundamental frequency, its 
second harmonic, third harmonic etc. Where each of these frequencies is 
simply related to the period T. Note that the fundamental frequency and 
period are related as follows: 0 0
2 2w f
T
   
 
Where 0f  is the fundamental frequency in cycles per second or  0,ZH w    
is the fundamental frequency in radians per second (rad/s), and T is the 
period in seconds per cycle. 
A square wave can be built up from a sum of harmonically related sine 
waves. The sum begins to approach a square wave as more terms are 
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added. Higher frequency is needed to reproduce the sharp corners of the 
square wave will be derived below: 
If f (t) is periodic, the Fourier series is        
             
  0 1 0 2 0 0
1 0 0
cos  cos  2 ... cos   
               sin ... sin
n
n
f t a a w t a w t a n w t
b w t b nw t
   
    
 
The series can be written in a number of equivalent forms, one of which is 
obtained by recognizing that for all n. 
 
   0 1 0 0cos   sin cos   n n na n w t b w t C n w t     
 
Where  2 2 1tan nn n n n
n
b
C a b and
a
     
 
Combining pairs of terms gives the equivalent from of the Fourier series, U 
(p) to every point, so that,  
    2, U p    tifeu t p R e      
 
We need a preliminary result, show a ray directed along an arbitrary axis 
O ZO . The disturbance is given by  
 
 , cos 2   t zu t Z a
T
 
          
 
 
Where, ,     T and   are the period, wave length, and a constant phase 
angle, and the wave velocity v T  is directed towards the right. 
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Let Q and P be arbitrary fixed points on ZO . 
 
In an obvious notation 
 
 
 
, cos 2   
, cos 2   
Q
Q
p
P
Ztu t Z a
T
Ztu t Z a
T


 
 
        
        
 
 
The corresponding pharos or complex amplitudes at Q and P are 
QU  , PU  
given by  
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The out -of-step behavior of the oscillations at Q and P is defined by the 
phase difference  
 2QP P Q P QZ Z          
 
Phase change  QP    along the ray QP 
If   
21 1    8
2 2
hh x h and
r
   ?     then    
 2 sinQP r x         With an error << 2 ( )radians  
Note that the approximation to  QP    is linear  
   0 1 0 1 0( ) ...... ....n nf t C C Cos w t Cos nw t         
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0 0C a    And all other n nC a n d    defined earlier. 
Additionally: for a continuous time, T periodic signal X (t), the N- 
harmonic Fourier series approximation can be written as  
    
 0 1 0 1 2 0 20
( ) 2
              ....... N N
x t a a Cos w t a Cos w t
a Cos Nw t
 

    
    
Where the fundamental frequency 0w  is 2
T
  rad /sec, the amplitude 
coefficients 1,................, Na a  are non-negative, and the radian phase angles 
satisfy  1,...................,0 2N     
 
Under diffraction from a uniformly radiating strip; consider the half-space 
Z > 0, crises-crossed by traveling waves all having the same frequency f 
and wave-length . At every point P there is a disturbance u (t, p) produced 
by superposition of all the rays passing through P, and interference between 
rays determines the resultant amplitude and phase of the oscillation at P. 
Instead of using u (t, p), we shall assign a pharos, or complex amplitude in 
X sin  . 
  
Various consideration of Fourier series concepts like periodic functions, 
coefficients, functions of finite range spectrum. Sine and cosine transforms, 
exponential expressions, other scientific function will be tested for Fourier 
series approximation. 
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(1.11) BIOMEDICAL ALGORITHM: 
 
The volume of biomedical text is growing at a fast rate, creating challenges 
for humans and Computer systems alike.  One  of  these  challenges  arises  
from  the  frequent  use  of  novel abbreviations  in  these  texts,  thus  
requiring that biomedical lexical ontologies be continually Updated.  We 
show that the problem of identifying abbreviations’ definitions can be 
solved with a much simpler algorithm than that proposed by other research 
efforts.The Algorithm achieves 96% precision and 82% recall on a standard 
testCollection, which is at least As good as existing approaches.  It also 
achieves 95% precision and 82% recall on another, larger test set. A 
notable advantage of the algorithm is that, unlike other approaches, it does 
not require any training data.   
There has been an increased interest recently in techniques to automatically 
extract Information from biomedical text, and particularly from MEDLINE 
the size and growth rate of biomedical literature creates new challenges for 
Researchers who need to keep up to date. One specific issue is the high rate 
at which new abbreviations are introduced in biomedical texts.  Existing 
databases, ontologies, and ictionaries must be continually updated with new 
abbreviations and their definitions.  In an attempt to help resolve the 
problem, new techniques have been introduced to automatically extract 
abbreviations and their definitions From MEDLINE abstracts.  
 we  propose  a  new,  simple,  fast  algorithm  for  extraction  of 
Abbreviations from biomedical text.  The scope of the task addressed here 
is the same  as  the  one  described  in  Pustejovsky  et  al.:14  identify  
<“short  form”,  “long Form”> pairs where there exists a mapping (of any 
kind) from characters in the short Form to characters in the long form.  
 We use the terms “short form” and “long form” interchangeably with 
“Abbreviation” and “definition”.  We also use the term “short form” to 
indicate both abbreviations and Acronyms, conflating these as have 
previous authors.  
Many abbreviations in biomedical text follow a predictable pattern, in 
which the first letter of each word in the long form corresponds to one 
letter in the short Form, as in methyl methanesulfonate sulfate (MMS).  
However, there are many cases in which the correct match between the 
short form and long form requires words in The long form to be skipped or 
matching of internal letters in long formwords, as in Gcn5-related N-
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acetyltransferase (GNAT.we describe a very simple, Fast algorithm for this 
problem that achieves both high recall and high precision.  
 
Related Works:  
 
Pustejovsky et al.13, 14 present a solution for identifying  abbreviations 
based on hand-built regular expressions and syntactic  information to 
identify boundaries of Noun phrases. When a noun  phrase  is  found  to  
precede  a  short  form  enclosed  in parentheses,  each  of  the  characters  
within  the  short  form  is matched  in  the  long Form. A score is assigned 
that corresponds to the number of non-stopwords in the long  form  divided  
by  the  number  of  characters  in  the  short  form.  If the result is below a 
threshold of 1.5, then the match is accepted. This algorithm achieved 72% 
Recall and 98% on “the gold standard,” a small, publicly available 
evaluation corpus that this group created, working better than a similar 
algorithm that does not take Syntax into account b Pustejovsky et al.13 also 
summarize some  drawbacks of other earlier pattern based approaches, 
noting  that  the  results of Taghva et al.17 look good (98% precision  and  
93%  recall  on  a  different  test  set),  but  do  not  account  for 
abbreviations whose letters may correspond to a character internal  to  a  
definition Word, a common occurrence in biomedical text. They also find 
that the Acrophile Algorithm of Larkey ET al.8 does not perform well on 
the gold standard. Chang ET al.5 presents an algorithm that uses linear 
regression on a pre-Selected Set of features, achieving 80% precision at a 
recall level of 83%, and 95% precision at 75% recall on the same 
evaluation collection (this increases to 82% recall and 99% precision on a 
corrected version).c their algorithm uses dynamic programming to find 
potential alignments between short and long form, and uses the results of 
this to compute feature vectors for correctly identified definitions. They 
then use binary Logistic regression to train a classifier on 1000 candidate 
pairs. 
Yeates ET al.19 examines acronyms in technical text.  They address a more 
 Difficult problem than some other groups in that their test set includes 
instances that do not have distinct orthographic markers such as  
Parentheses to indicate the B There is some errors in the gold standard.  
The results reported by Pustejovsky ET al.13 is on a Variation of the gold 
standard with some Corrections, but the actual corrections made are not 
reported in   Unfortunately, the corrections needed on the standard are not 
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Standardized. C Personal communication. Proximity of a definition to an 
abbreviation (they report that only two thirds of the Examples take this 
form). Their algorithm creates a code that indicates the distance of the 
definition words from the corresponding characters in the acronym, and 
uses Compression to learn the associations.  They compile a large 
estcollectionConsisting of 1080 definitions; training on two thirds and 
testing on the remainder, reporting the results on a Precision/recall curve. 
Park and Byrd12 present a rule-based algorithm for extraction of 
abbreviation Definitions from general text. The algorithm creates rules on 
the fly that model how the short form can be translated into the long form.  
They create a set of five Translation rules, a set of five rules for 
determining candidate long forms based on their length and a set of six 
heuristics for determining which definition to choose if there are many 
potential candidates. These are: syntactic cues, rule priority, distance 
between definition and abbreviation, capitalization criteria, number of 
words in the Definition and number of stop words in the definition. Rule 
priority is based on how often the rule has been applied in the past. They 
evaluate their algorithm on 177 abbreviations taken from engineering texts, 
achieving 98% precision and 95% Recall. No mention is made of the size 
and nature of the training set or whether it was distinct from the test set.  
Yu ET al.21 presents another rule-based algorithm for mapping 
abbreviations to their full forms in biomedical text. Their algorithm is 
similar to that of Park and Byrd. For a given short form, the algorithm  
extracts  all  the  candidate  long  forms that  start  with  the  same  
character as the short form.  The algorithm then tries to match the  
candidate  long  forms  to  the  short  form  starting  from  the  shortest  
long Form, by iteratively applying 5 pattern-matching rules. The rules 
include heuristics such as prioritizing matching the first character of a  
word,  allowing  the  use  of internal letters  only  if  the  first  letter  of  a  
word was matched, and so on.  The algorithm was evaluated on a  Small 
collection of biomedical text containing 62 Matching pairs, achieving 95% 
precision and 70% recall on average.Adar2 presents an algorithm that 
generates a set of paths through the window of text  adjacent  to  an  
bbreviation  (starting  from  the  leftmost  character),  and  scores these 
paths to find the most likely definition. Scoring rules used include “for 
every Abbreviation character that occurs at the start of a definition word, 
add 1”, and “A bonus point is awarded for definitions those are  
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Immediately adjacent to the Parenthesis”. After processing a large set of 
abbreviation-definition pairs, the results are clustered in order to identify 
spelling variants among the definitions. N-gram clustering is coupled with 
lookup into the Mesh hierarchy to further improve the Clusters. 
Performance on a smaller subset of the gold standard yielded 85% recall 
and 94% precision;  the  author  notes  that  2  definitions  identified  by  
his  algorithm Should have been marked correct in the standard, resulting in 
a precision of 95%.d  D Results verified through personal communication 
with the author.  
The work described in this paper arose because the authors found 
difficulties making  the  Park  and  Byrd  algorithm  work  well  on  
biomedical  text.  The rules it produces are very specific to the format of 
candidate abbreviations, and so many Abbreviations were being 
represented by patterns that had not yet been ncountered by the algorithm, 
and thus rule priority was not often applicable. The approach closest to the 
one we present here is the algorithm of Yoshida et Al.20 their algorithm 
assumes that the definition or the abbreviation occurs adjacent to 
parentheses, but their paper does not state how the length of candidate 
definitions Is determined. Their algorithm scans words from the end of the 
abbreviation and Candidate definition to the beginning, trying at each 
iteration to find a match for the Substring of the abbreviation in the 
definition. The algorithm assumes that in order For a character from the 
bbreviation to be represented in the interior of a word in the definition, 
there must be a match of some other character from the abbreviationOn the 
first letter of that word.  In addition, characters that matches in the interior 
of the  word  must  either  be  adjacent  to  one  another  following  that  
initial  letter,  or Adjacent to one another following a syllable boundary.  
Each iteration of thealgorithm  requires  a  check  to  see  if  a  subsequence  
can  be  properly  formed According to these rules. They test this algorithm 
on a very large collection (They had an independent assessor evaluate more 
that 15,000 categorizations), achieving 97.5% precision and 95.5% recall. 
Another important processing issue for abbreviations is disambiguation of 
multiple senses of the same short form. Pustejovsky et al.13 describe an 
algorithm that  yields  abbreviation  sense  disambiguation  accuracies  of  
98%,  and Pakhomov9 Achieves accuracies of 89% on clinical records.  
Yet  another  issue  is  normalization  of  different  spellings  of  the  same 
Abbreviation. It is difficult to define what it means for two biomedical 
terms to refer to the same concept; Cohen ET al.6 provides one set of rules.  
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 Methods and Implementation:  
 
Identifying Short Form and Long Form Candidates  
The process of extracting abbreviations and their definitions frommedical 
text is composed of two main tasks. The first is the extraction of <short-
form, long-form> Pair candidates from the text. The second task is 
identifying the correct long form from among the candidates in the 
Sentence that surrounds the short form. Most approaches, including the one 
presented here, use a similar method for finding Candidate pairs. 
 
 Abbreviation candidates are determined by adjacency to Parentheses.      
The two cases are:    
 1) Long form ‘(‘short form ‘)’ and (ii) Short form ‘(‘long form ‘) In         
practice,  most  <short  form,  long  form>  pairs  conform  to  pattern  (i). 
whenever the expression inside the parentheses includes more  than  two  
words, pattern  (ii)  is  assumed,  and  a  short  form  is  searched  for just 
before the left Parenthesis (word boundaries are indicated by spaces). Short 
forms are considered valid candidates only if they consist of at most two 
words, their length is between two to ten characters, at least  one  of  these  
characters  is  a  letter,  and  the  first Character is alphanumeric. For 
simplicity, pattern (i) is assumed in the discussion below.   
 The  next  step  is  to  identify  candidates  for  the  long  form.  The long         
form candidate must  appear  in  the  same  sentence  as  the  short  
form,and as in Park and Byrd12, it should have no more than min (|A| + 5, 
|A| * 2) Words, where |A| is the Number of characters in the short form.  
Although the algorithm of Park and Byrd allows for an offset between the 
short and long forms, we consider only long forms that are adjacent to the 
short form. For a given short form, a long form candidate is composed of 
contiguous words from the original text that include the word just before 
the short form.   
 
Algorithm for Identifying Correct Long Forms:   
 
When the previous steps are completed there is a list of long formcandidate 
wordsfor  the  short  form,  and  the  task  is  to  choose  the  right  subset  
of words.  Figure 1Presents the code that performs this task. The main idea 
is: starting from the end of both the short  form  and  the  long  form, move  
right  to  left,  trying  find  the  shortest Long form that matches the short 
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form. Every character in the short form must match a character in the long 
form and the matched characters in the long form must be in the same order 
as the characters in the short form. Any character in the long form can 
match a character in the short form, with  one  exception:  the  match  of  
the character  at  the  beginning  of  the short form must match a character 
in  the  initial Position of the first (leftmost) word in the long form (this 
initial position can be the first letter  of  a word  that  is  connected  to  
other words  by  hyphens  and  other  nonalphanumeric Characters).  
The implementation in Figure 1 uses two indices, lIndex for the long form, 
and SIndex for the short form. The two indices are initialized to point to the 
end of their Respective strings. For each character sIndex points to, lIndex 
is decremented until a Matching character is found.  If lIndex reaches the 
beginning of the long form candidate list before sIndex does, the algorithm 
returns null (no match found).   
 
An Alternative Algorithm: 
  
When we began to investigate the problem of abbreviation 
definitionidentification, we devised a much more complex algorithm than 
that presented here.  This Algorithm uses the representation of Park and 
Byrd12 in combination with a variation on the decision lists algorithm, as 
applied by Yarowsky18 to the lexical ambiguity Resolution task. The 
algorithm makes use of training data to rank features that are Combinations 
of matching rule transformations.space restrictions prevent detailed 
description of that algorithm (the interested reader should refer to Schwartz 
and Hearst16 for a complete description of the Algorithm). 
However,  we  found  that  it  performed  mildly  better  than  our  simple 
Algorithm on both training sets, achieving for the gold standard 97% 
precision and 82% recall, which is a reduction in error of 17% over the 
simpler algorithm. For the larger test collection, it achieves 96% precision 
and 82% recall, which is an error Reduction of 22% over the simpler 
algorithm.  
                                                           
The dataset was originally annotated by a graduate student in 
computational and biosciences. WeFurthered verified the data by 
comparing any questionable pairs against other occurrences of the 
SameAbbreviation in other abstracts, using the web site provided by Chang 
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ET al.5 a pair extracted by the Algorithm is considered correct only if it 
exactly matches a pair labeled in the dataset.  
Because the simple algorithm is so much easier to implement and requires 
no training data, we recommend its use, in combination with checking 
    The entire Data set for redundancy in definitions in order to further 
reduce   the error rates.  
    We introduced a new algorithm for extracting abbreviations and their 
Definitions from biomedical text. Although the algorithm is 
extremelysimple, it is highly effective, and is less specific – and therefore 
less potentially brittle – than other approaches that use carefully crafted 
rules. 
   Although we are staunch advocates of machine learning approaches for 
problems in computational linguistics, it seems that in the case of this 
particular problem, simpler is better. One can argue that the problem may  
vary  across  collections  or  languages,  and  so  machine  learning  can 
help  in  these  cases,  but  our  experience  with  a  machine  learning  
approach to Sentence boundary determination11 suggests that most 
practitioners do not want to bother with labeling training data for relatively 
simple tasks.  
   Another  advantage  of  the  simplicity  of  the  algorithm  is  its  fast 
running time Performance. The task of extracting the definition of an 
abbreviation, is a common pre-processing step of larger  multi-layered  
text-mining  tasks.1,  10  Therefore,  it  is essential  that  this  step  be  as  
efficient as possible.  Since our algorithm needs toconsider  only  one  
possible  long  form  per  short  form,  it  is  much faster than the 
Alternative algorithms that first extracts many possible long forms and then 
pick the Best of them.  To provide a rough comparison,  using an IBM T21 
laptop with a Single CPU (800 MHz, 256 Mb RAM) running MS-Windows 
2000, it takes our Algorithm about 1 second to process 1000 abstracts, 
while the algorithm in Chang et al.5 using a 5 Processor Sun Enterprise 
E3500 server, processed only 25.5 abstracts Per second. While our 
algorithm is clearly I/O bound (running time depends almost entirely on the 
time it takes to read the files from disk, and write the results back to the 
disk), the algorithms of Chang et al. seem to be heavily CPU bound. The 
algorithm performs better or the same as the best results of other work, 
with the possible exception of that of Yoshida et al.20 However, the main 
advantage of the proposed algorithm over the alternatives are its simplicity, 
and transparency. It was implemented with 260 lines of Java code and 
requires no training data to run. 
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   The Yoshida et al.  Algorithm is more complex, in that it requires a 
module for Recognizing syllable boundaries, and it performs a substring 
check at each iteration of the loop. Analysis of the errors produced  
indicates that further improvement of the Algorithm requires the use of 
Syntactic information, as suggested in Pustejovsky et al.13 shallow parsing 
Of the text as a preprocessing step might help correct some of the 
errorsInherent in the algorithm, by helping to identify the noun phrases 
near the Abbreviations.  In addition, combining evidence from more than 
one MEDLINE abstract  at  a  time,  as  was  done  in  Adar2,  might  also  
prove to be beneficial for Increasing both precision and recall. Finally, the 
algorithm currently only considers candidate definitions when the 
abbreviation is enclosed in parentheses (and vice Versa); finding all 
possible pairs is a more difficult problem and requires additional Study.  
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(1.12) ORGANISATION OF THESIS: 
 
Chapter 1 Deals with Introduction of a biomedical statistics, biomedical 
statistical inference, importance of biomedical statistics,use of 
biostatistics,application of biostatistics,fourier series, weighted fourier 
series,weighted fourier series approximation,parameter estimations-WFSA 
and Algorithm. 
Chapter 2 Discuss Literature review of a fourier series. 
In Chapter 3 Research Methodology is presented. 
In Chapter 4 Objectives and hypothesis of study are discussed. 
Chapter 5 Includes Data analysis and Description by using frequence          
table, t-test, f-test Chi-Square t-test and logestics regression. 
Chapter 6 Discusses concluding remark and future prospects 
Chapter 7 presents some case study of a cancer like Brest cancer, survival 
cancer, lung cancer etc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
 
Literature review 
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CHAPTER 2 LITERATURE REVIEW: 
 
Literature review: 
Over the last few decades there has been a dramatic surge in the number of 
published Articles that show different ways of implernenting exact methods 
for a variety of Applications (March, 1972; Baker, 1977; Mehta and Patel, 
1980, 1983; Hajj et al, 1987; Pagans and Twitchier, 1983; snitcher, 1984). 
The different approaches that Appeared in the literature fail in one of the 
following three categories: 
 Exhaustive enumerations (e-g. March, 1972) Graph-theory basics network 
algorithm (e-g. Hajji et al., 1987) Recurrence relations and Fourier 
transform (e.g. tetchier, 1984). 
Two comprehensive sunray papers on exact methods and available 
algorithm for computing exact payees are due to A m (1992) and Verbreek 
and Rotenberg (1985). A recent book titled 'Exact Statistical Methods for 
Data Analysis' (Weerahandi, 1995) shows various uses methods for exact 
inference with an emphasis on Normal theory methods such as ANOVA 
and regression. 
Weerahandi (1995) notes that the methods describes in his book are exact 
in the sense that the tests and confidence intimae’s are based on exact 
probability Statements rather than on asymptotic approximations. 
Inferences based on this Approach can be made with any desired 
accuracy, provided that assumed parametricmode1 and/or other 
assumptions are correct. Exact methods are also widely used in 
nonparametric settings. These methods provide exact values instead of 
approximate fixed-Ivied tests. Most of the exact Nonpararnetric techniques 
are based on the idea of conditional inference first intru-Duced by Fisher 
(1925). The basic principle behind this approach is to alginate Nuisance 
parameters from the inference problem by conditioning on certain functions 
of the observable random variables. 
In most cases, sufficient statistics are used as conditioning functions. Exact 
Values are obtained as conditional probabilities based on extreme regions 
and they serve as a measure of how w d the data supports or demerits the 
underlying. 
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History And Literature Of The Theory The history of the theory of the 
representation of functions by series of sines and cosines is of great interest 
in connexion with the progressive development of the notion of an arbitrary 
function of a real variable, and of the peculiarities which such a function 
may possess; the modern views on the foundations of the infinitesimal 
calculus have been to a very considerable extent formed in this connexion 
(see Function). The representation of functions by these series was first 
considered in the, 8th century, in connexion with the problem of a vibrating 
cord, and led to a controversy as to the possibility of such expansions. In a 
memoir published in 1747 (Memoirs of the Academy of Berlin, vol. iii.) 
D'Alembert showed that the ordinate y at any time t of a vibrating cord 
satisfies a differential equation of the form 621,i = a 2 Sx, where x is 
measured along the undisturbed length of the cord, and that with the ends 
of the cord of length l fixed, the appropriate solution is y = f (at+x) -f (at-
x), where f is a function such that f(x) = f (x+21); in another memoir in the 
same volume he seeks for functions which satisfy this condition. In the year 
1748 (Berlin Memoirs, vol. IV.) Euler, in discussing the problem, gave f(x) 
= a sin l + (3 sin 2 l xx +... as a particular solution, and maintained that 
every curve, whether regular or irregular, must be represent able in this 
form. This was objected to by D'Alembert (, 750) and also by Lagrange on 
the ground that irregular curves are inadmissible. D. Bernoulli (Berlin 
Memoirs, vol. ix, 1753) based a similar result to that of Euler on physical 
intuition; his method was criticized by Euler (1753). The question was then 
considered from a new point of view by Lagrange, in a memoir on the 
nature and propagation of sound (Miscellanea Taurensia, 1759; (Euvres, 
vol. i.), who, while criticizing Euler's method, considers a finite number of 
vibrating particles, and then makes the number of them infinite; he did not, 
however, quite fully carry out the determination of the coefficients in 
Bernoulli's Series. These mathematicians were hampered by the narrow 
conception of a function, in which it is regarded as necessarily continuous; 
a discontinuous function was considered only as a succession of several 
different functions. Thus the possibility of the expansion of a broken 
function was not generally admitted. The first cases in which rational 
functions are expressed in sines and cosines were given by Euler 
(Subsidium calculi sinuum, Novi Comm. Petrop., vol. v., 1754-1755), who 
obtained the formulae 2¢ =sin ¢-2 sin 2¢+4 sin 30...  
12 4 =cos ¢-4 cos 2¢+1 cos 3¢....  
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In a memoir presented to the Academy of St Petersburg in 1777, but not 
published until 1798: Euler gave the method afterwards used by Fourier, of 
determining the coefficients in the expansions; he remarked that if is 
expansible in the form A+B cos ¢+C cos 2¢+..., then A = 7 d¢, B =- f ir 4, 
cos ¢d¢, &c. ir The second period in the development of the theory 
commenced in 1807, when Fourier communicated his first memoir on the 
Theory of Heat to the French Academy. His exposition of the present 
theory is contained in a memoir sent to the Academy in, 81, of which his 
great treatise the Theories analytique de la chaleur, published in 1822, is, 
in the main, a reproduction. Fourier set himself to consider the 
representation of a function given graphically, and was the first fully to 
grasp the idea that a single function may consist of detached portions given 
arbitrarily by a graph. He had an accurate conception of the convergence of 
a series, and although he did not give a formally complete proof that a 
function with discontinuities is represent able by the series, he indicated in 
particular cases the method of procedure afterwards carried out by 
Dirichlet. As an exposition of principles, Fourier's work is still worthy of 
careful perusal by all students of the subject. Poisson's treatment of the 
subject, which has been adopted in English, works (see the Journal de 
l'ecole polytechnique, vol. xi. 1820, and vol. Xii, 1823, and also his treatise, 
Theories de la chaleur, 1835), 2 depends upon the equality f W f (a) 1-2h 
cos (x-a) +h'da J r = r f (a) da +? h n f? f (a) cos?  
Where o < h< I; the limit of the integral on the left-hand side is evaluated 
when h= i, and found to be 2 {f (x+o) +f (x -o)}, the series on the right-
hand side becoming Fourier's Series. The equality of the two limits is then 
inferred. If the series is assumed to be convergent when h=i, by a theorem 
of Abel's its sum is continuous with the sum for values of h less than unity, 
but a proof of the convergences for h= I is requisite for the validity of 
Poisson's proof; as Poisson gave no such proof of convergences, his proof 
of the general theorem cannot be accepted. The deficiency cannot be 
removed except by a process of the same nature as that afterwards applied 
by Dirichlet. The definite integral has been carefully studied by Schwarz 
(see two memoirs in his collected works on the integration of the equation 
Sx +b y z=0), whoshowed that the limiting value of the integral depends 
upon the manner in which the limit is approached. Investigations of 
Fourier's Series were also given by Cauchy (see his " Memoire sur les 
developpements des functions en series periodiques," Mem. de l'Inst., vol. 
vi., also Ouvres completes, vol. vii.); his method, which depends upon a 
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use of complex variables, was accepted, with some modification, as valid 
by Riemann, but one at least of his proofs is no longer regarded as 
satisfactory. The first completely satisfactory investigation is due to 
Dirichlet; his first memoir appeared in Crelle's Journal for 1829, and the 
second, which is a model of clearness, in Dove's Repertorium der Physik. 
Dirichlet laid down certain definite sufficient conditions in regard to the 
nature of a function which is expansible, and found under these conditions 
the limiting value of the sum of n terms of the series. Dirichlet's 
determination of the sum of the series at a point of discontinuity has been 
criticized by Schlafli (see Crelle's Journal, vol. lxxii.) and by Du Bois-
Reymond (Mathem. Annalen, vol. vii.), who maintained that the sum is 
really 7r sin n sin nt f i (x) cos nxdx= f i (-, r+0) n +f l (r-0) n indeterminate. 
Their objection appears, however, to rest upon a misapprehension as to the 
meaning of the sum of the series; if x i be the point of discontinuity, it is 
possible to make x approach xi, and n become indefinitely great, so that the 
sum of the series takes any assigned value in a certain interval, whereas we 
ought to make x= x i first and afterwards n = oo, and no other way of going 
to the double limit is really admissible. Other papers by Dircksen (Crelle, 
vol. iv.) and Bessel (Astronomische Nachrichten, vol. xvi.), on similar lines 
to those by Dirichlet, are of inferior importance. Many of the investigations 
subsequent to Dirichlet's have the object of freeing a function from some of 
the restrictions which were imposed upon it in Dirichlet's proof, but no 
complete set of necessary and sufficient conditions as to the nature of the 
function has been obtained. Lipschitz (" De explicatione per series 
trigonometric as," Crelle's Journal, vol. lxiii., 1864) showed that, under a 
certain condition, a function which has an infinite number of maxima and 
minima in the neighborhood of a point is still expansible; his condition is 
that at the point of discontinuity /3, I f (a+ a) - f (a) I < Baa as a converges 
to zero, B being a constant, and a a positive exponent. A somewhat wider 
condition is f (1 3-1-5) - AO)} log a= o, = o for which Lipschitz's results 
would hold. This last condition is adopted by Dini in his treatise (Sopra la 
serie di Fourier, &c., Pisa, 1880).  
         The modern period in the theory was inaugurated by the publication 
by Riemann in 1867 of his very important memoir, written in 1854, Uber 
die Darstellbarkeit einer Function durch sine trigonometric Rehire. The 
first part of his memoir contains a historical account of the work of 
previous investigators; in the second part there is a discussion of the 
foundations of the Integral Calculus, and the third part is mainly devoted to 
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a discussion of what can be inferred as to the nature of a function 
respecting the changes in its value for a continuous change in the variable, 
if the function is capable of representation by a trigonometrically series. 
Dirichlet and probably Riemann thought that all continuous functions were 
everywhere represent able by the series; this view was refuted by Du Bois-
Reymond (Abh. der Bayer. Aced. Vol. xii. 2). It was shown by Riemann 
that the convergence or non-convergence of the series at a particular point 
x depends only upon the nature of the function in an arbitrarily small 
neighborhood of the point x. The first to call attention to the importance of 
the theory of uniform convergence of series in connexion with Fourier's 
Series was Stokes, in his memoir On the Critical Values of the Sums of 
Periodic Series “(Camb. Phil. Trans., 1847; Collected Papers, vol. i.). As 
the method of determining the coefficients in a trigonometrically series is 
invalid unless the series converges in general uniformly, the question arose 
whether series with coefficients other than those of Fourier exist which 
represent arbitrary functions. Heine showed (Crelle's Journal, vol. lxxi., 
1870, and in his treatise Kugelfunctionen, vol. i.) that Fourier's Series is in 
general uniformly convergent, and that if there is a uniformly convergent 
series which represents a function, it is the only one of the kind. G. Cantor 
then showed (Crelle's Journal, vols. lxxii. lxxiii.) that even if uniform 
convergence be not demanded, there can be but one convergent expansion 
for a function, and that it is that of Fourier. In the Math. Ann. vol. v., 
Cantor extended his investigation to functions having an infinite number of 
discontinuities. Important contributions to the theory of the series have 
been published by Du Bois-Reymond (Abh. der Bayer. Academia, vol. xii. 
1875, two memoirs, also in Crelle's Journal, vols. lxxiv. Lxxvi. lxxix.), by 
Kronecker (Berliner Berichte, 1885), by O. Holder (Berliner Berichte, 
1885), by Jordan (Comptes rendus, 1881, vol. xcii.), by Ascoli (Math. 
Annal, 1873, and Annali di matematica, vol. vi.), and by Gnocchi (Atti 
della R. Acc. di Torino, vol. x., 1875). Hamilton's memoir on “Fluctuating 
Functions " (Trans. R.I.A., vol. xix., 1842) may also be studied with profit 
in this connexion. A memoir by Broden (Math. Annalen, vol. lii.) Contains 
a good investigation of some of the most recent results on the subject. The 
scope of Fourier's Series has been extended by Lebesgue, who introduced a 
conception of integration wider than that due to Riemann. Lebesgue's work 
on Fourier's Series will be found in his treatise, Lecons sur les series 
trigonometriques (1906); also in a memoir, “Sur les series 
trigonometriques," Annales sc. de l'ecole normale superieure, series ii. Vol. 
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xx. (1903), and in a chapter " Sur la convergence des series de Fourier," 
Math. Annalen, vol. lxiv. (1905).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               
 
 
 
CHAPTER 3 
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CHAPTER 3  RESEARCH METHODOLOGY: 
 
 Using Statistics: 
Once we have found relevant statistics, it is important to consider the 
following ideas. In order to get complete information on the methods used 
in compiling statistics, it is often necessary to go to the original source, 
rather than use information quoted elsewhere. 
 Reliability of Source: 
 
It is important to know what group actually gathered the data you are going 
to use and why they did so. This is of particular concern when considering 
international statistics. It is also important to know what methods were 
used to gather the information you are using. One example of a problem in 
this area is if the survey was a written one in areas where much of the 
studied population cannot read or write. When comparing data gathered by 
multiple groups, it is also important to consider the differences in the study 
methodologies 
 Time: 
Time is one of the chief variables in considering statistics. Even data 
gathered in a single year can be misleading. For example, if a nationwide 
study was done comparing the level of stress-related disorders on a state-
by-state basis, it is likely that states surveyed after September 11, 2001 
would show a higher incidence than they would have earlier in the year, 
even though all of the figures are from the same year. Also important to 
consider when data is presented for a year is whether that is a calendar year 
or a fiscal year. School years, for example, often go from summer to 
summer. 
 Geographic Location: 
Another consideration is what geographic area the statistics you are using 
cover. This is of particular importance when comparing statistics that have 
been gathered in different studies. In the United States, one of the biggest 
differences is whether information has been gathered on the census tract or 
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zip code level. These areas rarely match up exactly, making it extremely 
difficult to relate data gathered in one way to data gathered in another. 
 Population: 
Try to get as specific a definition of the social group covered as possible. 
Even such seemingly simple concepts such as “adults in area x” can be 
deceptive. Does “adults” include individuals over 18? Over 21? In many 
parts of the world this age can go as low as 15, or even 12. Comparing 
numbers from a study that includes anyone over 15 an adult to a study that 
considers anyone over 18 an adult can result in serious discrepancies. 
    The importance of statistics in biomedical research, explaining examples 
of several different ways in which medical statistics might help: sample 
size and power calculations, questionnaires, choice of sample and control 
subjects, study design, data display, and choice of summary statistics and 
statistical analysis. 
    The basics of every good clinical research – “Design”. This explains the 
enormous importance of defining the objectives of a study first, before 
actually starting with the study itself. After that, various types of clinical 
studies are observed in detail, including their advantages and limitations. It 
is worth mentioning that methodological studies are also reviewed – 
reference ranges, method comparison studies, and studies of diagnostic 
tests. Controlled trials in single subjects, dose-response studies, and mixed 
studies are briefly mentioned. The questionnaire and form design, seldom 
found in biomedical statistical manuals, has been required to understand in 
length. The most important advice to those planning a questionnaire is look 
for an already existing one and iate guidelines for writing a protocol of the 
randomized controlled trial as well as the checklists for the design, analysis 
and reporting of trials. Another concept deals with “Designed 
Observational Studies”, particularly with two main types of those studies: 
the cohort study and the case control study. This is actually focused on 
different summary statistics used to describe the outcomes of those studies. 
The “Common Pitfalls in Medical Statistics” is my favorite. Although, 
virtually all biostatistician manuals point out some mistause it, because 
making a good questionnaire is a time consuming and labor- intensive job. 
The last few sections of the chapter are dedicated to the methods of 
randomization and give practical tips on different randomization protocols. 
The concept of probability in the context of clinical tests, two major 
parameters of diagnostic tests – sensitivity and specificity,. Bayes’ 
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theorem, which allows prior assessments about the chances of a diagnosis 
to be combined with the test result in order to obtain a posteriori 
assessment, is illustrated in the context of a predictive value of a test and a 
likelihood ratio. Relative (or receiver) operating characteristic curves (ROC 
curves), valuable tools for decisions on cut-off points in diagnostic tests, 
are also invariably discussed. Statistical methods are most frequently used 
to summarize or, in other words, describe data. In the “Data Description” is 
the subject for defining qualitative and quantitative data, and scales of 
measurement. The section on the categorical data is particularly interesting. 
In presentation use of pie charts are discouraged for summarizing 
categorical data, since the human eye is not very good at comparing angles. 
In addition, the theory describes different statistical approaches to 
summarizing categorical data, particularly useful in epidemiological and 
clinical studies: absolute and relative risk reduction, and number needed to 
treat (expect to number of people to treat in each group for every person to 
benefit the test treatment). Another interesting and useful topic is within-
subject variability, i.e., variability of measurements made repeatedly on one 
subject.” From Sample to Population”, the general introduction of the terms 
population, parameters, and sample. Then, they describe the well-known 
normal distribution, as well as two other distributions: binomial distribution 
and Poisson distribution. The latter two sections, although short, are not 
only straightforward and easy to understand, but are also illustrated with 
simple and practical examples from clinical research. “Statistical 
Inference”, must begin with the description of the null hypothesis and 
introduces the p-value. Three common statistical tests are described: 
Student’s t-test, the chi-squared test,  
     The statistical power and non-parametric tests are mentioned as well. 
Although greater statistical power makes parametric tests more popular 
than the non-parametric, the use of a non-parametric test is sometimes 
unavoidable. Therefore, the section on non-parametric statistics should 
have been more detailed. Statistical techniques used for dealing with 
relationships between variables are the subject of the seventh chapter. If we 
have in mind that the substantial parts of published research include 
correlation or regression analyses, it is a very good idea to pay so much 
attention to their description. Their advantages and limitations are 
explained in detail, as well as assumptions and possible problems (and 
solutions!) one might have performing them. Describing dedication to a  
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Single type of study: “The Randomized Controlled Trial”, widely 
recognized as the most valuable clinical study. This study highlights two 
features of the randomized controlled trial: design and protocol. The 
investigator planning her/his trial will certainly appreckes as frequent in 
statistical analysis, different misuses of statistics can be found even in 
manuscripts published in very fine journals. Among other common 
mistakes, the authors deal with the use of correlation to compare two, 
usually diagnostic, protocols. Since that comparison is inappropriate for a 
number of reasons, an alternative approach is given – scatter diagram of 
difference between methods against mean of both. It is both efficient and 
easy to perform. Another pitfall based on correlation analysis, but seldom 
explained in other literature is plotting the change against the initial value. 
Again the authors offer a simple solution – regression to the mean. Problem 
of repeated measures, common in clinical practice, requires detail 
discussion, including both the invalid and valid approaches. The 
inexperienced reader will probably find some of them difficult to follow. 
However, I am not aware of anyone who performs statistics “manually” 
these days. Moreover, the authors recommend the use of commercial 
software packages, in order to avoid arithmetical mistakes. If you want to 
test your knowledge and understanding of statistics, there is a list of 
multiple choice questions in Appendix II. Fortunately, unlike most books, 
the authors have provided not only the answers, but explanations as well. 
The list of statistical tables is rather short, including only 5. A feature very 
useful for a “novice” in medical statistics and medical research is that all 
the chapters are accompanied with guidelines for evaluation of statistical 
methods in the literature. In addition, the literature must contain an 
excellent list of references. “Medical Statistics”, it certainly is not a classic 
statistical manual. The investigator feel that “The design of studies is often 
not given sufficient emphasis  on statistics, but as practical medical 
statisticians, we spend much more of our time giving advice on the design 
of the studies than we do on actual analysis”. 
     Consequently, the focus of this literature is not on the different 
statistical tests, but on the design of (most) clinical studies. Therefore, 
readers interested in statistical tests and statistics in some other fields of 
biomedical research should consult some other manuals. “Medical 
statistics” provides an excellent overview of clinical studies and introduces 
the reader to medical research. It can be recommended not only to medical 
students but to medical practitioners as well. Although “most medical  
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Practitioners do not carry out medical research if they pride themselves on 
being up to date, they will definitely be consumers of medical research, and 
apply the research in everyday work.  
 
(Foot note)  *Ivan Krešimir Lucia 1 Emerson JD, Cowlitz GA. Use of 
statistical analysis in the New England Journal of Medicine. N Engle J Med 
1983; 309:709-13. 
2 Petroveèki M. Approach to scientific research [in Croatian]. In: Marušiæ 
M, Petroveèki M, Petrakis J, Marušiæ A, editors. Introduction to scientific 
research in medicine. 2nd ed. Zagreb: Medici’s macadam; 2000. p. 63-
73.222 
 
 Data collection:  
          
The statistical classification of data by using Statistical software spss. The 
frequency, Mean, Median, s.d, Variance, Mode, T-test, F-test and Chi-
Square Test was perfomed. 
 
The following person helped and supported in the data collection process 
 Dr. Kirtibhai patel, Deputy Director, (GCRI). He gave the permission 
to collect data and recommended to  
 Dr. Parimalbhai Jivra Jani. 
 Dr. Parimalbhai Jivra Jani of community oncology centre. Asked to 
come after a month, Later he recommended Statistical Assiststant 
Mr.Jayesh Solanki and Mr.Himanshu Patel Both Mr. Jayesh Solanki 
and Mr. Himanshu patel provided the required data. A daily visit was 
required to collect the data from GCRI. 
 
The Gujarat Cancer & Research Institute (GCRI) established in the year  
1972, is a functional autonomous body jointly managed by Government of 
Gujarat and Gujarat Cancer Society. It is also a Regional Cancer Centre of 
Government of India and getting assistance under National Cancer Control 
Programme. GCRI is a unique example of cooperation between State 
Government, Central Government, and Non-Government Organization – 
Gujarat Cancer & Research Institute. It is good and fortunate that Gujarat 
Cancer Society established in 1961 and is instrumental in creating initial 
infrastructure of Cancer Hospital in Gujarat with the donation from people 
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of Gujarat. It is worth mentioning that Gujarat Cancer Society is blessed by 
His Excellency, Governor of Gujarat. Today our Institute has attained the 
status of premier cancer institute of the country and caters to patients from 
Gujarat, Rajasthan, Madhya Pradesh and neighbouring State of 
Maharashtra. 
  GCRI is a regional comprehensive cancer centre recognized by Health & 
Family Welfare, GOI; UICC; WHO. 
 GCRI is a 650 Beds teaching hospital with Multi-disciplinary 
superspecialty Comprehensive cancer care under a single roof in western 
India. GCRI has the first dedicated pediatric oncology center. 
 
In this thesis we have use the following statistical methodology: 
1 discriptive statistics like mean median, mode, sd and plot histographs. 
2 test of mean (t-test).  
3 Analysis of variance 
4 independent sample t-tests 
5 Test of association and propotion (chi –square tests). 
6 Logestic regressions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
 
Objectives and 
Hypothesis of Study 
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  CHAPTER 4 OBJECTIVES AND HYPOTHESIS OF 
STUDY: 
 
(4.1) OBJECTIVES: 
1. To develop approximation smoothing in parameter estimatio for   Bio 
medical inferences. 
2. To develop algorithms, Numerical calculation and accuracy by 
measuring approximation fundamentals. 
3. To Estimate Sample Weights Vs Sample errors. 
4. Develop innovative techniques for large scale parameter estimation in 
Biomedical Inferences.  
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(4.2) HYPOTHESIS: 
 There is no significance difference between Male & Female as far 
as as occurance of disease /calsenoma is concered. 
 There is no significance difference between Married & 
Unmarried person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between Unmarried & 
widowed person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between Unmarried & 
Divorced person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between Married & Widowed 
person as far as occurance of calsenoma/disease is concered. 
 There is no significance difference between Married & Divorced 
person as far as occurance of calsenoma/disease is concered. 
 There is no significance difference between Widowed & 
Divorced person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between person’s having 
different monther tongue (Guj & Hindi) as far as occurance of 
calsenoma/disease is concered.  
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 There is no significance difference between person’s having 
different monther tongue (Guj & Other) as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between person’s having   
different monther tongue (Hindi & Other) as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between the Religions (Hindu 
&Muslim) of a person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between the Religions (Hindu 
&Jain) of a person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between the Religions (Hindu 
&Sikh) of a person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between the Religions (Hindu& 
Christian) of a person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between the Religions (Muslim 
&Jain) of a person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between the Religions (Muslim 
&Sikh) of a person as far as occurance of calsenoma/disease is 
concered. 
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 There is no significance difference between the Religions 
(Muslim& Christian) of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between the Religions (Jain 
&Christian) of a person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between the Religions (Sikh& 
Christian) of a person as far as occurance of calsenoma/disease is 
concered. 
 There is no significance difference between below 20 age group 
and 20-30 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between below 20 age group 
and 30-40 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between below 20 age group 
and 40-50 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between below 20 age groups 
and 50-60 age groups of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between below 20 age group 
and 60-70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between below 20 age group 
and above 70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
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 There is no significance difference between 20-30 age groups and 
30-40 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 20-30 age groups and 
30-40 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 20-30 age groups and 
40-50 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 20-30 age group and 
50-60 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 20-30 age group and 
60-70 age groups of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 20-30 age group and 
above 70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 30-40 age groups and 
40-50 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 30-40 age groups and 
50-60 age groups of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 30-40 age groups and 
60-70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
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 There is no significance difference between 30-40 age groups and 
above 70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 40-50 age group and 
above 50-60 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 40-50 age group and 
above 60-70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 40-50 age groups and 
above 70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 50-60 age groups and 
60-70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 50-60 age group and 
above 70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between 60-70 age groups and 
above 70 age group of a person as far as occurance of 
calsenoma/disease is concered. 
 There is no significance difference between below 40 age group 
and above 40 age group of a person as far as occurance of            
disease/cilesenoma is concered. 
  There is no significant difference between the Proportions of the 
disease 1 to 76 in two age groups.  
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  There is no significant difference between the Proportions of the 
disease numbers 11, 13, 15, 17, 23, 33, 36, 48 & 68 in two age 
groups.  
  There is no significant difference between propotions of the 
disease between male & female having disease numbers 11, 13, 15, 
17, 23, 33, 36, 48 & 68. 
  There is no significant effect between propotion of the diseases of 
the marital-status having disease no. 11, 13, 15, 17, 23, 33, 36, 48 
& 68. 
  There is no significant effect between propotions of the disease of 
a language having disease number 11, 13, 15, 23, 33, 36, 48 & 68. 
  There is no significant effect of the propotions of the disease of the 
different Age-group having disease number 11, 13, 15, 23, 33, 36, 
48 & 68. 
  There is no significant effect of the propotions of the disease of the 
different Age-group having disease number 11, 13, 15, 23, 33, 36, 
48 & 68. 
 There is no significance difference between male and female of 
persons having disease number 1 to 76 as far as occurance of 
calsenoma/disease is concered. 
  There is no significance difference between male and female of 
persons having disease number 11, 13, 15, 23, 33, 36, 48, & 68 as 
far as occurance of calsenoma/disease is concered. 
  There is no significance difference between Unmarried and 
married of persons as far as occurance of calsenoma/disease is 
concered. 
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  There is no significance difference between Unmarried and 
widowed of a persons having disease number 11, 13, 15, 23, 33, 36, 
48, & 68 as far as occurance of calsenoma/disease is concered. 
  There is no significance difference between Unmarried and 
divorced of a person as far as occurance of calsenoma/disease is 
concered. 
  There is no significance difference between married and widowed 
of a person as far as occurance of calsenoma/disease is concered. 
  There is no significance difference between married and divorced 
of a person as far as occurance of calsenoma/disease is concered. 
  There is no significance difference between widowed and divorced 
of a person as far as occurance of calsenoma/disease is concered. 
  There is no significance difference between persons having 
different   
  Mother tongue (Gujarati&Hindi) as far as occurrence of 
cailsenoma/disease is concerned. 
  There is no significance difference between persons having 
different mother tongue (Gujarati&Other) as far as occurrence of 
cailsenoma/disease are concerned. 
  There is no significance difference between persons having 
different mother tongue (Hindi&Other) as far as occurrence of 
cailsenoma/disease are concerned. 
  There is no significance difference between religions (Hindu 
&Muslim) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
  There is no significance difference between religions (Hindu&Jain) 
of persons as far as occurrence of cailsenoma/disease is concerned. 
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  There is no significance difference between religions (Hindu 
&Sikh) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
  There is no significance difference between religions (Hindu 
&Christian) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
  There is no significance difference between religions (Muslim 
&Jain) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
  There is no significance difference between religions (Muslim 
&Sikh) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
  There is no significance difference between religions (Muslim 
&Christian) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
 There is no significance difference between religions (Jain 
&Christian) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
  There is no significance difference between religions (Sikh 
&Christian) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
  Average number of patients in the below 40 age Group is same as 
the above 40 age Group. 
 
 
 
 
 
 
 
 
CHAPTER 5 
 
Data Analysis and 
Description 
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CHAPTER 5 DATA ANALYSIS AND DESCRIPTION: 
 
Preface: 
             With reference to the subject biomedical statistical inferences: 
Weighted Fourier series approximationparameter estimation. The data 
process has been done for this process. The population has been considered 
and selection of sample was done to collect the data. The collected data 
was classified into statistical method and analystical process was carried 
out. 
 
Subject: Biomedical statistical inferences: Weighted Fourier series 
approximationparameter estimation. 
 
Population: Cancer patients From Gujarat cancer research institute 
(GCRI) at Ahmedabad Civil hospital. 
 
Sample: Data of Gujarat cancer research institute (GCRI) of the 
year2000, 2002,2003,2004,2005 and 2006.We have collected a data of 
cancer patients from Gujarat cancer research institute (GCRI) in different 
years as below. 
127 patients from year 2000. 
130 patients from year 2002. 
127 patients from year 2003. 
226 patients from year 2004. 
308 patients from year 2005. 
091 patients from year 2006. 
Thus we have total 1009 patients. Also we have collected extra information 
of the cancer patient like gender, Martial-status, Religions, Languange and 
age-group. 
 Table-1 denotes frequency distribution of the patient Yearwise. 
 Table-2 denotes frequency distribution of the male & female patient. 
 Table-3 denotes frequency distribution of the patient Matrial status 
wise. 
 Table-4 denotes frequency distribution of the patient Mother Tounge 
wise. 
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 Table-5 denotes frequency distribution of the patient Religion wise. 
 Table-6 denotes frequency distribution of the patient Age –group 
wise. 
 Table-7 some measures of central tendency and dispersion are 
calculated. 
 Table-8 demostrare the test of significance difference between cancer 
disease of male and female. 
 Table-9 demostrare the test of significance difference between cancer 
diseases of Marital-status wise. (Unmarried and Married). 
 Table-10 demostrare the test of significance difference between 
cancer diseases of Marital-status wise. (Unmarried and Widowed). 
 Table-11 demostrare the test of significance difference between 
cancer diseases of Marital-status wise. (Unmarried and Divorced). 
 Table-12 demostrare the test of significance difference between 
cancer diseases of Marital-status wise. (Married and Widowed). 
 Table-13 demostrare the test of significance difference between 
cancer diseases of Marital-status wise. (Married and Divorced).  
 Table-14 demostrare the test of significance difference between 
cancer disease of Marital-status wise.(Widowed and Divorced).  
 Table-15 demostrare the test of significance difference between 
cancer diseases of Mother-tounge wise. (Gujarati and Hindi).  
 Table-16 demostrare the test of significance difference between 
cancer diseases of Mother-tounge wise. (Gujarati and other). 
 Table-17 demostrare the test of significance difference between 
cancer diseases of Mother-tounge wise. (Hindi and other). 
 Table-18 demostrare the test of significance difference between 
cancer disease of Religion wise (Hindu and Muslim). 
 Table-19 demostrare the test of significance difference between 
cancer disease of Religion wise (Hindu and Jain). 
 Table-20 demostrare the test of significance difference between 
cancer disease of Religion wise (Hindu and Sikh). 
 Table-21 demostrare the test of significance difference between 
cancer disease of Religion wise (Hindu and Christian).  
 Table-22 demostrare the test of significance difference between 
cancer disease of Religion wise (Muslim and Jain). 
 Table-23 demostrare the test of significance difference between 
cancer disease of Religion wise (Muslim and Sikh). 
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 Table-24 demostrare the test of significance difference between 
cancer disease of Religion wise (Muslim and Christian).  
 Table-25 demostrare the test of significance difference between 
cancer disease of Religion wise (Jain and Christian).  
 Table-26 demostrare the test of significance difference between 
cancer disease of Religion wise (Sikh and Christian).  
 Table-27 demostrare the test of significance difference between 
cancer disease of Age-Group wise (Below 20 and 20-30).  
 Table-28 demostrare the test of significance difference between 
cancer disease of Age-Group wise (Below 20 and 30-40).  
 Table-29 demostrare the test of significance difference between 
cancer disease of Age-Group wise (Below 20 and 40-50).  
 Table-30 demostrare the test of significance difference between 
cancer disease of Age-Group wise (Below20 and 50-60). 
 Table-31 demostrare the test of significance difference between 
cancer disease of Age-Group wise (Below 20 and 60-70).  
 Table-32 demostrare the test of significance difference between 
cancer disease of Age-Group wise (Below 20 and above70).  
 Table-33 demostrare the test of significance difference between 
cancer disease of Age-Group wise (20-30 and 30-40).  
 Table-34 demostrare the test of significance difference between 
cancer disease of Age-Group wise (20-30 and 40-50).  
 Table-35 demostrare the test of significance difference between 
cancer disease of Age-Group wise (20-30 and 50-60).  
 Table-36 demostrare the test of significance difference between 
cancer disease of Age-Group wise (20-30 and 60-70).  
 Table-37 demostrare the test of significance difference between 
cancer disease of Age-Group wise (20-30 and Above70). 
 Table-38 demostrare the test of significance difference between 
cancer disease of Age-Group wise (30-40 and 40-50).  
 Table-39 demostrare the test of significance difference between 
cancer disease of Age-Group wise (30-40 and 50-60).  
 Table-40 demostrare the test of significance difference between 
cancer disease of Age-Group wise (30-40 and 60-70). 
 Table-41 demostrare the test of significance difference between 
cancer disease of Age-Group wise (30-40 and above70). 
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 Table-42 demostrare the test of significance difference between 
cancer disease of Age-Group wise (40-50 and 50-60).  
 Table-43 demostrare the test of significance difference between 
cancer disease of Age-Group wise (40-50 and 60-70). 
 Table-44 demostrare the test of significance difference between 
cancer disease of Age-Group wise (40-50 and above70). 
 Table-45 demostrare the test of significance difference between 
cancer disease of Age-Group wise (50-60 and 60-70). 
 Table-46 demostrare the test of significance difference between 
cancer disease of Age-Group wise (50-60 and above70). 
 Table-47 demostrare the test of significance difference between 
cancer disease of Age-Group wise (60-70 and above70).  
 Table-48 we have made comprision between gender, martial-status, 
mother-tongue, religion and age-group using oneway anova. The 
results are tabulate in the number so and so 
 Table 49 demostrate the number of count of disease & year. 
 Table 50 demostrate the number of count of disease & Gender. 
 Table 51 demostrate the number of count of disease & marital-status. 
 Table 52 demostrate the number of count of disease & languages. 
 Table 53 demostrate the number of count of disease & religions. 
 Table 54 demostrate the number of count of disease & Age-groups. 
 Table 55 demostrate the test of significance difference between 
cancer diseases of below age 40 & above age 40. 
 Table 56 demostrate the test of significance difference between 
cancer diseases of propotion of two age groups (age below 40 
&above 40). 
 Table 57 demostrate the test of significance difference between 
cancer disease of propotion of male &female having disease number 
11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 58 demostrate the test of significance difference between 
cancer disease of propotion of marital status having disease number 
11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 59 demostrate the test of significance difference between 
cancer disease of propotion of language having disease number 11, 
13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 60 demostrate the test of significance difference between 
cancer disease of propotions of religions (Hindu, Muslim, Jain, 
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Charistian) having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 
68. 
 Table 61 demostrate the test of significance difference between 
cancer disease of propotion of age group (below 20, 20-30, 30-40, 40-
50, 50-60, 60-70 & above 70) having disease number 11, 13, 15, 17, 
23, 33, 36 ,48 & 68. 
 Table 62 demostrate the test of significance difference between 
cancer disease of propotion of male&female of a person having 
disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 63 demostrate the test of significance difference between 
cancer disease of propotion of male&female of a person having 
disease number 1 to 76. 
 Table 64 demostrate the test of significance difference between 
cancer disease of propotion of unmarried & married of a person 
having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 65 demostrate the test of significance difference between 
cancer disease of propotion of unmarried & widowed of a person 
having Disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 66 demostrate the test of significance difference between 
cancer disease of propotion of unmarried & divoced of a person 
having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 67 demostrate the test of significance difference between 
cancers disease of propotion of married & widowed of a person 
having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 68 demostrate the test of significance difference between 
cancers disease of propotion of married & divoced of a person having 
disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 69 demostrate the test of significance difference between 
cancer disease of propotion of widowed & divoced of a person having 
disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 70 demostrate the test of significance difference between 
cancer disease of propotion of mother tongue (Guj & Hindi Lang ) of 
a person having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 71 demostrate the test of significance difference between 
cancer disease of propotion of mother tongue (Guj &other Lang) of a 
person having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 94
 Table 72 demostrate the test of significance difference between 
cancer disease of propotion of mother tongue (Hindi &other Lang) of 
a person having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 73 demostrate the test of significance difference between 
cancer disease of propotion of religion (Hindu & mulsim) of a person 
having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 74 demostrate the test of significance difference between 
cancer disease of propotion of religion (Hindu &Jain) of a person 
having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 75 demostrate the test of significance difference between 
cancer disease of propotion of religion (Hindu & Sikh) of a person 
having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 76 demostrate the test of significance difference between 
cancer Disease of propotion of religion (Hindu & Christian) of a 
person having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 77 demostrate the test of significance difference between 
cancer disease of propotion of religion (Muslim &Jain) of a person 
having disease number 11, 13,15,17,23, 33, 36, 48 & 68. 
 Table 78 demostrate the test of significance difference between 
cancer disease of propotion of religion (Muslim & Sikh) of a person 
having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 79 demostrate the test of significance difference between 
cancer diseases of propotion of religions (Muslim & Christian) of a 
person having disease number 11, 13, 15, 17, 23, 33, 36, 48, 68. 
 Table 80 demostrate the test of significance difference between 
cancer disease of propotion of religions (Jain &Christian) of a person 
having disease number 11, 13,15,17,23, 33, 36, 48 & 68. 
 Table 81 demostrate the test of significance difference between 
cancer disease of propotion of religions (Sikh & Christian) of a 
person having disease number 11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 Table 82 demostrate the test of significance difference between 
cancers disease of propotion of Age group (below 40 & above 40) of 
a person having disease number 1 to 76. 
 Table 83 demostrate the test of Cancer disease of Logestics         
Regression Analysis. 
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Data collection:  
          
The statistical classification of data by using Statistical software spss. The 
frequency, Mean, Median, s.d, Variance, Mode, T-test and F-test was 
perfomed. 
 
The following persone helped and supported in the data collection process 
 Dr. Kirtibhai patel, Deputy Director, (GCRI). He gave the permission 
to collect data and recommended to  
 Dr. Parimalbhai Jivra Jani. 
 Dr. Parimalbhai Jivra Jani of community oncology centre. Asked to 
come after a month, Later he recommended Statistical Assiststant 
Mr.Jayesh Solanki and Mr.Himanshu Patel Both Mr. Jayesh Solanki 
and Mr. Himanshu patel provided the required data. A daily visit was 
required to collect the data from GCRI. 
 
The Gujarat Cancer & Research Institute (GCRI) established in the year  
1972, is a functional autonomous body jointly managed by Government of 
Gujarat and Gujarat Cancer Society. It is also a Regional Cancer Centre of 
Government of India and getting assistance under National Cancer Control 
Programme. GCRI is a unique example of cooperation between State 
Government, Central Government, and Non-Government Organization – 
Gujarat Cancer & Research Institute. It is good and fortunate that Gujarat 
Cancer Society established in 1961 and is instrumental in creating initial 
infrastructure of Cancer Hospital in Gujarat with the donation from people 
of Gujarat. It is worth mentioning that Gujarat Cancer Society is blessed by 
His Excellency, Governor of Gujarat. Today our Institute has attained the 
status of premier cancer institute of the country and caters to patients from 
Gujarat, Rajasthan, Madhya Pradesh and neighbouring State of 
Maharashtra. 
  GCRI is a regional comprehensive cancer centre recognized by Health & 
Family Welfare, GOI; UICC; WHO. 
 GCRI is a 650 Beds teaching hospital with Multi-disciplinary 
superspecialty Comprehensive cancer care under a single roof in western 
India. GCRI has the first dedicated pediatric oncology center. 
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 Frequencies 
 
 YEAR GENDER MAR_STAT LANG RELIGION AGE_GR
N 
Valid 1009 1009 1009 1009 1009 1009 
Missing 0 0 0 0 0 0 
Frequency Table -1 
YEAR 
 
 Frequency Percent Valid Percent Cumulative Percent
Valid 
2000 127 12.6 12.6 12.6 
2002 130 12.9 12.9 25.5 
2003 127 12.6 12.6 38.1 
2004 226 22.4 22.4 60.5 
2005 308 30.5 30.5 91.0 
2006 91 9.0 9.0 100.0 
Total 1009 100.0 100.0  
Frequency Table-2 
GENDER
 
 Frequency Percent Valid Percent Cumulative Percent
Valid 
Male 603 59.8 59.8 59.8 
Female 406 40.2 40.2 100.0 
Total 1009 100.0 100.0  
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Frequency Table-3 
MAR_STAT
 
 Frequency Percent Valid Percent Cumulative Percent
Valid 
Unmarried 63 6.2 6.2 6.2 
Married 861 85.3 85.3 91.6 
Widowed 80 7.9 7.9 99.5 
Divorced 5 .5 .5 100.0 
Total 1009 100.0 100.0  
 
 
Frequency Table-4 
LANG 
 
 Frequency Percent Valid Percent Cumulative Percent
Valid 
Gujarati 822 81.5 81.5 81.5 
Hindi 167 16.6 16.6 98.0 
Other 20 2.0 2.0 100.0 
Total 1009 100.0 100.0  
Frequency Table-5 
RELIGION 
 
 Frequency Percent Valid Percent Cumulative Percent
Valid 
Hindu 936 92.8 92.8 92.8 
Muslim 69 6.8 6.8 99.6 
Jain 1 .1 .1 99.7 
Sikh 1 .1 .1 99.8 
Christian 2 .2 .2 100.0 
Total 1009 100.0 100.0  
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Frequency Table-6 
AGE_GR 
 
 Frequency Percent Valid Percent Cumulative Percent
Valid 
< 20 39 3.9 3.9 3.9 
20 - 30 58 5.7 5.7 9.6 
30 - 40 156 15.5 15.5 25.1 
40 - 50 263 26.1 26.1 51.1 
50 - 60 262 26.0 26.0 77.1 
60 - 70 159 15.8 15.8 92.9 
> 70 72 7.1 7.1 100.0 
Total 1009 100.0 100.0  
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Table-7 
Case Processing Summary  
 
 
Cases 
Included Excluded Total 
N Percent N Percent N Percent
DIESEAS * GENDER * LANG * 
MAR_STAT * RELIGION * AGE_GR 1009 100.0% 0 .0% 1009 100.0%
 
Report  
DIESEAS  
GENDE
R LANG 
MAR_STA
T 
RELIGIO
N 
AGE_G
R 
Mea
n N 
Std. 
Deviatio
n 
Media
n Variance 
Male Gujarati 
Unmarried 
Hindu 
< 20 25.67 21 20.723 20.00 429.433 
20 – 30 26.29 7 21.061 15.00 443.571 
30 – 40 15.00 1 . 15.00 . 
40 – 50 41.67 3 16.503 37.00 272.333
50 – 60 28.00 1 . 28.00 . 
60 – 70 54.00 1 . 54.00 . 
Total 27.79 34 20.101 23.00 404.047 
Muslim 
< 20 26.50 2 17.678 26.50 312.500 
20 – 30 20.00 1 . 20.00 . 
Total 24.33 3 13.051 20.00 170.333 
Total 
< 20 25.74 23 20.116 20.00 404.656 
20 – 30 25.50 8 19.625 17.50 385.143 
30 – 40 15.00 1 . 15.00 . 
40 – 50 41.67 3 16.503 37.00 272.333 
50 – 60 28.00 1 . 28.00 . 
60 – 70 54.00 1 . 54.00 . 
Total 27.51 37 19.513 22.00 380.757 
Married Hindu 
20 – 30 40.71 14 24.721 37.00 611.143 
30 – 40 34.17 59 20.326 26.00 413.143 
40 – 50 89.23 109 577.511 33.00 333519.030 
50 – 60 32.85 123 18.784 33.00 352.837 
60 – 70 37.58 71 17.890 36.00 320.047 
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> 70 41.03 32 19.218 39.00 369.322 
Total 49.84 408 298.902 33.00 89342.295
Muslim 
20 – 30 37.67 3 26.577 52.00 706.333 
30 – 40 42.40 5 23.384 47.00 546.800 
40 – 50 31.89 9 18.543 23.00 343.861 
50 – 60 27.80 10 21.070 22.50 443.956 
60 – 70 56.40 5 14.293 60.00 204.300 
Total 36.63 32 21.455 34.50 
460.306 
 
 
 
 
 
Christian 
40 – 50 84.00 1 . 48.00 . 
Total 48.00 1 . 48.00 . 
Total 
20 – 30 40.18 17 24.213 48.00 586.279 
30 – 40 34.81 64 20.495 27.00 420.028 
40 – 50 84.55 119 552.740 33.00 305521.080 
50 – 60 32.47 133 18.925 33.00 358.160 
60 – 70 38.82 76 18.212 36.50 331.672 
> 70 41.03 32 19.218 39.00 369.322 
Total 48.87 441 287.551 33.00 82685.825
Widowed 
Hindu 
30 – 40 28.00 1 . 28.00 . 
40 – 50 47.00 1 . 47.00 . 
50 – 60 57.50 2 14.849 57.50 220.500 
60 – 70 35.50 4 9.539 34.50 91.000 
> 70 43.80 5 21.833 47.00 476.700 
Total 42.38 13 16.546 47.00 273.756 
Total 
30 – 40 28.00 1 . 28.00 . 
40 – 50 47.00 1 . 47.00 . 
50 – 60 57.50 2 14.849 57.50 220.500 
60 – 70 35.50 4 9.539 34.50 91.000 
> 70 43.80 5 21.833 47.00 476.700 
Total 42.38 13 16.546 47.00 273.756 
Divorced Hindu 
40 – 50 29.00 1 . 29.00 . 
Total 29.00 1 . 29.00 . 
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Total 
40 – 50 29.00 1 . 29.00 . 
Total 29.00 1 . 29.00 . 
Total 
Hindu 
< 20 25.67 21 20.723 20.00 429.433 
20 – 30 35.90 21 24.060 26.00 578.890 
30 – 40 33.75 61 20.148 26.00 405.955 
40 – 50 87.08 114 564.685 33.00 318869.649 
50 – 60 33.20 126 18.866 33.00 355.920 
60 – 70 37.68 76 17.498 36.00 306.166 
> 70 41.41 37 19.285 40.00 371.914 
Total 47.93 456 282.823 33.00 79988.919 
Muslim 
< 20 26.50 2 17.678 26.50 312.500 
20 – 30 33.25 4 23.429 36.00 548.917 
30 – 40 42.40 5 23.384 47.00 546.800 
40 – 50 31.89 9 18.543 23.00 343.861 
50 – 60 27.80 10 21.070 22.50 443.956 
60 – 70 56.40 5 14.293 60.00 204.300 
Total 35.57 35 21.021 33.00 441.899 
Christian 
40 – 50 48.00 1 . 48.00 . 
Total 48.00 1 . 48.00 . 
Total 
< 20 25.74 23 20.116 20.00 404.656 
20 – 30 35.48 25 23.495 26.00 552.010 
30 – 40 34.41 66 20.339 27.00 413.692 
40 – 50 82.76 124 541.465 33.00 293184.120 
50 – 60 32.80 136 19.004 33.00 361.153 
60 – 70 38.84 81 17.827 36.00 317.786 
> 70 41.41 37 19.285 40.00 371.914 
Total 47.05 492 272.332 33.00 74164.871 
Hindi Unmarried 
Hindu 
< 20 22.33 3 17.898 12.00 320.333 
20 – 30 14.00 1 . 14.00 . 
40 – 50 35.00 1 . 35.00 . 
Total 23.20 5 14.721 14.00 216.700 
Total 
< 20 22.33 3 17.898 12.00 320.333 
20 – 30 14.00 1 . 14.00 . 
40 – 50 35.00 1 . 35.00 . 
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Total 23.20 5 14.721 14.00 216.700 
Married 
Hindu 
20 – 30 34.50 6 32.365 34.50 1047.500 
30 – 40 30.11 9 22.779 20.00 518.861 
40 – 50 32.62 13 20.378 25.00 415.256 
50 – 60 33.16 25 17.738 33.00 314.640 
60 – 70 37.17 23 18.396 36.00 338.423 
> 70 38.31 16 18.431 41.50 339.696 
Total 34.77 92 19.645 36.00 385.914 
Muslim 
20 – 30 37.00 1 . 37.00 . 
40 – 50 31.50 2 23.335 31.50 544.500 
Total 33.33 3 16.803 37.00 282.333 
Total 
20 – 30 34.86 7 29.560 37.00 873.810 
30 – 40 30.11 9 22.779 20.00 518.861 
40 – 50 32.47 15 19.874 25.00 394.981 
50 – 60 33.16 25 17.738 33.00 314.640 
60 – 70 37.17 23 18.396 36.00 338.423 
> 70 38.31 16 18.431 41.50 339.696 
Total 34.73 95 19.485 36.00 379.669
Total 
Hindu 
< 20 22.33 3 17.898 12.00 320.333 
20 – 30 31.57 7 30.544 14.00 932.952 
30 – 40 30.11 9 22.779 20.00 518.861 
40 – 50 32.79 14 19.589 26.50 383.720 
50 – 60 33.16 25 17.738 33.00 314.640
60 – 70 37.17 23 18.396 36.00 338.423 
> 70 38.31 16 18.431 41.50 339.696 
Total 34.18 97 19.531 36.00 381.459 
Muslim 
20 – 30 37.00 1 . 37.00 . 
40 – 50 31.50 2 23.335 31.50 544.500
Total 33.33 3 16.803 37.00 282.333 
Total 
< 20 22.33 3 17.898 12.00 320.333 
20 – 30 32.25 8 28.344 25.50 803.357 
30 – 40 30.11 9 22.779 20.00 518.861 
40 – 50 32.63 16 19.211 26.50 369.050 
50 – 60 33.16 25 17.738 33.00 314.640 
60 – 70 37.17 23 18.396 36.00 338.423 
> 70 38.31 16 18.431 41.50 339.696 
Total 34.15 100 19.381 36.00 375.624 
Other Married Hindu 30 – 40 34.00 4 23.509 28.50 552.667 
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40 – 50 14.00 1 . 14.00 . 
50 – 60 54.50 2 9.192 54.50 84.500 
60 – 70 41.00 2 11.314 41.00 128.000 
> 70 36.00 1 . 36.00 . 
Total 37.70 10 18.488 34.50 341.789 
Muslim 
> 70 68.00 1 . 68.00 .
Total 68.00 1 . 68.00 . 
Total 
30 – 40 34.00 4 23.509 28.50 552.667 
40 – 50 14.00 1 . 14.00 . 
50 – 60 54.50 2 9.192 54.50 84.500 
60 – 70 41.00 2 11.314 41.00 128.000
> 70 52.00 2 22.627 52.00 512.000 
Total 40.45 11 19.776 36.00 391.073 
Total 
Hindu 
30 – 40 34.00 4 23.509 28.50 552.667 
40 – 50 14.00 1 . 14.00 . 
50 – 60 54.50 2 9.192 54.50 84.500 
60 – 70 41.00 2 11.314 41.00 128.000 
> 70 36.00 1 . 36.00 . 
Total 37.70 10 18.488 34.50 341.789 
Muslim 
> 70 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Total 
30 – 40 34.00 4 23.509 28.50 552.667 
40 – 50 14.00 1 . 14.00 . 
50 – 60 54.50 2 9.192 54.50 84.500 
60 – 70 41.00 2 11.314 41.00 128.000 
> 70 52.00 2 22.627 52.00 512.000 
Total 40.45 11 19.776 36.00 391.073 
Total Unmarried 
Hindu 
< 20 25.25 24 20.063 18.50 402.543 
20 – 30 24.75 8 19.977 14.50 399.071 
30 – 40 15.00 1 . 15.00 . 
40 – 50 40.00 4 13.880 36.00 192.667 
50 – 60 28.00 1 . 28.00 . 
60 – 70 54.00 1 . 54.00 . 
Total 27.21 39 19.394 22.00 376.115 
Muslim 
< 20 26.50 2 17.678 26.50 312.500 
20 – 30 20.00 1 . 20.00 . 
Total 24.33 3 13.051 20.00 170.333 
Total < 20 25.35 26 19.569 18.50 382.955 
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20 – 30 24.22 9 18.754 15.00 351.694 
30 – 40 15.00 1 . 15.00 . 
40 – 50 40.00 4 13.880 36.00 192.667 
50 – 60 28.00 1 . 28.00 . 
60 – 70 54.00 1 . 54.00 . 
Total 27.00 42 18.907 21.00 357.463
Married 
Hindu 
20 – 30 38.85 20 26.502 37.00 702.345 
30 – 40 33.65 72 20.521 25.50 421.131 
40 – 50 82.63 123 543.720 32.00 295631.267 
50 – 60 33.19 150 18.610 33.00 346.341
60 – 70 37.55 96 17.772 36.00 315.829 
> 70 40.04 49 18.619 38.00 346.665 
Total 46.88 510 267.486 33.50 71548.927 
Muslim 
20 – 30 37.50 4 21.703 44.50 471.000 
30 – 40 42.40 5 23.384 47.00 546.800 
40 – 50 31.82 11 18.154 23.00 329.564 
50 – 60 27.80 10 21.070 22.50 443.956 
60 – 70 56.40 5 14.293 60.00 204.300 
> 70 68.00 1 . 68.00 . 
Total 37.22 36 21.273 36.00 452.521 
Christian 
40 – 50 48.00 1 . 48.00 . 
Total 48.00 1 . 48.00 . 
Total 
20 – 30 38.63 24 25.336 42.50 641.897 
30 – 40 34.22 77 20.662 26.00 426.911 
40 – 50 78.24 135 519.021 32.00 269382.869 
50 – 60 32.85 160 18.746 33.00 351.399
60 – 70 38.49 101 18.030 36.00 325.092 
> 70 40.60 50 18.847 39.00 355.224 
Total 46.25 547 258.331 34.00 66735.131 
Widowed 
Hindu 
30 – 40 28.00 1 . 28.00 . 
40 – 50 47.00 1 . 47.00 . 
50 – 60 57.50 2 14.849 57.50 220.500 
60 – 70 35.50 4 9.539 34.50 91.000 
> 70 43.80 5 21.833 47.00 476.700 
Total 42.38 13 16.546 47.00 273.756 
Total 
30 – 40 28.00 1 . 28.00 . 
40 – 50 47.00 1 . 47.00 . 
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50 – 60 57.50 2 14.849 57.50 220.500 
60 – 70 35.50 4 9.539 34.50 91.000 
> 70 43.80 5 21.833 47.00 476.700 
Total 42.38 13 16.546 47.00 273.756 
Divorced 
Hindu 
40 – 50 29.00 1 . 29.00 . 
Total 29.00 1 . 29.00 .
Total 
40 – 50 29.00 1 . 29.00 . 
Total 29.00 1 . 29.00 . 
Total 
Hindu 
< 20 25.25 24 20.063 18.50 402.543 
20 – 30 34.82 28 25.294 24.00 639.782 
30 – 40 33.32 74 20.364 25.50 414.688
40 – 50 80.62 129 530.908 33.00 281863.175 
50 – 60 33.47 153 18.677 33.00 348.830 
60 – 70 37.63 101 17.482 36.00 305.634 
> 70 40.39 54 18.739 39.00 351.148 
Total 45.38 563 254.673 33.00 64858.357 
Muslim 
< 20 26.50 2 17.678 26.50 312.500 
20 – 30 34.00 5 20.359 37.00 414.500 
30 – 40 42.40 5 23.384 47.00 546.800 
40 – 50 31.82 11 18.154 23.00 329.564 
50 – 60 27.80 10 21.070 22.50 443.956 
60 – 70 56.40 5 14.293 60.00 204.300 
> 70 68.00 1 . 68.00 . 
Total 36.23 39 20.925 36.00 437.866 
Christian 
40 – 50 48.00 1 . 48.00 . 
Total 48.00 1 . 48.00 . 
Total 
< 20 25.35 26 19.569 18.50 382.955 
20 – 30 34.70 33 24.325 26.00 591.718 
30 – 40 33.90 79 20.521 26.00 421.092 
40 – 50 76.58 141 507.844 33.00 257905.317 
50 – 60 33.12 163 18.810 33.00 353.824 
60 – 70 38.52 106 17.744 36.00 314.842 
> 70 40.89 55 18.934 40.00 358.506 
Total 44.79 603 246.133 33.00 60581.562 
Female Gujarati Unmarried Hindu < 20 26.22 9 16.917 20.00 286.194 
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20 – 30 51.00 3 32.909 70.00 1083.000 
30 – 40 54.00 1 . 54.00 . 
40 – 50 13.00 1 . 13.00 . 
60 – 70 73.00 1 . 73.00 . 
Total 35.27 15 24.209 32.00 586.067 
Muslim 
< 20 44.00 1 . 44.00 . 
Total 44.00 1 . 44.00 . 
Total 
< 20 28.00 10 16.912 26.00 286.000 
20 – 30 51.00 3 32.909 70.00 1083.000 
30 – 40 54.00 1 . 54.00 . 
40 – 50 13.00 1 . 13.00 . 
60 – 70 73.00 1 . 73.00 . 
Total 35.81 16 23.490 35.50 551.763 
Married 
Hindu 
20 – 30 25.86 14 16.801 19.50 282.286 
30 – 40 20.72 53 13.939 17.00 194.284 
40 – 50 26.99 79 19.734 17.00 389.449 
50 – 60 28.22 60 18.595 19.50 345.766 
60 – 70 30.17 24 17.402 27.50 302.841 
> 70 27.50 4 20.091 20.00 403.667 
Total 26.15 234 17.941 17.00 321.879 
Muslim 
20 – 30 41.50 2 40.305 41.50 1624.500 
30 – 40 13.67 3 1.155 13.00 1.333 
40 – 50 25.91 11 21.178 15.00 448.491 
50 – 60 13.00 1 . 13.00 . 
60 – 70 13.00 2 .000 13.00 .000 
> 70 5.00 1 . 5.00 . 
Total 22.65 20 20.226 13.00 409.082 
Sikh 
30 – 40 65.00 1 . 65.00 . 
Total 65.00 1 . 65.00 . 
Christian 
60 – 70 17.00 1 . 17.00 . 
Total 17.00 1 . 17.00 . 
Total 
20 – 30 27.81 16 19.532 19.50 381.496 
30 – 40 21.12 57 14.764 17.00 217.967 
40 – 50 26.86 90 19.795 17.00 391.833 
50 – 60 27.97 61 18.542 18.00 343.799 
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60 – 70 28.41 27 17.147 23.00 294.020 
> 70 23.00 5 20.100 17.00 404.000 
Total 25.99 256 18.215 17.00 331.772 
Widowed 
 
 
 
 
Hindu 
30 – 40 23.67 3 5.859 26.00 34.333 
40 – 50 31.85 13 21.181 23.00 448.641 
50 – 60 25.64 14 17.679 17.00 312.555 
60 – 70 24.64 11 17.287 17.00 298.855 
> 70 29.63 8 22.174 19.00 491.696 
Total 27.59 49 18.490 17.00 341.872 
Muslim 
30 – 40 51.00 1 . 51.00 . 
40 – 50 27.00 1 . 27.00 . 
60 – 70 52.00 2 28.284 52.00 800.000 
> 70 49.00 2 15.556 49.00 242.000 
Total 46.67 6 17.409 44.50 303.067 
Total 
30 – 40 30.50 4 14.480 27.00 209.667 
40 – 50 31.50 14 20.391 25.00 415.808 
50 – 60 25.64 14 17.679 17.00 312.555 
60 – 70 28.85 13 20.526 21.00 421.308 
> 70 33.50 10 21.819 28.50 476.056 
Total 29.67 55 19.182 21.00 367.965 
Divorced 
Hindu 
20 – 30 73.00 1 . 73.00 . 
30 – 40 28.50 2 21.920 28.50 480.500 
Total 43.33 3 30.006 44.00 900.333 
Total 
20 – 30 73.00 1 . 73.00 . 
30 – 40 28.50 2 21.920 28.50 480.500 
Total 43.33 3 30.006 44.00 900.333 
Total 
Hindu 
< 20 26.22 9 16.917 20.00 286.194 
20 – 30 32.67 18 23.162 24.00 536.471 
30 – 40 21.69 59 14.294 17.00 204.319 
40 – 50 27.52 93 19.846 17.00 393.883 
50 – 60 27.73 74 18.334 17.00 336.145 
60 – 70 29.67 36 18.606 23.00 346.171 
> 70 28.92 12 20.593 19.00 424.083 
Total 27.01 301 18.567 17.00 344.750 
Muslim 
< 20 44.00 1 . 44.00 . 
20 – 30 41.50 2 40.305 41.50 1624.500
30 – 40 23.00 4 18.690 14.00 349.333 
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40 – 50 26.00 12 20.195 16.00 407.818 
50 – 60 13.00 1 . 13.00 . 
60 – 70 32.50 4 27.815 22.50 773.667 
> 70 34.33 3 27.683 38.00 766.333 
Total 28.78 27 21.653 15.00 468.872 
Sikh 
30 – 40 65.00 1 . 65.00 .
Total 65.00 1 . 65.00 . 
Christian 
60 – 70 17.00 1 . 17.00 . 
Total 17.00 1 . 17.00 . 
Total 
< 20 28.00 10 16.912 26.00 286.000 
20 – 30 33.55 20 23.935 24.00 572.892
30 – 40 22.45 64 15.298 17.00 234.030 
40 – 50 27.34 105 19.794 17.00 391.804 
50 – 60 27.53 75 18.289 17.00 334.495 
60 – 70 29.63 41 19.124 23.00 365.738 
> 70 30.00 15 21.159 21.00 447.714 
Total 27.24 330 18.876 17.00 356.310 
Hindi 
Unmarried 
Hindu 
< 20 13.00 2 12.728 13.00 162.000 
40 – 50 54.00 1 . 54.00 . 
50 – 60 13.00 1 . 13.00 . 
Total 23.25 4 21.777 17.50 474.250 
Total 
< 20 13.00 2 12.728 13.00 162.000 
40 – 50 54.00 1 . 54.00 . 
50 – 60 13.00 1 . 13.00 . 
Total 23.25 4 21.777 17.50 474.250 
Married 
Hindu 
20 – 30 24.67 3 19.348 14.00 374.333 
30 – 40 45.91 11 20.584 44.00 423.691 
40 – 50 22.38 13 14.655 17.00 214.756 
50 – 60 23.20 15 15.974 17.00 255.171 
60 – 70 27.57 7 14.741 21.00 217.286 
> 70 37.00 1 . 37.00 . 
Total 28.96 50 18.512 17.00 342.692 
Muslim 
40 – 50 48.00 1 . 48.00 . 
50 – 60 13.00 1 . 13.00 . 
Total 30.50 2 24.749 30.50 612.500 
Total 
20 – 30 24.67 3 19.348 14.00 374.333 
30 – 40 45.91 11 20.584 44.00 423.691 
40 – 50 24.21 14 15.656 17.00 245.104 
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50 – 60 22.56 16 15.642 17.00 244.663 
60 – 70 27.57 7 14.741 21.00 217.286 
> 70 37.00 1 . 37.00 . 
Total 29.02 52 18.476 17.00 341.353 
Widowed 
Hindu 
50 – 60 29.60 5 24.079 23.00 579.800 
60 – 70 44.75 4 22.824 45.00 520.917
> 70 57.00 1 . 57.00 . 
Total 38.40 10 23.037 31.50 530.711 
Total 
50 – 60 29.60 5 24.079 23.00 579.800 
60 – 70 44.75 4 22.824 45.00 520.917 
> 70 57.00 1 . 57.00 .
Total 38.40 10 23.037 31.50 530.711 
Divorced 
Hindu 
20 – 30 22.00 1 . 22.00 . 
Total 22.00 1 . 22.00 . 
Total 
20 – 30 22.00 1 . 22.00 . 
Total 22.00 1 . 22.00 . 
Total 
Hindu 
< 20 13.00 2 12.728 13.00 162.000 
20 – 30 24.00 4 15.853 18.00 251.333 
30 – 40 45.91 11 20.584 44.00 423.691 
40 – 50 24.64 14 16.420 17.00 269.632 
50 – 60 24.24 21 17.575 17.00 308.890 
60 – 70 33.82 11 19.020 35.00 361.764 
> 70 47.00 2 14.142 47.00 200.000 
Total 29.95 65 19.364 21.00 374.951 
Muslim 
40 – 50 48.00 1 . 48.00 . 
50 – 60 13.00 1 . 13.00 . 
Total 30.50 2 24.749 30.50 612.500 
Total 
< 20 13.00 2 12.728 13.00 162.000 
20 – 30 24.00 4 15.853 18.00 251.333 
30 – 40 45.91 11 20.584 44.00 423.691 
40 – 50 26.20 15 16.933 17.00 286.743 
50 – 60 23.73 22 17.318 17.00 299.922 
60 – 70 33.82 11 19.020 35.00 361.764 
> 70 47.00 2 14.142 47.00 200.000 
Total 29.97 67 19.310 21.00 372.878 
Other Unmarried 
Hindu 
< 20 14.00 1 . 14.00 . 
Total 14.00 1 . 14.00 . 
Total < 20 14.00 1 . 14.00 . 
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Total 14.00 1 . 14.00 . 
Married 
Hindu 
20 – 30 13.00 1 . 13.00 . 
30 – 40 13.00 1 . 13.00 . 
40 – 50 13.00 1 . 13.00 . 
50 – 60 38.00 2 29.698 38.00 882.000 
Total 23.00 5 20.199 13.00 408.000
Muslim 
30 – 40 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Total 
20 – 30 13.00 1 . 13.00 . 
30 – 40 40.50 2 38.891 40.50 1512.500 
40 – 50 13.00 1 . 13.00 .
50 – 60 38.00 2 29.698 38.00 882.000 
Total 30.50 6 25.766 15.00 663.900 
Widowed 
Hindu 
60 – 70 14.00 1 . 14.00 . 
Total 14.00 1 . 14.00 . 
Jain 
40 – 50 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Total 
40 – 50 68.00 1 . 68.00 . 
60 – 70 14.00 1 . 14.00 . 
Total 41.00 2 38.184 41.00 1458.000 
Total 
Hindu 
< 20 14.00 1 . 14.00 . 
20 – 30 13.00 1 . 13.00 . 
30 – 40 13.00 1 . 13.00 . 
40 – 50 13.00 1 . 13.00 . 
50 – 60 38.00 2 29.698 38.00 882.000 
60 – 70 14.00 1 . 14.00 . 
Total 20.43 7 17.067 14.00 291.286 
Muslim 
30 – 40 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Jain 
40 – 50 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Total 
< 20 14.00 1 . 14.00 . 
20 – 30 13.00 1 . 13.00 . 
30 – 40 40.50 2 38.891 40.50 1512.500 
40 – 50 40.50 2 38.891 40.50 1512.500 
50 – 60 38.00 2 29.698 38.00 882.000 
60 – 70 14.00 1 . 14.00 . 
Total 31.00 9 25.661 14.00 658.500 
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Total 
Unmarried 
Hindu 
< 20 23.00 12 16.028 17.00 256.909 
20 – 30 51.00 3 32.909 70.00 1083.000 
30 – 40 54.00 1 . 54.00 . 
40 – 50 33.50 2 28.991 33.50 840.500 
50 – 60 13.00 1 . 13.00 . 
60 – 70 73.00 1 . 73.00 .
Total 31.80 20 23.415 21.00 548.274 
Muslim 
< 20 44.00 1 . 44.00 . 
Total 44.00 1 . 44.00 . 
Total 
< 20 24.62 13 16.414 20.00 269.423 
20 – 30 51.00 3 32.909 70.00 1083.000
30 – 40 54.00 1 . 54.00 . 
40 – 50 33.50 2 28.991 33.50 840.500 
50 – 60 13.00 1 . 13.00 . 
60 – 70 73.00 1 . 73.00 . 
Total 32.38 21 22.977 22.00 527.948 
Married 
Hindu 
20 – 30 24.94 18 16.401 17.00 268.997 
30 – 40 24.86 65 17.794 17.00 316.621 
40 – 50 26.19 93 19.044 17.00 362.680 
50 – 60 27.49 77 18.275 17.00 333.990 
60 – 70 29.58 31 16.639 27.00 276.852 
> 70 29.40 5 17.911 23.00 320.800 
Total 26.58 289 18.048 17.00 325.737 
Muslim 
20 – 30 41.50 2 40.305 41.50 1624.500 
30 – 40 27.25 4 27.183 14.00 738.917 
40 – 50 27.75 12 21.175 16.00 448.386 
50 – 60 13.00 2 .000 13.00 .000 
60 – 70 13.00 2 .000 13.00 .000 
> 70 5.00 1 . 5.00 . 
Total 25.30 23 21.745 13.00 472.858 
Sikh 
30 – 40 65.00 1 . 65.00 . 
Total 65.00 1 . 65.00 . 
Christian 
60 – 70 17.00 1 . 17.00 . 
Total 17.00 1 . 17.00 . 
Total 
20 – 30 26.60 20 18.766 17.00 352.147 
30 – 40 25.57 70 18.681 17.00 348.973 
40 – 50 26.37 105 19.196 17.00 368.505 
50 – 60 27.13 79 18.185 17.00 330.676 
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60 – 70 28.24 34 16.470 22.00 271.276 
> 70 25.33 6 18.864 20.00 355.867 
Total 26.58 314 18.387 17.00 338.085 
Widowed 
Hindu 
30 – 40 23.67 3 5.859 26.00 34.333 
40 – 50 31.85 13 21.181 23.00 448.641 
50 – 60 26.68 19 18.915 17.00 357.784
60 – 70 29.00 16 19.963 19.00 398.533 
> 70 32.67 9 22.661 21.00 513.500 
Total 29.17 60 19.481 17.00 379.497 
Muslim 
30 – 40 51.00 1 . 51.00 . 
40 – 50 27.00 1 . 27.00 .
60 – 70 52.00 2 28.284 52.00 800.000 
> 70 49.00 2 15.556 49.00 242.000 
Total 46.67 6 17.409 44.50 303.067 
Jain 
40 – 50 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Total 
30 – 40 30.50 4 14.480 27.00 209.667 
40 – 50 33.93 15 21.793 27.00 474.924 
50 – 60 26.68 19 18.915 17.00 357.784 
60 – 70 31.56 18 21.308 22.00 454.026 
> 70 35.64 11 21.878 36.00 478.655 
Total 31.31 67 20.204 23.00 408.218 
Divorced 
Hindu 
20 – 30 47.50 2 36.062 47.50 1300.500 
30 – 40 28.50 2 21.920 28.50 480.500 
Total 38.00 4 26.721 33.00 714.000 
Total 
20 – 30 47.50 2 36.062 47.50 1300.500 
30 – 40 28.50 2 21.920 28.50 480.500 
Total 38.00 4 26.721 33.00 714.000 
Total 
Hindu 
< 20 23.00 12 16.028 17.00 256.909 
20 – 30 30.30 23 21.777 22.00 474.221 
30 – 40 25.32 71 17.598 17.00 309.679 
40 – 50 27.01 108 19.345 17.00 374.215 
50 – 60 27.19 97 18.268 17.00 333.715 
60 – 70 30.29 48 18.537 23.00 343.615 
> 70 31.50 14 20.429 22.00 417.346 
Total 27.40 373 18.692 17.00 349.407 
Muslim 
< 20 44.00 1 . 44.00 . 
20 – 30 41.50 2 40.305 41.50 1624.500 
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30 – 40 32.00 5 25.826 15.00 667.000 
40 – 50 27.69 13 20.275 17.00 411.064 
50 – 60 13.00 2 .000 13.00 .000 
60 – 70 32.50 4 27.815 22.50 773.667 
> 70 34.33 3 27.683 38.00 766.333 
Total 30.20 30 22.196 16.00 492.648
Jain 
40 – 50 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Sikh 
30 – 40 65.00 1 . 65.00 . 
Total 65.00 1 . 65.00 . 
Christian 
60 – 70 17.00 1 . 17.00 .
Total 17.00 1 . 17.00 . 
Total 
< 20 24.62 13 16.414 20.00 269.423 
20 – 30 31.20 25 22.627 22.00 512.000 
30 – 40 26.27 77 18.522 17.00 343.069 
40 – 50 27.42 122 19.633 17.00 385.452 
50 – 60 26.90 99 18.191 17.00 330.928 
60 – 70 30.21 53 18.947 23.00 358.975 
> 70 32.00 17 20.884 23.00 436.125 
Total 27.77 406 19.091 17.00 364.482 
Total Gujarati 
Unmarried 
Hindu 
< 20 25.83 30 19.370 20.00 375.178 
20 – 30 33.70 10 26.056 18.50 678.900 
30 – 40 34.50 2 27.577 34.50 760.500 
40 – 50 34.50 4 19.672 32.50 387.000 
50 – 60 28.00 1 . 28.00 . 
60 – 70 63.50 2 13.435 63.50 180.500 
Total 30.08 49 21.467 24.00 460.827 
Muslim 
< 20 32.33 3 16.073 39.00 258.333 
20 – 30 20.00 1 . 20.00 . 
Total 29.25 4 14.500 29.50 210.250 
Total 
< 20 26.42 33 18.967 20.00 359.752 
20 – 30 32.45 11 25.061 20.00 628.073 
30 – 40 34.50 2 27.577 34.50 760.500 
40 – 50 34.50 4 19.672 32.50 387.000 
50 – 60 28.00 1 . 28.00 . 
60 – 70 63.50 2 13.435 63.50 180.500 
Total 30.02 53 20.918 24.00 437.557 
Married Hindu 20 – 30 33.29 28 22.077 26.00 487.397 
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30 – 40 27.80 112 18.773 17.00 352.412 
40 – 50 63.07 188 440.150 26.00 193731.962 
50 – 60 31.33 183 18.798 26.00 353.353 
60 – 70 35.71 95 17.970 33.00 322.912 
> 70 39.53 36 19.502 37.00 380.313 
Total 41.20 642 238.694 26.00 56974.639 
Muslim 
20 – 30 39.20 5 27.635 52.00 763.700 
30 – 40 31.63 8 23.108 19.00 533.982 
40 – 50 28.60 20 19.752 21.00 390.147 
50 – 60 26.45 11 20.481 22.00 419.473
60 – 70 44.00 7 24.180 48.00 584.667 
> 70 5.00 1 . 5.00 . 
Total 31.25 52 21.894 23.00 479.328 
Sikh 
30 – 40 65.00 1 . 65.00 . 
Total 65.00 1 . 65.00 . 
Christian 
40 – 50 48.00 1 . 48.00 . 
60 – 70 17.00 1 . 17.00 . 
Total 32.50 2 21.920 32.50 480.500 
Total 
20 – 30 34.18 33 22.613 26.00 511.341 
30 – 40 28.36 121 19.218 17.00 369.317 
40 – 50 59.70 209 417.507 23.00 174312.075 
50 – 60 31.05 194 18.874 26.00 356.225 
60 – 70 36.09 103 18.439 33.00 339.982 
> 70 38.59 37 20.049 36.00 401.970 
Total 40.47 697 229.164 26.00 52516.040 
Widowed 
Hindu 
30 – 40 24.75 4 5.252 27.00 27.583
40 – 50 32.93 14 20.749 25.50 430.533 
50 – 60 29.63 16 20.099 17.00 403.983 
60 – 70 27.53 15 16.053 23.00 257.695 
> 70 35.08 13 22.299 36.00 497.244 
Total 30.69 62 18.966 23.00 359.724 
Muslim 
30 – 40 51.00 1 . 51.00 . 
40 – 50 27.00 1 . 27.00 . 
60 – 70 52.00 2 28.284 52.00 800.000 
> 70 49.00 2 15.556 49.00 242.000 
Total 46.67 6 17.409 44.50 303.067 
Total 30 – 40 30.00 5 12.590 28.00 158.500 
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40 – 50 32.53 15 20.053 27.00 402.124 
50 – 60 29.63 16 20.099 17.00 403.983 
60 – 70 30.41 17 18.480 25.00 341.507 
> 70 36.93 15 21.622 36.00 467.495 
Total 32.10 68 19.260 25.50 370.959 
Divorced 
Hindu 
20 – 30 73.00 1 . 73.00 .
30 – 40 28.50 2 21.920 28.50 480.500 
40 – 50 29.00 1 . 29.00 . 
Total 39.75 4 25.526 36.50 651.583 
Total 
20 – 30 73.00 1 . 73.00 . 
30 – 40 28.50 2 21.920 28.50 480.500
40 – 50 29.00 1 . 29.00 . 
Total 39.75 4 25.526 36.50 651.583 
Total 
Hindu 
< 20 25.83 30 19.370 20.00 375.178 
20 – 30 34.41 39 23.396 26.00 547.354 
30 – 40 27.82 120 18.464 17.00 340.919 
40 – 50 60.32 207 419.490 26.00 175971.908 
50 – 60 31.17 200 18.812 26.00 353.884 
60 – 70 35.11 112 18.171 33.00 330.169 
> 70 38.35 49 20.139 36.00 405.565 
Total 39.61 757 219.962 26.00 48383.290 
Muslim 
< 20 32.33 3 16.073 39.00 258.333 
20 – 30 36.00 6 25.931 36.00 672.400 
30 – 40 33.78 9 22.560 23.00 508.944 
40 – 50 28.52 21 19.255 23.00 370.762 
50 – 60 26.45 11 20.481 22.00 419.473 
60 – 70 45.78 9 23.472 48.00 550.944 
> 70 34.33 3 27.683 38.00 766.333 
Total 32.61 62 21.394 23.00 457.684 
Sikh 
30 – 40 65.00 1 . 65.00 . 
Total 65.00 1 . 65.00 . 
Christian 
40 – 50 48.00 1 . 48.00 . 
60 – 70 17.00 1 . 17.00 . 
Total 32.50 2 21.920 32.50 480.500 
Total 
< 20 26.42 33 18.967 20.00 359.752 
20 – 30 34.62 45 23.440 26.00 549.422 
30 – 40 28.52 130 18.941 17.00 358.748 
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40 – 50 57.35 229 398.885 26.00 159109.605 
50 – 60 30.93 211 18.879 26.00 356.428 
60 – 70 35.75 122 18.710 33.00 350.075 
> 70 38.12 52 20.314 36.00 412.653 
Total 39.10 822 211.167 26.00 44591.637 
Hindi 
Unmarried 
Hindu 
< 20 18.60 5 15.060 12.00 226.800 
20 – 30 14.00 1 . 14.00 . 
40 – 50 44.50 2 13.435 44.50 180.500 
50 – 60 13.00 1 . 13.00 . 
Total 23.22 9 16.917 14.00 286.194
Total 
< 20 18.60 5 15.060 12.00 226.800 
20 – 30 14.00 1 . 14.00 . 
40 – 50 44.50 2 13.435 44.50 180.500 
50 – 60 13.00 1 . 13.00 . 
Total 23.22 9 16.917 14.00 286.194 
Married 
Hindu 
20 – 30 31.22 9 27.793 14.00 772.444 
30 – 40 38.80 20 22.505 40.50 506.484 
40 – 50 27.50 26 18.155 18.00 329.620 
50 – 60 29.43 40 17.580 23.00 309.071 
60 – 70 34.93 30 17.854 36.00 318.754 
> 70 38.24 17 17.848 38.00 318.566 
Total 32.73 142 19.389 34.00 375.917 
Muslim 
20 – 30 37.00 1 . 37.00 . 
40 – 50 37.00 3 19.053 48.00 363.000 
50 – 60 13.00 1 . 13.00 . 
Total 32.20 5 17.225 37.00 296.700 
Total 
20 – 30 31.80 10 26.267 25.50 689.956 
30 – 40 38.80 20 22.505 40.50 506.484 
40 – 50 28.48 29 18.136 19.00 328.901 
50 – 60 29.02 41 17.548 23.00 307.924 
60 – 70 34.93 30 17.854 36.00 318.754 
> 70 38.24 17 17.848 38.00 318.566 
Total 32.71 147 19.266 35.00 371.181 
Widowed Hindu 
50 – 60 29.60 5 24.079 23.00 579.800 
60 – 70 44.75 4 22.824 45.00 520.917 
> 70 57.00 1 . 57.00 . 
Total 38.40 10 23.037 31.50 530.711 
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Total 
50 – 60 29.60 5 24.079 23.00 579.800 
60 – 70 44.75 4 22.824 45.00 520.917 
> 70 57.00 1 . 57.00 . 
Total 38.40 10 23.037 31.50 530.711 
Divorced 
Hindu 
20 – 30 22.00 1 . 22.00 . 
Total 22.00 1 . 22.00 .
Total 
20 – 30 22.00 1 . 22.00 . 
Total 22.00 1 . 22.00 . 
Total 
Hindu 
< 20 18.60 5 15.060 12.00 226.800 
20 – 30 28.82 11 25.490 14.00 649.764 
30 – 40 38.80 20 22.505 40.50 506.484
40 – 50 28.71 28 18.214 20.50 331.767 
50 – 60 29.09 46 18.036 23.00 325.281 
60 – 70 36.09 34 18.379 36.00 337.780 
> 70 39.28 18 17.871 41.50 319.389 
Total 32.48 162 19.514 30.50 380.810 
Muslim 
20 – 30 37.00 1 . 37.00 . 
40 – 50 37.00 3 19.053 48.00 363.000 
50 – 60 13.00 1 . 13.00 . 
Total 32.20 5 17.225 37.00 296.700 
Total 
< 20 18.60 5 15.060 12.00 226.800 
20 – 30 29.50 12 24.419 18.00 596.273 
30 – 40 38.80 20 22.505 40.50 506.484 
40 – 50 29.52 31 18.138 22.00 328.991 
50 – 60 28.74 47 17.992 23.00 323.716 
60 – 70 36.09 34 18.379 36.00 337.780 
> 70 39.28 18 17.871 41.50 319.389 
Total 32.47 167 19.403 33.00 376.492 
Other 
Unmarried 
Hindu 
< 20 14.00 1 . 14.00 . 
Total 14.00 1 . 14.00 . 
Total 
< 20 14.00 1 . 14.00 . 
Total 14.00 1 . 14.00 . 
Married Hindu 
20 – 30 13.00 1 . 13.00 . 
30 – 40 29.80 5 22.421 25.00 502.700 
40 – 50 13.50 2 .707 13.50 .500 
50 – 60 46.25 4 20.320 53.50 412.917 
60 – 70 41.00 2 11.314 41.00 128.000 
> 70 36.00 1 . 36.00 . 
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Total 32.80 15 19.691 32.00 387.743 
Muslim 
30 – 40 68.00 1 . 68.00 . 
> 70 68.00 1 . 68.00 . 
Total 68.00 2 .000 68.00 .000 
Total 
20 – 30 13.00 1 . 13.00 . 
30 – 40 36.17 6 25.404 28.50 645.367
40 – 50 13.50 2 .707 13.50 .500 
50 – 60 46.25 4 20.320 53.50 412.917 
60 – 70 41.00 2 11.314 41.00 128.000 
> 70 52.00 2 22.627 52.00 512.000 
Total 36.94 17 21.816 33.00 475.934
Widowed 
Hindu 
60 – 70 14.00 1 . 14.00 . 
Total 14.00 1 . 14.00 . 
Jain 
40 – 50 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Total 
40 – 50 68.00 1 . 68.00 . 
60 – 70 14.00 1 . 14.00 . 
Total 41.00 2 38.184 41.00 1458.000 
Total 
Hindu 
< 20 14.00 1 . 14.00 . 
20 – 30 13.00 1 . 13.00 . 
30 – 40 29.80 5 22.421 25.00 502.700 
40   -  50  2 .707 13.50 .500 
50 – 60 46.25 4 20.320 53.50 412.917 
60 – 70 32.00 3 17.521 33.00 307.000 
> 70 36.00 1 . 36.00 . 
Total 30.59 17 19.449 25.00 378.257 
Muslim 
30 – 40 68.00 1 . 68.00 . 
> 70 68.00 1 . 68.00 . 
Total 68.00 2 .000 68.00 .000 
Jain 
40 – 50 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Total 
< 20 14.00 1 . 14.00 . 
20 – 30 13.00 1 . 13.00 . 
30 – 40 36.17 6 25.404 28.50 645.367 
40 – 50 31.67 3 31.470 14.00 990.333 
50 – 60 46.25 4 20.320 53.50 412.917 
60 – 70 32.00 3 17.521 33.00 307.000 
> 70 52.00 2 22.627 52.00 512.000 
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Total 36.20 20 22.503 32.50 506.379 
Total 
Unmarried 
Hindu 
< 20 24.50 36 18.613 18.50 346.429 
20 – 30 31.91 11 25.422 15.00 646.291 
30 – 40 34.50 2 27.577 34.50 760.500 
40 – 50 37.83 6 17.175 36.00 294.967 
50 – 60 20.50 2 10.607 20.50 112.500
60 – 70 63.50 2 13.435 63.50 180.500 
Total 28.76 59 20.757 22.00 430.839 
Muslim 
< 20 32.33 3 16.073 39.00 258.333 
20 – 30 20.00 1 . 20.00 . 
Total 29.25 4 14.500 29.50 210.250
Total 
< 20 25.10 39 18.362 20.00 337.147 
20 – 30 30.92 12 24.482 17.50 599.356 
30 – 40 34.50 2 27.577 34.50 760.500 
40 – 50 37.83 6 17.175 36.00 294.967 
50 – 60 20.50 2 10.607 20.50 112.500 
60 – 70 63.50 2 13.435 63.50 180.500 
Total 28.79 63 20.328 22.00 413.231 
Married 
Hindu 
20 – 30 32.26 38 23.103 24.00 533.767 
30 – 40 29.48 137 19.704 20.00 388.266 
40 – 50 58.33 216 410.723 23.00 168693.405 
50 – 60 31.26 227 18.653 26.00 347.952 
60 – 70 35.61 127 17.772 36.00 315.860 
> 70 39.06 54 18.651 37.50 347.865 
Total 39.54 799 214.126 26.00 45849.908 
Muslim 
20 – 30 38.83 6 24.734 44.50 611.767 
30 – 40 35.67 9 24.784 23.00 614.250 
40 – 50 29.70 23 19.450 23.00 378.312 
50 – 60 25.33 12 19.910 18.50 396.424 
60 – 70 44.00 7 24.180 48.00 584.667 
> 70 36.50 2 44.548 36.50 1984.500 
Total 32.58 59 22.064 23.00 486.800 
Sikh 
30 – 40 65.00 1 . 65.00 . 
Total 65.00 1 . 65.00 . 
Christian 
40 – 50 48.00 1 . 48.00 . 
60 – 70 17.00 1 . 17.00 . 
Total 32.50 2 21.920 32.50 480.500 
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Total 
20 – 30 33.16 44 23.144 26.00 535.625 
30 – 40 30.10 147 20.148 22.00 405.942 
40 – 50 55.55 240 389.692 23.00 151859.872 
50 – 60 30.96 239 18.719 26.00 350.410 
60 – 70 35.90 135 18.148 36.00 329.356 
> 70 38.96 56 19.275 37.50 371.526 
Total 39.07 861 206.354 26.00 42581.818 
Widowed 
Hindu 
30 – 40 24.75 4 5.252 27.00 27.583 
40 – 50 32.93 14 20.749 25.50 430.533 
50 – 60 29.62 21 20.468 17.00 418.948
60 – 70 30.30 20 18.333 24.00 336.116 
> 70 36.64 14 22.211 36.00 493.324 
Total 31.52 73 19.558 23.00 382.531 
Muslim 
30 – 40 51.00 1 . 51.00 . 
40 – 50 27.00 1 . 27.00 . 
60 – 70 52.00 2 28.284 52.00 800.000 
> 70 49.00 2 15.556 49.00 242.000 
Total 46.67 6 17.409 44.50 303.067 
Jain 
40 – 50 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Total 
30 – 40 30.00 5 12.590 28.00 158.500 
40 – 50 34.75 16 21.306 27.50 453.933 
50 – 60 29.62 21 20.468 17.00 418.948 
60 – 70 32.27 22 19.570 28.50 382.970 
> 70 38.19 16 21.482 37.00 461.496 
Total 33.11 80 19.988 25.50 399.519 
Divorced 
Hindu 
20 – 30 47.50 2 36.062 47.50 1300.500 
30 – 40 28.50 2 21.920 28.50 480.500 
40 – 50 29.00 1 . 29.00 . 
Total 36.20 5 23.488 29.00 551.700 
Total 
20 – 30 47.50 2 36.062 47.50 1300.500 
30 – 40 28.50 2 21.920 28.50 480.500 
40 – 50 29.00 1 . 29.00 . 
Total 36.20 5 23.488 29.00 551.700 
Total Hindu 
< 20 24.50 36 18.613 18.50 346.429 
20 – 30 32.78 51 23.649 22.00 559.293 
30 – 40 29.41 145 19.413 22.00 376.868 
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40 – 50 56.19 237 392.123 23.00 153760.519 
50 – 60 31.03 250 18.736 26.00 351.019 
60 – 70 35.27 149 18.096 35.00 327.481 
> 70 38.56 68 19.284 36.50 371.862 
Total 38.22 936 197.992 26.00 39200.991 
Muslim 
< 20 32.33 3 16.073 39.00 258.333 
20 – 30 36.14 7 23.674 37.00 560.476 
30 – 40 37.20 10 23.864 35.00 569.511 
40 – 50 29.58 24 19.031 23.00 362.167 
50 – 60 25.33 12 19.910 18.50 396.424
60 – 70 45.78 9 23.472 48.00 550.944 
> 70 42.75 4 28.182 49.00 794.250 
Total 33.61 69 21.537 27.00 463.859 
Jain 
40 – 50 68.00 1 . 68.00 . 
Total 68.00 1 . 68.00 . 
Sikh 
30 – 40 65.00 1 . 65.00 . 
Total 65.00 1 . 65.00 . 
Christian 
40 – 50 48.00 1 . 48.00 . 
60 – 70 17.00 1 . 17.00 . 
Total 32.50 2 21.920 32.50 480.500 
Total 
< 20 25.10 39 18.362 20.00 337.147 
20 – 30 33.19 58 23.470 22.00 550.823 
30 – 40 30.13 156 19.868 22.00 394.750 
40 – 50 53.78 263 372.281 23.00 138593.419 
50 – 60 30.77 262 18.789 26.00 353.012 
60 – 70 35.75 159 18.515 36.00 342.822
> 70 38.79 72 19.632 37.50 385.407 
Total 37.95 1009 190.780 26.00 36396.835 
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One-Sample Statistics
 
 N Mean Std. Deviation Std. Error Mean 
DIESEAS 1009 37.95 190.780 6.006 
 
One-Sample Test  
 
 
Test Value = 0 
t df Sig. (2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
Lower Upper 
DIESEAS 6.318 1008 .000 37.95 26.16 49.73 
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T-Test Table 8 
 
Group Statistics  
 
 GENDER N Mean Std. Deviation Std. Error Mean
DIESEAS 
Male 603 44.79 246.133 10.023 
Female 406 27.77 19.091 .947 
HYPOTHESIS Hо: There is no significance difference between male and 
female as far as occurrence of cailsenoma/diseas is concerned. 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference
Lower Upper 
DIESEAS 
Equal 
variances 
assumed 
1.127 .289 1.390 1007 .165 17.02 12.242 -7.002 41.044 
Equal 
variances 
not 
assumed 
  1.691 612.734 .091 17.02 10.068 -2.751 36.793 
CONCLUSION: Here tcal= 1.390 & ttab = 1.96 at 5% level of 
significance d.f. = 1007 tcal < ttab accept the hypo Hо. Here we conclude 
that there is no significance difference between male and female as far as 
occurrence of cailsenoma/ disease is concerned.    
 
T-Test Table 9 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Unmarried 63 28.79 20.328 2.561 
Married 861 39.07 206.354 7.033 
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HYPOTHESIS Hо: There is no significance difference between unmarried 
and married persons as far as occurrence of cailsenoma/disease are 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.101 .750 -.395 922 .693 -10.28 26.020 -61.347 40.785
Equal 
variances 
not 
assumed 
  -1.374 886.861 .170 -10.28 7.484 
-
24.970 4.408 
 
CONCLUSION: Here tcal=-.395 ttab= 1.96 at 5% level of significance 
and d.f. = 922 tcal < ttab accept the hypo. Here we conclude that there is no 
significance difference between unmarried and married persons as far as 
occurrence of cailsenoma/disease are occurred. 
T-Test Table 10 
  
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Unmarried 63 28.79 20.328 2.561 
Widowed 80 33.11 19.988 2.235 
 
HYPOTHESIS Hо: There is no significance difference between 
unmarried and widowed persons as far as occurrence of cailsenoma/disease 
are concerned.  
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.040 .842 -1.273 141 .205 -4.32 3.392 
-
11.025 2.387 
Equal 
variances 
not 
assumed 
  -1.271 132.205 .206 -4.32 3.399 
-
11.042 2.405 
 
CONCLUSION: Here tcal=1.273 &   ttab= 1.96 at 5% level of 
significance and d.f. = 141 tcal < ttab accept the hypo. Here we conclude 
that there is no significance difference between unmarried and widowed 
persons as far as occurrence of cailsenoma/disease are occurred. 
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T-Test Table 11 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Unmarried 63 28.79 20.328 2.561 
Divorced 5 36.20 23.488 10.504 
      
HYPOTHESIS Hо: There is no significance difference between 
unmarried and divorced persons as far as occurrence of cailsenoma/disease 
are concerned.  
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.022 .883 -.776 66 .440 -7.41 9.540 -26.454 11.641
Equal 
variances 
not 
assumed 
  -.685 4.489 .527 -7.41 10.812 -36.179 21.367
CONCLUSION: Here tcal=-.776 ttab= 1.96 at 5% level of significance 
and d.f. = 66 tcal < ttab accept the hypo. Here we conclude that there is no 
significance difference between unmarried and divorced persons as far as 
occurrence of cailsenoma/disease are occurred. 
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T-Test Table 12 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Married 861 39.07 206.354 7.033 
Widowed 80 33.11 19.988 2.235 
HYPOTHESIS Hо: There is no significance difference between married 
and widowed persons as far as occurrence of cailsenoma/disease are 
concerned.  
 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.118 .731 .258 939 .796 5.96 23.092 -39.356 51.280
Equal 
variances 
not 
assumed 
  .808 938.300 .419 5.96 7.379 -8.519 20.443
 
CONCLUSION: Here tcal = .258 ttab = 1.96 at 5% level of significance 
and d.f. = 939 tcal < ttab accept the hypo. And we conclude that there is no 
significance difference between married and widowed persons as far as 
occurrence of cailsenoma/disease are occurred. 
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T-Test Table 13 
 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Married 861 39.07 206.354 7.033 
Divorced 5 36.20 23.488 10.504 
HYPOTHESIS Hо:  There is no significance difference between married 
and divorced persons as far as occurrence of cailsenoma/disease are 
concerned.  
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
DIESEAS 
Equal 
variances 
assumed 
.007 .935 .031 864 .975 2.87 92.340 -178.363 184.111
Equal 
variances 
not 
assumed 
  .227 8.381 .826 2.87 12.641 -26.047 31.795 
 
CONCLUSION: Here tcal = .031& ttab = 1.96 at 5% level of significance 
and d.f. = 864.tcal < ttab accept the hypo. And we conclude that there is no 
significance difference between married and divoced persons as far as 
occurrence of cailsenoma/disease are occurred. 
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T-Test Table 14 
 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Widowed 80 33.11 19.988 2.235 
Divorced 5 36.20 23.488 10.504 
 
HYPOTHESIS Hо: There is no significance difference between widowed 
and divorced persons as far as occurrence of cailsenoma/disease are 
concerned.  
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.008 .928 -.332 83 .741 -3.09 9.298 -21.581 15.406
Equal 
variances 
not 
assumed 
  -.287 4.370 .787 -3.09 10.739 -31.935 25.760
CONCLUSION: Here tcal = -.332 & ttab = 1.96 at 5% level of 
significance and d.f. = 83. tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between widowed and divoced 
persons as far as occurrence of cailsenoma/disease are concered. 
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T-Test Table 15 
Group Statistics  
 
 LANG N Mean Std. Deviation Std. Error Mean
DIESEAS 
Gujarati 822 39.10 211.167 7.365 
Hindi 167 32.47 19.403 1.501 
HYPOTHESIS Hо: There is no significance difference between persons 
having different mother tongue (Gujarati & Hindi) as far as occurrence of 
cailsenoma/disease are concerned. 
 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.305 .581 .405 987 .686 6.63 16.361 -25.480 38.733
Equal 
variances 
not 
assumed 
  .882 883.113 .378 6.63 7.517 -8.126 21.380
CONCLUSION: Here tcal= .405 & ttab = 1.96 at 5% level of significance 
and d.f. = 987 tcal < ttab accept the hypo. And we conclude that there is no 
significance difference between persons having different mother tongue 
(Gujarati&Hindi) as far as occurrence of cailsenoma/disease are concerned.   
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T-Test Table 16 
Group Statistics  
 
 LANG N Mean Std. Deviation Std. Error Mean
DIESEAS 
Gujarati 822 39.10 211.167 7.365 
Other 20 36.20 22.503 5.032 
 
HYPOTHESIS Hо:  There is no significance difference between persons 
having different mother tongue (Gujarati&Other) as far as occurrence of 
cailsenoma/disease are concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.017 .898 .061 840 .951 2.90 47.252 -89.846 95.646
Equal 
variances 
not 
assumed 
  .325 169.620 .746 2.90 8.920 -14.709 20.508
 
CONCLUSION: Here tcal= .061& ttab = 1.96 at 5% level of significance 
and d.f. = 840. tcal < ttab accept the hypo. Here we conclude that there is 
no significance difference between persons having different mother tongue 
(Gujarati&Other) as far as occurrence of cailsenoma/disease are concerned.   
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T-Test Table 17 
 
Group Statistics  
 
 LANG N Mean Std. Deviation Std. Error Mean
DIESEAS 
Hindi 167 32.47 19.403 1.501 
Other 20 36.20 22.503 5.032 
HYPOTHESIS Hо: There is no significance difference between persons 
having different mother tongue (Hindi&Other) as far as occurrence of 
cailsenoma/disease are concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
1.718 .192 -.798 185 .426 -3.73 4.672 
-
12.944 5.490 
Equal 
variances 
not 
assumed 
  -.710 22.514 .485 -3.73 5.251 
-
14.603 7.149 
 
CONCLUSION: Here tcal= -.798 & ttab = 1.96 at 5% level of significance 
and d.f. = 185. tcal < ttab accept the hypo. And we conclude that there is no 
significance difference between persons having different mother tongue 
(Hindi&Other) as far as occurrence of cailsenoma/disease are concerned. 
 
 
 
 
 
 
 
 133
 
T-Test Table 18 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Hindu 936 38.22 197.992 6.472 
Muslim 69 33.61 21.537 2.593 
HYPOTHESIS Hо: There is no significance difference between the 
religions (Hindu&Muslim) of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.054 .816 .193 1003 .847 4.61 23.857 -42.208 51.422
Equal 
variances 
not 
assumed 
  .661 929.839 .509 4.61 6.972 -9.075 18.289
CONCLUSION: Here tcal = .193 &ttab = 1.96 at 5% level of significance 
and d.f. = 1003 tcal< ttab Accept the hypo H0. And we conclude that there 
is no significance difference between the religions (Hindu&Muslim) of 
persons as far as occurrence of cailsenoma/disease is concerned. 
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T-Test table 19 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Hindu 936 38.22 197.992 6.472 
Jain 1 68.00 . . 
HYPOTHESIS Hо: There is no significance difference between the 
religions (Hindu&Jain) of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
DIESEAS 
Equal 
variances 
assumed 
. . -.150 935 .881 -29.78 198.098 
-
418.553 358.984
Equal 
variances 
not 
assumed 
  . . . -29.78 . . . 
 
CONCLUSION: Here tcal = .150 & ttab = 1.96 at 5% level of significance 
and d.f. = 935.  tcal < ttab accept the hypo H0. And we conclude that there 
is no significance difference between the religions (Hindu&Jain) of persons 
as far as occurrence of cailsenoma/disease is concerned. 
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T-Test Table 20 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Hindu 936 38.22 197.992 6.472 
Sikh 1 65.00 . . 
 
HYPOTHESIS Hо: There is no significance difference between the 
religions (Hindu & Sikh) of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
 
Levene's 
Test for 
Equality 
of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
DIESEAS 
Equal 
variances 
assumed 
. . -.135 935 .892 -26.78 198.098 
-
415.553 361.984
Equal 
variances 
not 
assumed 
  . . . -26.78 . . . 
CONCLUSION: Here tcal = .135 & ttab = 1.96 at 5% level of significance 
and d.f. = 935. tcal < ttab accept the hypo Hо. And we conclude that there 
is no significance difference between the religions (Hindu&Sikh) of 
persons as far as occurrence of cailsenoma/disease is concerned. 
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T-test Table 21 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Hindu 936 38.22 197.992 6.472 
Christian 2 32.50 21.920 15.500 
HYPOTHESIS Hо: There is no significance difference between the 
religions (Hindu & Christian) of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
DIESEAS 
Equal 
variances 
assumed 
.004 .949 .041 936 .967 5.72 140.077 -269.186 280.618
Equal 
variances 
not 
assumed 
  .340 1.379 .778 5.72 16.797 -108.749 120.181
 
CONCLUSION:  Here tcal = .041 & ttab = 1.96 at 5% level of 
significance and d.f. = 936. tcal < ttab accept the hypo Hо. And we 
conclude that there is no significance difference between the religions 
(Hindu&Christian) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
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T-Test Table 22 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Muslim 69 33.61 21.537 2.593 
Jain 1 68.00 . . 
 
HYPOTHESIS Hо: There is no significance difference between the 
religions (Muslim & Jain) of persons as far as occurrence of 
cailsenoma/disease is concerned. 
 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
. . -1.585 68 .118 -34.39 21.693 
-
77.679 8.896 
Equal 
variances 
not 
assumed 
  . . . -34.39 . . . 
 
CONCLUSION: Here tcal = -1.585 & ttab = 1.96 at 5% level of 
significance and d.f. = 68. tcal < ttab accept the hypo H0. And we conclude 
that there is no significance difference between the religions 
(Muslim&Jain) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
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T-Test Table 23 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Muslim 69 33.61 21.537 2.593 
Sikh 1 65.00 . . 
HYPOTHESIS Hо: There is no significance difference between the 
religions (Muslim&Sikh) of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper 
DIESEAS 
Equal 
variances 
assumed 
. . -1.447 68 .152 -31.39 21.693 -74.679 11.896 
Equal 
variances 
not 
assumed 
  . . . -31.39 . . . 
 
CONCLUSION: Here tcal = -1.447 & ttab = 1.96 at 5% level of 
significance and d.f. = 68 tcal < ttab accept the hypo Hо. Here we conclude 
that there is no significance difference between the religions 
(Muslim&Sikh) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
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T-Test Table 24 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Muslim 69 33.61 21.537 2.593 
Christian 2 32.50 21.920 15.500 
 
HYPOTHESIS Hо: There is no significance difference between the 
religions (Muslim&Christian) of persons as far as occurrence of 
cailsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
DIESEAS 
Equal 
variances 
assumed 
.238 .627 .072 69 .943 1.11 15.452 -29.718 31.935 
Equal 
variances 
not 
assumed 
  .071 1.057 .955 1.11 15.715 -174.939 177.157
 
CONCLUSION: Here Tcal = .072 ttab = 1.96 at 5% level of significance 
and d.f. = 69 tcal < ttab accept the hypo Hо.  And we conclude that 
there is no significance difference between the religions 
(Muslim&Christian) of persons as far as occurrence of 
cailsenoma/disease is concerned. 
 
 140
 
T-Test Table 25 
 
Group Statistics  
 
 RELIGION N Mean 
Std. 
Deviation 
Std. Error 
Mean 
DIESEA
S 
Jain 1 68.00 . . 
Christian 2 32.50 21.920 15.500 
      
HYPOTHESIS Hо: There is no significance difference between the 
religions (Jain&Christian) of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Differen
ce 
Std. 
Error 
Differen
ce 
95% Confidence 
Interval of the 
Difference 
Lowe
r Upper 
DIESEA
S 
Equal 
varianc
es 
assume
d 
. . 1.322 1 .412 35.50 26.847 
-
305.62
1 
376.621 
Equal 
varianc
es not 
assume
d 
  . . . 35.50 . . . 
CONCLUSION: Here tcal = 1.322 & ttab = 12.71 at 5% level of 
significance and d.f. =1 69 tcal > ttab Reject the hypo Hо. And we 
conclude that there is significance difference between the religions 
(Jain&Christian) of persons as far as occurrence of 
cailsenoma/disease is concerned. 
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T-Test Table 26 
 
 
 
 
 
 
 
 
HYPOTHESIS Hо: There is no significance difference between the 
religions (Sikh&Christian) of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
DIESEAS 
Equal 
variances 
assumed 
. . 1.211 1 .440 32.50 26.847 -308.621 373.621
Equal 
variances 
not 
assumed 
  . . . 32.50 . . . 
 
CONCLUSION: Here tcal=1.211 ttab= 12.71 5% level of significance and 
d.f. = 1 tcal > ttab Reject the hypo H0. And we conclude that there is 
significance difference between the religions (Sikh&Christian) of persons 
as far as occurrence of cailsenoma/disease is concerned. 
 
 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Sikh 1 65.00 . . 
Christian 2 32.50 21.920 15.500 
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T-Test Table 27 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
< 20 39 25.10 18.362 2.940 
20 - 30 58 33.19 23.470 3.082 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20 and 20-30 of a person as far as occurrence of cailsenoma/disease 
is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
7.990 .006 -1.810 95 .073 -8.09 4.467 
-
16.956 .781 
Equal 
variances 
not 
assumed 
  -1.899 92.738 .061 -8.09 4.259 
-
16.546 .371 
 
CONCLUSION: Here tcal = -1.810 and ttab = 1.96 at 5% level of 
signification and d.f. = 95 tcal < ttab accept the hypo. And we conclude that 
there is no significance difference between age group below 20 and 20-30 
of a person as far as occurrence of cailsenoma/disease is concered. 
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T-Test Table 28 
. 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
< 20 39 25.10 18.362 2.940 
30 - 40 156 30.13 19.868 1.591 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20 and 30-40 of persons as far as occurrence of cailsenoma/disease 
is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
1.413 .236 -1.435 193 .153 -5.03 3.506 
-
11.946 1.882 
Equal 
variances 
not 
assumed 
  -1.505 62.196 .137 -5.03 3.343 
-
11.714 1.650 
CONCULISION: Here Tcal = -1.435 and Ttab = 1.96 at 5% level of 
signification and D.F. = 193 Tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 20 and 30-
40 of a person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 29 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
< 20 39 25.10 18.362 2.940 
40 - 50 263 53.78 372.281 22.956 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20 and 40-50 of a person as far as occurrence of cailsenoma/disease 
is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.339 .561 -.480 300 .631 -28.67 59.708 -146.172 88.826
Equal 
variances 
not 
assumed 
  -1.239 270.165 .216 -28.67 23.143 -74.237 16.891
 
CONCLUSION: Here tcal = -.480 and ttab = 1.96 at 5% level of 
significance and D.F. = 300 tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 20 and 40-
50 of a person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 30 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
< 20 39 25.10 18.362 2.940 
50 - 60 262 30.77 18.789 1.161 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20 and 50-60 of a person as far as occurrence of cailsenoma/disease 
is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.212 .645 -1.763 299 .079 -5.67 3.216 
-
11.996 .659 
Equal 
variances 
not 
assumed 
  -1.793 50.590 .079 -5.67 3.161 
-
12.016 .679 
CONCLUSION: Here tcal = -1.763 and ttab = 1.96 at 5% level of 
significance and d.f. = 2990 tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 20 and 50-
60 of a person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 31 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
< 20 39 25.10 18.362 2.940 
60 - 70 159 35.75 18.515 1.468 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20 and 60-70 of a person as far as occurrence of cailsenoma/disease 
is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.046 .831 -3.223 196 .001 -10.65 3.303 
-
17.160 -4.131
Equal 
variances 
not 
assumed 
  -3.239 58.445 .002 -10.65 3.286 
-
17.223 -4.068
 
CONCLUSION: Here tcal = -3.223 and ttab = 1.96 at 5% level of 
significance and d.f. = 196 tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 20 and 60-
70 of a person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 32 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
< 20 39 25.10 18.362 2.940 
> 70 72 38.79 19.632 2.314 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20 and above 70 of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.439 .509 -3.586 109 .001 -13.69 3.817 
-
21.254 -6.124
Equal 
variances 
not 
assumed 
  -3.659 82.665 .000 -13.69 3.741 
-
21.131 -6.247
 
CONCLUSION: Here tcal = -3.586and ttab = 1.96 at 5% level of 
significance and d.f. = 2990 tcal < ttab accept the hypo. And we conclude 
that there is n0 significance difference between age group below 20 and 
above 70 of a person as far as occurrence of cailsenoma/disease is 
conceder.  
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T-Test Table 33 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
20 - 30 58 33.19 23.470 3.082 
30 - 40 156 30.13 19.868 1.591 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20-30 and 30-40 of persons as far as occurrence of 
cilsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
6.256 .013 .951 212 .343 3.06 3.214 -3.280 9.390 
Equal 
variances 
not 
assumed 
  .881 89.096 .381 3.06 3.468 -3.836 9.946 
 
CONCLUSION: Here tcal = .951 & ttab = 1.96 at 5% level of significance 
and d.f. = 212. tcal < ttab accept the hypo. And we conclude that there is no 
significance difference between age group below 20-30 and 30-40 of a 
person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 34 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
20 - 30 58 33.19 23.470 3.082 
40 - 50 263 53.78 372.281 22.956 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20-30 and 40-50 of a person as far as occurrence of 
cilsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.346 .557 -.420 319 .674 -20.59 48.964 
-
116.919 75.747
Equal 
variances 
not 
assumed 
  -.889 271.124 .375 -20.59 23.162 -66.186 25.014
CONCLUSION: Here Tcal =-.420and Ttab = 1.96 at 5% level of 
significance and d.f. =319.  tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 20-30 and 
40-50 of a person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 35 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
20 - 30 58 33.19 23.470 3.082 
50 - 60 262 30.77 18.789 1.161 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20-30 and 50-60 of a person as far as occurrence of 
cailsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
12.487 .000 .846 318 .398 2.42 2.860 -3.209 8.046 
Equal 
variances 
not 
assumed 
  .734 73.996 .465 2.42 3.293 -4.143 8.980 
 
CONCLUSION: Here tcal =.846 & Ttab = 1.96 at 5% level of significance 
and d.f. =318 tcal < ttab accept the hypo. And we conclude that there is no 
significance difference between age group below 20-30 and 50-60 of a 
person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 36 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
20 - 30 58 33.19 23.470 3.082 
60 - 70 159 35.75 18.515 1.468 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20-30 and 60-70 of a person as far as occurrence of 
cilsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
12.805 .000 -.836 215 .404 -2.56 3.060 -8.590 3.473 
Equal 
variances 
not 
assumed 
  -.750 84.253 .456 -2.56 3.414 -9.347 4.229 
CONCLUSION: Here tcal =-.846 & ttab = 1.96 at 5% level of significance 
and d.f. =215. tcal < ttab accept the hypo. And we conclude that there is no 
significance difference between age group below 20-30 and 50-60 of a 
person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 37 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
20 - 30 58 33.19 23.470 3.082 
> 70 72 38.79 19.632 2.314 
 
HYPOTHESIS Hо: There is no significance difference between age group 
below 20-30 and above 70 of a person as far as occurrence of 
cilsenoma/disease is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
6.242 .014 -1.482 128 .141 -5.60 3.780 
-
13.082 1.878 
Equal 
variances 
not 
assumed 
  -1.454 111.042 .149 -5.60 3.854 
-
13.238 2.034 
CONCLUSION: Here tcal =-1.482 & ttab = 1.96 at 5% level of 
significance and d.f. =128. tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 20-30 and 
50-60 of a person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 38 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
30 - 40 156 30.13 19.868 1.591 
40 - 50 263 53.78 372.281 22.956 
 
HYPOTHESIS Hо: There is no significance difference between age group 
30-40 and 40-50 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
                                            Independent Samples Test  
 
 
 
Levene's 
Test for 
Equality 
of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of 
the Difference
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
1.198 .274 -.792 417 .429 -23.64 29.846 -82.308 35.026
Equal 
variances 
not 
assumed 
  -1.027 264.512 .305 -23.64 23.011 
-
68.949 21.667
 
CONCLUSION: Here tcal =-.792 & ttab = 1.96 at 5% level of significance 
and d.f. =417. tcal < ttab accept the hypo. And we conclude that there is no 
significance difference between age group below 20-30 and 50-60 of a 
person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 39 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
30 - 40 156 30.13 19.868 1.591 
50 - 60 262 30.77 18.789 1.161 
 
HYPOTHESIS Hо: There is no significance difference between age group 
30-40 and 50-60 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
1.720 .190 -.328 416 .743 -.64 1.941 -4.453 3.180 
Equal 
variances 
not 
assumed 
  -.323 311.553 .747 -.64 1.969 -4.511 3.238 
CONCLUSION: Here tcal =-.328 & ttab = 1.96 at 5% level of 
significance and d.f. =416. tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 20-30 and 
50-60 of a person as far as occurrence of cailsenoma/disease is conceder.  
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T-Test Table 40 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
30 - 40 156 30.13 19.868 1.591 
60 - 70 159 35.75 18.515 1.468 
HYPOTHESIS Hо: There is no significance difference between age group 
30-40 and 60-70 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of 
the Difference
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
2.35
5 .126
-
2.595 313 .010 -5.61 2.163 -9.870 -1.357
Equal 
variances 
not 
assumed 
  -2.593 310.515 .010 -5.61 2.165 -9.873 -1.354
CONCULISION: Here tcal =-2.595 & ttab = 1.96 at 5% level of 
significance and d.f. =313. tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 30-40 and 
60-70 of a person as far as occurrence of cailsenoma/disease is conceder.  
T-Test Table 41 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
30 - 40 156 30.13 19.868 1.591 
> 70 72 38.79 19.632 2.314 
 156
HYPOTHESIS Hо: There is no significance difference between age group 
30-40 and above70 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of 
the Difference
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
.266 .606 -3.070 226 .002 -8.66 2.820 
-
14.214 -3.100
Equal 
variances 
not 
assumed 
  -3.083 139.694 .002 -8.66 2.808 
-
14.208 -3.106
CONCLUSION: Here tcal =-3.070 & ttab = 1.96 at 5% level of 
significance and d.f. =226. tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 30-40 and 
above 70 of a person as far as occurrence of cailsenoma/disease is 
conceder.  
 
T-Test Table 42 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
40 - 50 263 53.78 372.281 22.956 
50 - 60 262 30.77 18.789 1.161 
HYPOTHESIS Hо: There is no significance difference between age group 
40-50 and 50-60 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of 
the Difference
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
2.181 .140 .999 523 .318 23.00 23.029 -22.236 68.245
Equal 
variances 
not 
assumed 
  1.001 263.340 .318 23.00 22.985 -22.253 68.263
CONCLUSION: Here tcal =.999 & ttab = 1.96 at 5% level of 
significance and d.f. =523 tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 40-50 and 
50-60 of a person as far as occurrence of cailsenoma/disease is conceder.  
 
T-Test Table 43 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
40 - 50 263 53.78 372.281 22.956 
60 - 70 159 35.75 18.515 1.468 
HYPOTHESIS Hо: There is no significance difference between age group 
40-50 and 60-70 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
D
IE
SE
A
S 
Equal 
variances 
assumed 
1.355 .245 .610 420 .542 18.03 29.560 -40.076 76.131 
Equal 
variances 
not 
assumed 
  .784 264.141 .434 18.03 23.003 -27.265 63.319 
CONCLUSION: Here tcal =.610 & ttab = 1.96 at 5% level of significance 
and D.F. =420 Tcal < ttab accept the hypo. And we conclude that there is 
no significance difference between age group below 40-50 and 60-70 of a 
person as far as occurrence of cailsenoma/disease is conceder.  
 
T-Test Table 44 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
40 - 50 263 53.78 372.281 22.956 
> 70 72 38.79 19.632 2.314 
HYPOTHESIS Hо: There is no significance difference between age group 
40-50 and above 70 of persons as far as occurrence of cilsenoma/disease is 
concerned. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
D
IE
SE
A
S 
Equal 
variances 
assumed 
.578 .448 .341 333 .733 14.98 43.938 -71.447 101.415 
Equal 
variances 
not 
assumed 
  .649 267.248 .517 14.98 23.072 -30.442 60.410 
 
 CONCLUSION: Here tcal =.341and ttab = 1.96 at 5% level of 
significance and d.f. =333. tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 40-50 and 
60-70 of a person as far as occurrence of cailsenoma/disease is conceder.  
 
T-Test Table 45 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
50 - 60 262 30.77 18.789 1.161 
60 - 70 159 35.75 18.515 1.468 
HYPOTHESIS Hо: There is no significance difference between age group 
50-60 and 60-70 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper 
D
IE
SE
A
S 
Equal 
variances 
assumed 
.162 .687 -2.650 419 .008 -4.98 1.878 -8.670 -1.285 
Equal 
variances 
not 
assumed 
  -2.659 337.408 .008 -4.98 1.872 -8.659 -1.296 
CONCLUSION: Here tcal =-2.650 & Ttab = 1.96 at 5% level of 
significance and d.f. = 419. tcal < ttab accept the hypo. Here we conclude 
that there is no significance difference between age group below 50-60 and 
60-70 of a person as far as occurrence of cailsenoma/disease is conceder.  
 
T-Test Table 46 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
50 - 60 262 30.77 18.789 1.161 
> 70 72 38.79 19.632 2.314 
HYPOTHESIS Hо: There is no significance difference between age group 
50-60 and above70 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper 
D
IE
SE
A
S 
Equal 
variances 
assumed 
.185 .668 -3.177 332 .002 -8.02 2.524 -12.987 -3.055 
Equal 
variances 
not 
assumed 
  -3.099 109.357 .002 -8.02 2.588 -13.151 -2.891 
CONCLUSION: Here tcal = -3.177and ttab = 1.96 at 5% level of 
significance and d.f. =332 tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 50-60 and 
above 70 of a person as far as occurrence of cailsenoma/disease is 
conceder.  
T-Test Table 47 
 
Group Statistics  
 
 AGE_GR N Mean Std. Deviation Std. Error Mean
DIESEAS 
60 - 70 159 35.75 18.515 1.468 
> 70 72 38.79 19.632 2.314 
HYPOTHESIS Hо: There is no significance difference between age group 
60-70 and above70 of a person as far as occurrence of cilsenoma/disease is 
concerned. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper 
D
IE
SE
A
S 
Equal 
variances 
assumed 
.459 .499 -1.135 229 .257 -3.04 2.680 -8.324 2.238 
Equal 
variances 
not 
assumed 
  -1.111 130.222 .269 -3.04 2.740 -8.464 2.378 
CONCLUSION: Here tcal =-1.135and ttab = 1.96 at 5% level of 
significance and d.f. =229 tcal < ttab accept the hypo. And we conclude 
that there is no significance difference between age group below 60-70 and 
above70 of a person as far as occurrence of cailsenoma/disease is conceder.  
 
General Conclusion: For T Test:  
 
(1) Here we conculed that they have the same chances of occurance 
of cailsenoma/diseases whether persons are male or female. 
(2) Here we conculed that they have the same chances of occurance 
of calisenoma/diseases whether persons are different martial-
status like unmarried, married, widowed, divoced. 
(3) Here we conculed that they have the same chances of occurance 
of calisenoma/diseases whether persons have any age groups like 
below 20, 20-30, 30-40, 40-50, 50-60, and above 70. 
(4) Here we conculed that this is the life style of the persons of two 
religious are different. Generally, Hindu or Jain is purely 
vageterion. Where as other community like Christian, Muslim, 
and Sikh are non-vegerterion. So they have the different chances 
of occurance of cailsenoma/diseases. 
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Table 48 
Univariate Analysis of Variance 
Between-Subjects Factors
 
 Value Label N 
YEAR 
2000  127
2002  130
2003  127
2004  226
2005  308
2006  91 
GENDER 
1 Male 603
2 Female 406
MAR_STAT
1 Unmarried 63 
2 Married 861
3 Widowed 80 
4 Divorced 5 
LANG 
1 Gujarati 822
2 Hindi 167
3 Other 20 
RELIGION 
1 Hindu 936
2 Muslim 69 
3 Jain 1 
4 Sikh 1 
5 Christian 2 
AGE_GR 
1 < 20 39 
2 20 - 30 58 
3 30 - 40 156
4 40 - 50 263
5 50 - 60 262
6 60 - 70 159
 > 70 72 
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Tests of Between-Subjects Effects
Dependent Variable: DIESEAS  
Source Type III Sum of Squares df 
Mean 
Square F Sig. 
Corrected Model 972214.110(a) 200 4861.071 .110 1.000
Intercept 76176.219 1 76176.219 1.723 .190 
YEAR 3165.271 5 633.054 .014 1.000
GENDER 2201.838 1 2201.838 .050 .823 
MAR_STAT 3273.175 3 1091.058 .025 .995 
LANG 750.560 2 375.280 .008 .992 
RELIGION 2605.786 3 868.595 .020 .996 
AGE_GR 4595.260 6 765.877 .017 1.000
YEAR * GENDER 3014.560 5 602.912 .014 1.000
YEAR * MAR_STAT 3996.425 7 570.918 .013 1.000
GENDER * MAR_STAT 3240.210 2 1620.105 .037 .964 
YEAR * GENDER * 
MAR_STAT 116.057 1 116.057 .003 .959 
YEAR * LANG 667.307 1 667.307 .015 .902 
GENDER * LANG 514.661 2 257.330 .006 .994 
YEAR * GENDER * LANG .000 0 . . . 
MAR_STAT * LANG 72.917 1 72.917 .002 .968 
YEAR * MAR_STAT * LANG .000 0 . . . 
GENDER * MAR_STAT * 
LANG .000 0 . . . 
YEAR * GENDER * 
MAR_STAT * LANG .000 0 . . . 
YEAR * RELIGION 1149.052 4 287.263 .006 1.000
GENDER * RELIGION 1245.522 1 1245.522 .028 .867 
YEAR * GENDER * 
RELIGION 25227.282 3 8409.094 .190 .903 
MAR_STAT * RELIGION 534.628 2 267.314 .006 .994 
YEAR * MAR_STAT * 
RELIGION .000 0 . . . 
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GENDER * MAR_STAT * 
RELIGION .000 0 . . . 
YEAR * GENDER * 
MAR_STAT * RELIGION .000 0 . . . 
LANG * RELIGION .000 0 . . . 
YEAR * LANG * RELIGION .000 0 . . . 
GENDER * LANG * 
RELIGION .000 0 . . . 
YEAR * GENDER * LANG * 
RELIGION .000 0 . . . 
MAR_STAT * LANG * 
RELIGION .000 0 . . . 
YEAR * MAR_STAT * LANG 
* RELIGION .000 0 . . . 
GENDER * MAR_STAT * 
LANG * RELIGION .000 0 . . . 
YEAR * GENDER * 
MAR_STAT * LANG * 
RELIGION 
.000 0 . . . 
YEAR * AGE_GR 17559.167 29 605.489 .014 1.000
 
GENDER * AGE_GR 4285.162 6 714.194 .016 1.000
YEAR * GENDER * AGE_GR 158623.663 18 8812.426 .199 1.000
MAR_STAT * AGE_GR 1650.263 7 235.752 .005 1.000
YEAR * MAR_STAT * 
AGE_GR 2352.269 8 294.034 .007 1.000
GENDER * MAR_STAT * 
AGE_GR 1202.972 3 400.991 .009 .999 
YEAR * GENDER * 
MAR_STAT * AGE_GR .000 0 . . . 
LANG * AGE_GR 3444.767 10 344.477 .008 1.000
YEAR * LANG * AGE_GR .000 0 . . . 
GENDER * LANG * AGE_GR 1810.619 5 362.124 .008 1.000
YEAR * GENDER * LANG * 
AGE_GR .000 0 . . . 
MAR_STAT * LANG * .000 0 . . . 
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AGE_GR 
YEAR * MAR_STAT * LANG 
* AGE_GR .000 0 . . . 
GENDER * MAR_STAT * 
LANG * AGE_GR .000 0 . . . 
 
 
YEAR * GENDER *  
MAR_STAT * LANG * 
AGE_GR 
.000 0 . . . 
RELIGION * AGE_GR 7706.940 4 1926.735 .044 .996 
YEAR * RELIGION * 
AGE_GR 30783.129 9 3420.348 .077 1.000
GENDER * RELIGION * 
AGE_GR 18794.940 3 6264.980 .142 .935 
YEAR * GENDER * 
RELIGION * AGE_GR .000 0 . . . 
MAR_STAT * RELIGION * 
AGE_GR 801.607 1 801.607 .018 .893 
YEAR * MAR_STAT * 
RELIGION * AGE_GR .000 0 . . . 
GENDER * MAR_STAT * 
RELIGION * AGE_GR .000 0 . . . 
YEAR * GENDER * 
MAR_STAT * RELIGION * 
AGE_GR 
.000 0 . . . 
LANG * RELIGION * 
AGE_GR .000 0 . . . 
YEAR * LANG * RELIGION 
* AGE_GR .000 0 . . . 
GENDER * LANG * 
RELIGION * AGE_GR .000 0 . . . 
YEAR * GENDER * LANG * 
RELIGION * AGE_GR .000 0 . . . 
MAR_STAT * LANG * 
RELIGION * AGE_GR .000 0 . . . 
YEAR * MAR_STAT * LANG .000 0 . . . 
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CONCLUSION:  
 (1)    Here Fcal= .020 & Ftab (3,808) at 5% level of significance=   
          8.53 Fcal < Ftab We accept the hypo.Not significant. i.e.  
         Experimental error is significant. There is no significance  
         Difference between Religions of a person as far as occurance of  
         Calsenoma/disease is concered. 
(2) Here Fcal= .017 & Ftab (6,808) at 5% level of significance= 
3.67 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between Age group of a person as far as occurance 
of calsenoma/disease is concered. 
(3) Here Fcal= .014 & Ftab (5,808) at 5% level of significance= 
5.63 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between intra groups (Year & Sex) of a person as far 
as occurance of calsenoma/disease is concered. 
(4) Here Fcal= .013 & Ftab (7,808) at 5% level of significance= 
3.23 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between intragroup (Year & Marital Status) of a 
person as far as occurance of calsenoma/disease is concered. 
(5) Here Fcal= .037 & Ftab (2,808) at 5% level of significance= 
19.50 Fcal < Ftab We accept the hypo.Not significant. I.e. 
experimental error is significant. There is no significance 
difference between intragroup (Sex & Marital Status) of a 
person as far as occurance of calsenoma/disease is concered. 
(6) Here Fcal= .003 & Ftab (1,808) at 5% level of significance= 
254.32 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
* RELIGION * AGE_GR 
GENDER * MAR_STAT * 
LANG * RELIGION * 
AGE_GR 
.000 0 . . . 
Error 35715795.892 808 44202.718   
Total 38140829.000 1009    
Corrected Total 36688010.002 1008    
a R Squared = .026 (Adjusted R Squared = -.214)  
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difference between intragroup (Year & Sex & Marital status) of 
a persons as far as occurance of calsenoma/disease is concered. 
(7) Here Fcal= .015 & Ftab (1,808) at 5% level of significance= 
254.32 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between intragroup (Year & Mother tongue 
(langue)) of a persons as far as occurance of calsenoma/disease 
is concered. 
(8) Here Fcal= .006 & Ftab (2,808) at 5% level of significance= 
19.50 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between intragroup (Sex & Mother tongue (langue)) 
of a persons as far as occurance of calsenoma/disease is 
concered. 
(9) Here Fcal= .002 & Ftab (1,808) at 5% level of significance= 
254.32 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between intragroup (Marital status & Mother tongue 
(langue)) of a persons as far as occurance of calsenoma/disease 
is concered. 
(10) Here Fcal= .006 & Ftab (4,808) at 5% level of significance= 
5.63 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between intragroup (Year & Religion) of a person as 
far as occurance of calsenoma/disease is concered. 
(11) Here Fcal= .190 & Ftab (1,808) at 5% level of 
significance=254.32 Fcal < Ftab We accept the hypo.Not 
significant. i.e. experimental error is significant. There is no 
significance difference between three intragroup (Year &Sex & 
Religion) of a persons as far as occurance of calsenoma/disease 
is concered. Here Fcal= .006 & Ftab (2,808) at 5% level of 
significance= 19.50 Fcal < Ftab We accept the hypo.Not 
significant.  
(12) Experimental error is significant. There is no significance 
difference between two intragroup (Marital Status & Religion) 
of a person as far as occurance of calsenoma/disease is 
concered. 
(13) Here Fcal= .014 & Ftab (29,808) at 5% level of significance= 
1.64 Fcal < Ftab We accept the hypo.Not significant. i.e. 
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experimental error is significant. There is no significance 
difference between two intragroup (Year &Age Group) of a 
person as far as occurance of calsenoma/disease is concered. 
(14) Here Fcal= .016 & Ftab (6,808) at 5% level of significance= 
3.67 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between two intragroup (Sex &Age Group) of a 
person as far as occurance of calsenoma/disease is concered. 
(15) Here Fcal= .199 & Ftab (18,808) at 5% level of significance= 
1.92 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between three intragroup (Year &Sex &Age Group) 
of a person as far as occurance of calsenoma/disease is 
concered. 
(16) Here Fcal= .005 & Ftab (7,808) at 5% level of significance= 
3.23 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between two intragroup (Marital Status &Age 
Group) of a person as far as occurance of calsenoma/disease is 
concered. 
(17) Here Fcal= .007 & Ftab (8,808) at 5% level of significance= 
2.93 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between three intragroup (Year &Marital Status 
&Age Group) of a person as far as occurance of 
calsenoma/disease is concered. 
(18) Here Fcal= .009 & Ftab (3,808) at 5% level of significance= 
8.53 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between three intragroup (Sex &Marital Status 
&Age Group) of a person as far as occurance of 
calsenoma/disease is concered. 
(19) Here Fcal= .008 & Ftab (10,808) at 5% level of significance= 
2.54 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between two intragroup (Mother Tongue (Language) 
&Age Group) of a persons as far as occurance of 
calsenoma/disease is concered. 
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(20) Here Fcal= .008 & Ftab (5,808) at 5% level of significance= 
4.36 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between three intragroup (Sex & Mother Tongue, 
(Language) &Age Group) of a persons as far as occurance of 
calsenoma/disease is concered. 
(21) Here Fcal= .044 & Ftab (4,808) at 5% level of significance= 
5.63 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between two intragroup (Religion &Age Group) of a 
person as far as occurance of calsenoma/disease is concered. 
(22) Here Fcal= .077 & Ftab (9,808) at 5% level of significance= 
2.71 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between three intragroup (Year & Religion &Age 
Group) of a person as far as occurance of calsenoma/disease is 
concered. 
(23) Here Fcal= .142 & Ftab (3,808) at 5% level of significance= 
8.53 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between three intragroup (Sex & Religion &Age 
Group) of a person as far as occurance of calsenoma/disease is 
concered. 
(24) Here Fcal= .018 & Ftab (1,808) at 5% level of significance= 
.018 Fcal < Ftab We accept the hypo.Not significant. i.e. 
experimental error is significant. There is no significance 
difference between three intragroup (Marital Status & Religion 
&Age Group) of a person as far as occurance of 
calsenoma/disease is concered. 
 
General Conclusion: For F test:  
 
These factors are not important as far as occurance of 
calisenoma/diseases is concered. 
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Table-49 
DIESEAS * YEAR 
Crosstab  
Count  
 
 
YEAR 
Total 
2000 2002 2003 2004 2005 2006  
 
DIESEAS 
1 1 1 2 1 2 1 8 
2 2  2   1 5 
3     1  1 
4  1 1 1 1 1 5 
5   1  1  2 
6     1  1 
7     2  2 
8    1 2 2 5 
9     1  1 
10     2  2 
11 7 9 5 14 16 3 54 
12 3 2 2 2 8 1 18 
13 15 14 13 20 24 11 97 
14 6  5 7 9 3 30 
15 6 6 7 14 15 10 58 
16 1  2  3  6 
17 10 11 9 26 30 9 95 
18 1 1 2    4 
19 1 2  1 3 2 9 
20  1 2 1 3  7 
21 1 1 1 1 3  7 
22 1 4 5 1 2  13 
23 7 6 7 14 12 4 50 
24   2    2 
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25 1 1 1   1 4 
26  2 2 8 8 5 25 
27 1  1 3  1 6 
28  2 2 2 14 1 21 
29   1 3   4 
30     1  1 
        
31  1  1   2 
32 1  2 1 1 2 7 
33 3 3 3 9 13 1 32 
34  2 2 5 2 1 12 
35  3  2 4  9 
36 12 6 10 8 12 3 51 
37  2 1 5 5  13 
38  1 4 2   7 
39  1 1 1   3 
40 2 2   1  5 
41 2 5 2 8 9  26 
42    1   1 
43  1   2  3 
44 1 2 2 3 5  13 
45 1 1  1 2 1 6 
46 2  1 3   6 
47 2 1 2 3 6 1 15 
48 9 4 1 12 15 1 42 
49 3 4  1  1 9 
50 1      1 
51 1  1 2 7 1 12 
52   1   1 2 
53   1  2 2 5 
54 3 4 1 4 3 2 17 
55 1  1 3 1  6 
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56   1 2   3 
57 1 2 1 3 1 2 10 
58 1      1 
59 1 2 1 1 4 3 12 
60 1 1 1 3 3 1 10 
61 1    2  3 
62 1 1  2 1  5 
63  1     1 
64  1   1  2 
65    1   1 
66     1 1 2 
67 3 4   4  11 
68 3 7 3 8 16 5 42 
69 5  3 7 8 3 26 
70 1 2 2 2 4  11 
71   1    1 
72 1 2 1 1 5 2 12 
73   1  2 1 4 
74    1   1 
75     1  1 
76   1    1 
Total 127 130 127 226 308 91 1009 
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Table-50 
DIESEAS * GENDER 
Crosstab  
Count  
 
 
GENDER 
Total
Male Female 
DIESEAS
1 4 4 8 
2 5  5 
3 1  1 
4 2 3 5 
5 1 1 2 
6  1 1 
7 2  2 
8 3 2 5 
9  1 1 
10  2 2 
11 51 3 54 
12 16 2 18 
13 2 95 97 
14 20 10 30 
15 50 8 58 
16 6  6 
17 3 92 95 
18 2 2 4 
19 9  9 
20 5 2 7 
21  7 7 
22 9 4 13 
23 35 15 50 
24 2  2 
25 4  4 
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26 18 7 25 
27 2 4 6 
28 13 8 21 
29 3 1 4 
30 1  1 
31 2  2 
32 3 4 7 
33 30 2 32 
34 8 4 12 
35 7 2 9 
36 41 10 51 
37 8 5 13 
38 2 5 7 
39 2 1 3 
40 2 3 5 
41 19 7 26 
42 1  1 
43 3  3 
44  13 13 
45 6  6 
46 6  6 
47 13 2 15 
48 38 4 42 
49 9  9 
50  1 1 
51 10 2 12 
52 2  2 
53 3 2 5 
54 8 9 17 
55 3 3 6 
56 2 1 3 
57 5 5 10 
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58  1 1 
59 10 2 12 
60 7 3 10 
61 2 1 3 
62 3 2 5 
63 1  1 
64 2  2 
65  1 1 
66 2  2 
67 10 1 11 
68 29 13 42 
69 25 1 26 
70 4 7 11 
71 1  1 
72 1 11 12 
73  4 4 
74 1  1 
75 1  1 
76 1  1 
Total 603 406 1009
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Table-51 
DIESEAS * MAR_STAT 
Crosstab  
Count  
 
 
MAR_STAT 
Total
Unmarried Married Widowed Divorced  
DIESEAS 
1  7 1  8 
2 2 3   5 
3 1    1 
4 2 3   5 
5  2   2 
6 1    1 
7  2   2 
8  5   5 
9  1   1 
10  2   2 
11  53 1  54 
12 6 12   18 
13 3 83 10 1 97 
14 10 19 1  30 
15 2 54 2  58 
16  6   6 
17 1 77 17  95 
18  4   4 
19  9   9 
20 3 4   7 
21  5 2  7 
22 2 10  1 13 
23  45 5  50 
24 2    2 
25  3 1  4 
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26  24 1  25 
27  5 1  6 
28 2 16 3  21 
29  3  1 4 
30  1   1 
31 1 1   2 
32 1 5 1  7 
33  31 1  32 
34 2 10   12 
35 2 7   9 
36  47 4  51 
37 1 12   13 
38  6 1  7 
39 3    3 
40  3 2  5 
41 1 25   26 
42  1   1 
43 1 2   3 
44 2 9 1 1 13 
45  6   6 
46  6   6 
47  12 3  15 
48  40 2  42 
49  9   9 
50   1  1 
51  10 2  12 
52  2   2 
53  5   5 
54 3 14   17 
55 1 5   6 
56  3   3 
57  5 5  10 
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58  1   1 
59  12   12 
60 1 6 3  10 
61  3   3 
62  5   5 
63  1   1 
64  2   2 
65  1   1 
66  2   2 
67 2 9   11 
68 2 36 4  42 
69  25 1  26 
70 2 9   11 
71  1   1 
72  9 3  12 
73 1 1 1 1 4 
74  1   1 
75  1   1 
76  1   1 
Total 63 861 80 5 1009
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Table-52 
DIESEAS * LANG 
Crosstab  
Count  
 
 
LANG 
Total 
Gujarati Hindi Other 
DIESEAS
1 7 1  8 
2 3 2  5 
3 1   1 
4 4 1  5 
5 2   2 
6 1   1 
7 2   2 
8 5   5 
9 1   1 
10 2   2 
11 41 13  54 
12 14 3 1 18 
13 78 16 3 97 
14 23 4 3 30 
15 51 7  58 
16 5 1  6 
17 80 14 1 95 
18 2 2  4 
19 8 1  9 
20 6 1  7 
21 6 1  7 
22 10 3  13 
23 40 10  50 
24 2   2 
25 2 1 1 4 
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26 25   25 
27 5 1  6 
28 20 1  21 
29 4   4 
30 1   1 
31 2   2 
32 6  1 7 
33 29 2 1 32 
34 12   12 
35 6 3  9 
36 34 16 1 51 
37 11 2  13 
38 6 1  7 
39 3   3 
40 3 2  5 
41 22 4  26 
42 1   1 
43 2 1  3 
44 11 2  13 
45 4 2  6 
46 4 2  6 
47 13 2  15 
48 30 11 1 42 
49 5 3 1 9 
50  1  1 
51 11 1  12 
52 2   2 
53 5   5 
54 13 4  17 
55 5 1  6 
56 3   3 
57 7 3  10 
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58  1  1 
59 10 1 1 12 
60 9 1  10 
61 2  1 3 
62 4 1  5 
63 1   1 
64 2   2 
65 1   1 
66 2   2 
67 6 4 1 11 
68 36 3 3 42 
69 21 5  26 
70 9 2  11 
71 1   1 
72 9 3  12 
73 4   4 
74 1   1 
75 1   1 
76 1   1 
Total 822 167 20 1009 
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Table-53 
DIESEAS * RELIGION 
Crosstab  
Count  
 
 
RELIGION 
Total 
Hindu Muslim Jain Sikh Christian  
DIESEAS 
1 8     8 
2 5     5 
3 1     1 
4 4 1    5 
5  2    2 
6 1     1 
7 1 1    2 
8 5     5 
9 1     1 
10 2     2 
11 52 2    54 
12 18     18 
13 87 10    97 
14 27 3    30 
15 52 6    58 
16 6     6 
17 93 1   1 95 
18 4     4 
19 8 1    9 
20 6 1    7 
21 7     7 
22 12 1    13 
23 45 5    50 
24 2     2 
25 4     4 
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26 25     25 
27 5 1    6 
28 21     21 
29 4     4 
30 1     1 
31 2     2 
32 6 1    7 
33 30 2    32 
34 12     12 
35 9     9 
36 48 3    51 
37 12 1    13 
38 6 1    7 
39 2 1    3 
40 5     5 
41 26     26 
42 1     1 
43 3     3 
44 12 1    13 
45 6     6 
46 6     6 
47 13 2    15 
48 38 3   1 42 
49 9     9 
50 1     1 
51 11 1    12 
52 1 1    2 
53 3 2    5 
54 16 1    17 
55 5 1    6 
56 3     3 
57 10     10 
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58 1     1 
59 11 1    12 
60 8 2    10 
61 3     3 
62 5     5 
63 1     1 
64 2     2 
65    1  1 
66 2     2 
67 10 1    11 
68 38 3 1   42 
69 23 3    26 
70 10 1    11 
71 1     1 
72 11 1    12 
73 4     4 
74 1     1 
75  1    1 
76 1     1 
Total 936 69 1 1 2 1009 
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Table-54 
DIESEAS * AGE_GR 
Crosstab  
Count  
 
 
AGE_GR 
Total
< 20 20 - 30 30 - 40 40 - 50 50 - 60 60 - 70 > 70  
DIESEAS 
1   2 1 3 2  8 
2 2 2  1    5 
3 1       1 
4 2  1 2    5 
5     1  1 2 
6 1       1 
7  1   1   2 
8    3 2   5 
9    1    1 
10  1 1     2 
11  1 6 9 22 10 6 54 
12 4 4 2 2 3 2 1 18 
13  4 22 33 24 10 4 97 
14 8 7 4 6 3 2  30 
15  3 15 20 16 4  58 
16   1 2  2 1 6 
17 1 2 21 32 26 11 2 95 
18     4   4 
19  1  3 2 2 1 9 
20 2 1 1 2   1 7 
21    1 2 3 1 7 
22 1 3 5 2 2   13 
23   6 13 18 7 6 50 
24 2       2 
25   2 1  1  4 
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26  3 3 8 11   25 
27  1  3 1 1  6 
28   5 8 4 4  21 
29   1 2  1  4 
30       1 1 
31 1   1    2 
32 1  1 2 1 2  7 
33   1 7 12 11 1 32 
34 2 1 1 1 5 2  12 
35 1  1 3 1 2 1 9 
36   3 11 15 14 8 51 
37  1 1 3 5 2 1 13 
38    1 2 1 3 7 
39 3       3 
40   1 2  1 1 5 
41  3 6 7 6 3 1 26 
42     1   1 
43 1  1  1   3 
44 2  4 4 2 1  13 
45     4 1 1 6 
46   2 2  2  6 
47  1 1 2 7 2 2 15 
48  1 2 10 12 12 5 42 
49     1 4 4 9 
50      1  1 
51   3  4 4 1 12 
52  1   1   2 
53    4 1   5 
54  1 2 8  4 2 17 
55 1  2 2 1   6 
56  1 2     3 
57  1   2 4 3 10 
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58   1     1 
59   1 3 4 4  12 
60   1 3 1 4 1 10 
61   2  1   3 
62   1  1 3  5 
63     1   1 
64   1   1  2 
65   1     1 
66    1 1   2 
67 2 3 4 2    11 
68 1 4 7 14 9 1 6 42 
69   1 7 8 6 4 26 
70  4 1 2 2 1 1 11 
71   1     1 
72  1 2 3 3 3  12 
73  1  1  1 1 4 
74     1   1 
75     1   1 
76    1    1 
Total 39 58 156 263 262 159 72 1009
 
 
 190
Table- 55 T-Test  
Frequency Table   
AGE_GR  
 
 Frequency Percent Valid Percent Cumulative Percent
Valid 
< 20 39 3.9 3.9 3.9
20 - 30 58 5.7 5.7 9.6
30 - 40 156 15.5 15.5 25.1
40 - 50 263 26.1 26.1 51.1
50 - 60 262 26.0 26.0 77.1
60 - 70 159 15.8 15.8 92.9
> 70 72 7.1 7.1 100.0
Total 1009 100.0 100.0  
 
AGE_GR2  
 
 Frequency Percent Valid Percent Cumulative Percent
Valid 
<= 40 253 25.1 25.1 25.1
> 40 756 74.9 74.9 100.0
Total 1009 100.0 100.0  
 
HYPOTHESIS Hо: There is no significance difference between below 
and equal to 40 age group and above 40 age group of a person as far as 
occurance of disease/cilesenoma is concered. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed
) 
Mean 
Differenc
e 
Std. Error 
Differenc
e 
95% 
Confidence 
Interval of 
the 
Difference 
Lowe
r 
Uppe
r 
DIESEA
S 
Equal 
variance
s 
assumed 
3.542 .060
-
1.82
0
1007 .069 -2.59 1.423 -5.381 .203
Equal 
variance
s not 
assumed 
  
-
1.75
9
408.99
9 .079 -2.59 1.472 
-
5.482 .305
 
CONCLUSION: Here tcal=-1.820 & ttab=1.96 at 5% level of significance 
and d.f. =1007.tcal <ttab accept the hypothesis. And we conclude that there 
is no significance difference between below 40 age group and above 40 age 
group of a person as far as occurance of disease/cilesenoma is concered. 
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Table-56  
Crosstabs  
DIESEAS * AGE_GR2 Crosstabulation 
Count  
 
 
AGE_GR2 
Total 
<= 40 > 40 
DIESEAS 
1 2 6 8 
2 4 1 5 
3 1  1 
4 3 2 5 
5  2 2 
6 1  1 
7 1 1 2 
8  5 5 
9  1 1 
10 2  2 
11 7 47 54 
12 10 8 18 
13 26 71 97 
14 19 11 30 
15 18 40 58 
16 1 5 6 
17 24 71 95 
18  4 4 
19 1 8 9 
20 4 3 7 
21  7 7 
22 9 4 13 
23 6 44 50 
24 2  2 
25 2 2 4 
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26 6 19 25 
27 1 5 6 
28 5 16 21 
29 1 3 4 
30  1 1 
31 1 1 2 
32 2 5 7 
33 1 31 32 
34 4 8 12 
35 2 7 9 
36 3 48 51 
37 2 11 13 
38  7 7 
39 3  3 
40 1 4 5 
41 9 17 26 
42  1 1 
43 2 1 3 
44 6 7 13 
45  6 6 
46 2 4 6 
47 2 13 15 
48 3 39 42 
49  9 9 
50  1 1 
51 3 9 12 
52 1 1 2 
53  5 5 
54 3 14 17 
55 3 3 6 
56 3  3 
57 1 9 10 
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58 1  1 
59 1 11 12 
60 1 10 11 
61 2 1 3 
62 1 4 5 
63  1 1 
64 1 1 2 
65 1  1 
66  2 2 
67 9 2 11 
68 12 30 42 
69 1 25 26 
70 5 6 11 
71 1  1 
72 3 9 12 
73 1 3 4 
74  1 1 
75  1 1 
76  1 1 
Total 253 756 1009 
HYPOTHESIS Hо: There is no significant difference between the 
Proportions of the diseases in two age groups.  
 
Chi-Square Tests  
 
 Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 212.160(a) 75 .000
Likelihood Ratio 220.452 75 .000
Linear-by-Linear Association 3.303 1 .069
N of Valid Cases 1009   
a 102 cells (67.1%) have expected count less than 5. The minimum 
expected count is .25.  
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CONCLUSION: Here We Conclude that Proportion of disease is less than 
40 groups are smaller than above 40 groups. 
Table-57  
Crosstabs  
DIESEAS * GENDER  
Crosstab  
Count  
 
 
GENDER 
Total
Male Female 
DIESEAS
11 51 3 54
13 2 95 97
15 50 8 58
17 3 92 95
23 35 15 50
33 30 2 32
36 41 10 51
48 38 4 42
68 29 13 42
Total 279 242 521
HYPOTHESIS Hо: There is no significant difference between propotion 
of the disease between male & female having disease numbers 11, 
13,15,17,23,33,36,48 &68. 
 
Chi-Square Tests  
 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 329.621(a) 8 .000
Likelihood Ratio 398.878 8 .000
Linear-by-Linear Association 51.118 1 .000
N of Valid Cases 521   
a 0 cells (.0%) have expected count less than 5. The minimum expected 
count is 14.86. 
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CONCLUSION:Here we conclude that their is significant difference 
between propotion of the disease between male & female  having disease 
numbers11,13,15,17,23,33,36,48 &68. 
 
Table-58 
DIESEAS * MAR_STAT  
Crosstab  
Count  
 
 
MAR_STAT 
Total
Unmarried Married Widowed Divorced  
DIESEAS 
11  53 1  54
13 3 83 10 1 97
15 2 54 2  58
17 1 77 17  95
23  45 5  50
33  31 1  32
36  47 4  51
48  40 2  42
68 2 36 4  42
Total 8 466 46 1 521
  HYPOTHESIS Hо: There is no significant effect between propotion of 
the diseases of the marital-status having disease no. 11, 13, 15, 17, 23, 33, 
36, 48&68. 
 
Chi-Square Tests  
 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 31.798(a) 24 .132
Likelihood Ratio 33.085 24 .102
Linear-by-Linear Association .573 1 .449
N of Valid Cases 521   
a 24 cells (66.7%) have expected count less than 5. The minimum expected 
count is .06.  
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CONCLUSION: Here we conclude that there is no significant effect 
between propotion of the diseases of the marital-status having disease no. 
11, 13, 15, 17, 23, 33, 36, 48 & 68. 
 
Table-59 
DIESEAS * LANG  
Crosstab  
Count  
 
 
LANG 
Total 
Gujarati Hindi Other 
DIESEAS
11 41 13  54 
13 78 16 3 97 
15 51 7  58 
17 80 14 1 95 
23 40 10  50 
33 29 2 1 32 
36 34 16 1 51 
48 30 11 1 42 
68 36 3 3 42 
Total 419 92 10 521 
HYPOTHESIS Hо: Here we conclude that there is no significant effect 
between propotions of the disease of a language having disease number 11, 
13, 15, 23, 33, 36, 48 & 68. 
Chi-Square Tests  
 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 28.458(a) 16 .028
Likelihood Ratio 29.404 16 .021
Linear-by-Linear Association 1.370 1 .242
N of Valid Cases 521   
a 9 cells (33.3%) have expected count less than 5. The minimum expected 
count is .61.  
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CONCLUSION: There is significant effect between propotions of the 
disease of a language having disease number 11, 13, 15, 23, 33, 36, 48 & 
68. 
 
Table-60 
DIESEAS * RELIGION  
Crosstab  
Count  
 
 
RELIGION 
Total 
Hindu Muslim Jain Christian  
DIESEAS 
11 52 2   54 
13 87 10   97 
15 52 6   58 
17 93 1  1 95 
23 45 5   50 
33 30 2   32 
36 48 3   51 
48 38 3  1 42 
68 38 3 1  42 
Total 483 35 1 2 521 
 
HYPOYHESIS Hо: There is no significance effect between propotion of 
disease of a religion having disease no. 11, 13, 15, 23, 33, 36, 48 & 68. 
 
Chi-Square Tests  
 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 28.108(a) 24 .256
Likelihood Ratio 22.590 24 .544
Linear-by-Linear Association 1.161 1 .281
N of Valid Cases 521   
a 25 cells (69.4%) have expected count less than 5. The minimum expected 
count is .06.  
 199
CONCLUSION: Here we conclude that Religion has no effect at 5% level 
of significance having disease number 11, 13, 15, 23, 33, 36, 48 & 68. 
 
Table-61 
DIESEAS * AGE_GR 
Crosstab  
Count  
 
 
AGE_GR 
Total
< 20 20 - 30 30 - 40 40 - 50 50 - 60 60 - 70 > 70  
DIESEAS 
11  1 6 9 22 10 6 54
13  4 22 33 24 10 4 97
15  3 15 20 16 4  58
17 1 2 21 32 26 11 2 95
23   6 13 18 7 6 50
33   1 7 12 11 1 32
36   3 11 15 14 8 51
48  1 2 10 12 12 5 42
68 1 4 7 14 9 1 6 42
Total 2 15 83 149 154 80 38 521
HYPOTHESIS Hо: There is no significant effect of the propotion of the 
disease of the different Age-group having disease number 11, 13, 15, 23, 
33, 36, 48 & 68. 
 
Chi-Square Tests  
 
 Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 100.782(a) 48 .000
Likelihood Ratio 107.157 48 .000
Linear-by-Linear Association 4.939 1 .026
N of Valid Cases 521   
a 26 cells (41.3%) have expected count less than 5. The minimum expected 
count is .12.  
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CONCLUSION: Here we conclude that there is significant effect of the 
propotion of the disease of the different Age-group having disease number 
11, 13, 15, 23, 33, 36, 48 & 68. 
 
General Conclusion: For Chi-Square Test: 
 
(1)Here we conculed that they have the same Propotion of occurance of 
calisenoma/diseases of a persons having age-group below & equal to 40 
and age-group above 40. 
(2)Here we conculed that they have the same Propotion of occurance of 
calisenoma/diseases of a persons having different Martial-Status like 
unmarried, married, widowed, divoced. 
(3) Here we conculed that they have the same Propotion of occurance of 
calisenoma/diseases of a persons having different religions like Hindu, 
Muslim, Jain, Christian and Sikh. 
(4) Here we conculed that they have the differnt Propotion of occurance 
of calisenoma/diseases whether persons are male or female. 
(5) Here we conculed that they have the differnt Propotion of occurance 
of calisenoma/diseases of a persons having different Mother-tongue like 
Gujarati, Hindi and other. 
(6) Here we conculed that they have the differnt Propotion of occurance 
of calisenoma/diseases of a persons having age-groups like below 20, 
20-30, 30-40,40-50, 60-70 and above 70.  
Table-62 T-Test  
 
Group Statistics  
 
 
 
GENDER N Mean Std. Deviation Std. Error Mean
DIESEAS 
Male 279 30.30 17.829 1.067
Female 242 19.83 13.208 .849
HYPOTHESIS Hо: There is no significance difference between male and 
female of a person having disease number 11, 13, 15, 23, 33, 36, 48 & 68 
as far as occurance of calsenoma/disease is concered. 
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Independent Samples Test  
 
 
Levene's Test 
for Equality 
of Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference
Lower Upper
DIESEAS 
Equal 
variances 
assumed 
60.015 .000 7.522 519 .000 10.47 1.392 7.739 13.210
Equal 
variances 
not 
assumed 
  7.680 506.963 .000 10.47 1.364 7.795 13.154
CONCLUSION:  Here tcal=7.522 &ttab= 1.96 at 5%level of significance 
and d.f. =519. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between male and female of a person as far as 
occurance of calsenoma/disease is concered. 
Table-63 T-Test  
 
Group Statistics  
 
 GENDER N Mean Std. Deviation Std. Error Mean
DIESEAS 
Male 603 34.84 19.458 .792
Female 406 27.77 19.091 .947
HYPOTHESIS Hо: There is no significance difference between male and 
female of a person having disease number 1 to 76 as far as occurance of 
calsenoma/disease is concered. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed
) 
Mean 
Differenc
e 
Std. 
Error 
Differenc
e 
95% 
Confidence 
Interval of 
the 
Difference 
Lowe
r 
Uppe
r 
DIESEA
S 
Equal 
variance
s 
assume
d 
.753 .386 5.703 1007 .000 7.07 1.240 4.638 9.504
Equal 
variance
s not 
assume
d 
  5.724
880.03
1 .000 7.07 1.235 4.646 9.495
 
CONCLUSION: Here tcal=5.703 &ttab= 1.96at 5%level of significance 
and d.f. = 519. tcal > ttab Reject the hypothesis. And we conclude that 
there is significance difference between male and female of a person 
having disease number 1 to 76 as far as occurance of calsenoma/disease is 
concered. 
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Table-64 T-Test  
 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Unmarried 63 28.79 20.328 2.561
Married 861 32.11 19.513 .665
HYPOYHESIS Hо: There is no significance difference between 
Unmarried and married of a person as far as occurance of 
calsenoma/disease is concered. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed
) 
Mean 
Differenc
e 
Std. Error 
Differenc
e 
95% 
Confidence 
Interval of 
the 
Difference 
Lowe
r 
Uppe
r 
DIESEA
S 
Equal 
variance
s 
assumed 
.061 .806
-
1.29
7
922 .195 -3.31 2.554 -8.324 1.700
Equal 
variance
s not 
assumed 
  
-
1.25
2
70.61
9 .215 -3.31 2.646 
-
8.589 1.964
CONCLUSION: Here tcal=-1.297 &ttab=1.96 at 5%level of significance 
and d.f. =922. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between Unmarried and married of a person as 
far as occurance of calsenoma/disease is concered. 
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Table-65 T-Test  
 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS
Unmarried 63 28.79 20.328 2.561
Widowed 80 33.11 19.988 2.235
HYPOTHESIS Hо: There is no significance difference between 
Unmarried and widowed of a person as far as occurance of 
calsenoma/disease is concered. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed
) 
Mean 
Differenc
e 
Std. 
Error 
Differenc
e 
95% 
Confidence 
Interval of 
the 
Difference 
Lowe
r 
Uppe
r 
DIESEA
S 
Equal 
variance
s 
assume
d 
.040 .842
-
1.27
3
141 .205 -4.32 3.392 
-
11.02
5
2.387
Equal 
variance
s not 
assume
d 
  
-
1.27
1
132.20
5 .206 -4.32 3.399 
-
11.04
2
2.405
CONCLUSION: Here tcal=-1.273 &ttab=1.96 at 5%level of significance 
and d.f. =141. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between Unmarried and widowed of a person 
as far as occurance of calsenoma/disease is concered. 
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Table -66 T-Test  
 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS
Unmarried 63 28.79 20.328 2.561
Divorced 5 36.20 23.488 10.504
 HYPOTHESIS Hо: There is no significance difference between 
Unmarried and divorced of a person as far as occurance of 
calsenoma/disease is concered. 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
.02
2 .883 
-
.776 66 .440 -7.41 9.540 
-
26.454 11.641
Equal 
variances 
not 
assumed 
  -.685 4.489 .527 -7.41 10.812 
-
36.179 21.367
CONCLUSION: Here tcal=-.776 &ttab= 1.96   at 5%level of significance 
and d.f. =66. tcal< ttab accept the hypothesis. And we conclude that there is 
no significance difference between Unmarried and divorced of a person as 
far as occurance of calsenoma/disease is concered. 
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Table-67 T-Test  
 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Married 861 32.11 19.513 .665
Widowed 80 33.11 19.988 2.235
HYPOTHESIS Hо: There is no significance difference between married 
and widowed of a person as far as occurance of calsenoma/disease is 
concered. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
.32
7 .568 
-
.441 939 .660 -1.01 2.285 -5.492 3.478
Equal 
variances 
not 
assumed 
  -.432 93.543 .667 -1.01 2.332 -5.636 3.623
CONCLUSION: Here tcal=-.441 &ttab= 1.96 at 5%level of significance 
and d.f. =939. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between married and widowed of a person as 
far as occurance of calsenoma/disease is concered. 
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Table-68 T-Test  
 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS 
Married 861 32.11 19.513 .665
Divorced 5 36.20 23.488 10.504
HYPOTHESIS Hо: There is no significance difference between married 
and divorced of a person as far as occurance of calsenoma/disease is 
concered. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
.057 .811 -.467 864 .640 -4.09 8.761 
-
21.289 13.101
Equal 
variances 
not 
assumed 
  -.389 4.032 .717 -4.09 10.525 
-
33.226 25.037
CONCLUSION: Here tcal=-.467 & ttab= 1.96 at 5% level of significance 
and d.f. = 864. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between married and divorced of a person as 
far as occurance of calsenoma/disease is concered. 
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Table-69 T-Test  
 
Group Statistics  
 
 MAR_STAT N Mean Std. Deviation Std. Error Mean
DIESEAS
Widowed 80 33.11 19.988 2.235
Divorced 5 36.20 23.488 10.504
HYPOTHESIS Hо: There is no significance difference between widowed 
and divorced of a person as far as occurance of calsenoma/disease is 
concered. 
 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed
) 
Mean 
Differenc
e 
Std. Error 
Differenc
e 
95% 
Confidence 
Interval of 
the 
Difference 
Lower Upper
DIESEA
S 
Equal 
variance
s 
assumed 
.008 .928
-
.33
2
83 .741 -3.09 9.298 
-
21.58
1
15.40
6
Equal 
variance
s not 
assumed 
  
-
.28
7
4.37
0 .787 -3.09 10.739 
-
31.93
5
25.76
0
CONCLUSION: Here tcal=-.332 & ttab= 1.99 at 5%level of significance 
and d.f. =83. tcal< ttab accept the hypothesis. And we conclude that there is 
no significance difference between widowed and divorced of a person as 
far as occurance of calsenoma/disease is concered. 
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Table- 70 T-Test  
 
Group Statistics  
 
 LANG N Mean Std. Deviation Std. Error Mean
DIESEAS 
Gujarati 822 31.80 19.592 .683
Hindi 167 32.47 19.403 1.501
HYPOTHESIS Hо: There is no significance difference between persons 
having different mother tongue (Gujarati &Hindi) as far as occurrence of 
cailsenoma/disease are concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed
) 
Mean 
Differenc
e 
Std. Error 
Differenc
e 
95% 
Confidence 
Interval of 
the 
Difference 
Lowe
r 
Uppe
r 
DIESEA
S 
Equal 
variance
s 
assumed 
.031 .860
-
.40
5
987 .685 -.67 1.660 -3.931 2.586
Equal 
variance
s not 
assumed 
  
-
.40
8
239.80
9 .684 -.67 1.650 
-
3.922 2.577
CONCLUSION: Here tcal=-.405 & ttab=1.96 at 5%level of significance 
and d.f. =987. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between different mother tongue (Gujarati & 
Hindi) as far as occurance of calsenoma/disease is concered. 
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Table-71 T-Test 
 
Group Statistics  
 
 LANG N Mean Std. Deviation Std. Error Mean
DIESEAS 
Gujarati 822 31.80 19.592 .683
Other 20 36.20 22.503 5.032
HYPOTHESIS Hо: There is no significance difference between persons 
having different mother tongue (Gujarati & Other) as far as occurrence of 
cailsenoma/disease are concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
1.808 .179 -.989 840 .323 -4.40 4.450 
-
13.134 4.335
Equal 
variances 
not 
assumed 
  -.866 19.707 .397 -4.40 5.078 
-
15.002 6.203
CONCLUSION: Here tcal=-.989 & ttab= 1.96 at 5%level of significance 
and d.f. =840. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between different mother tongue (Gujarati 
&Other) as far as occurance of calsenoma/disease is concered. 
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Table-72 T-Test  
Group Statistics  
 
 LANG N Mean Std. Deviation Std. Error Mean
DIESEAS 
Hindi 167 32.47 19.403 1.501
Other 20 36.20 22.503 5.032
HYPOTHESIS Hо: There is no significance difference between persons 
having different mother tongue (Hindi & Other) as far as occurrence of 
cailsenoma/disease are concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
1.71
8 .192 
-
.798 185 .426 -3.73 4.672 
-
12.944 5.490
Equal 
variances 
not 
assumed 
  -.710 22.514 .485 -3.73 5.251 
-
14.603 7.149
CONCLUSION: Here tcal=-.798 &ttab= at 1.96 5%level of significance 
and d.f. =185. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between different mother tongue (Hindi & 
Other) as far as occurance of calsenoma/disease is concered. 
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Table-73 T-Test  
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS
Hindu 936 31.81 19.432 .635
Muslim 69 33.61 21.537 2.593
HYPOTHESIS Hо: There is no significance difference between religions 
(Hindu&Muslim) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed
) 
Mean 
Differenc
e 
Std. Error 
Differenc
e 
95% 
Confidence 
Interval of 
the 
Difference 
Lowe
r 
Uppe
r 
DIESEA
S 
Equal 
variance
s 
assumed 
3.41
0 
.06
5
-
.73
8
1003 .461 -1.80 2.443 -6.597 2.990
Equal 
variance
s not 
assumed 
  
-
.67
5
76.38
6 .501 -1.80 2.669 
-
7.119 3.513
CONCLUSION: tcal=-.738 &ttab=1.96 at 5%level of significance and d.f. 
=1003. tcal< ttab accept the hypothesis. Here we conclude that there is no 
significance difference between religions (Hindu&Muslim) of a person as 
far as occurance of calsenoma/disease is concered. 
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Table-74 T-Test  
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS
Hindu 936 31.81 19.432 .635
Jain 1 68.00 . .
HYPOTHESIS Hо: There is no significance difference between religions 
(Hidu&Jain) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
. . -1.862 935 .063 -36.19 19.442 
-
74.350 1.961
Equal 
variances 
not 
assumed 
  . . . -36.19 . . .
CONCLUSION: Here tcal=-.1.862 & ttab=1.96 at 5%level of significance 
and d.f. =935. tcal< ttab accept the hypothesis. Here we conclude that there 
is no significance difference between religions (Hindu&Jain) of a person as 
far as occurance of calsenoma/disease is concered. 
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Table- 75 T-Test  
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS
Hindu 936 31.81 19.432 .635
Sikh 1 65.00 . .
HYPOTHESIS Hо: There is no significance difference between religions 
(Hindu&Sikh) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
. . -1.707 935 .088 -33.19 19.442 
-
71.350 4.961
Equal 
variances 
not 
assumed 
  . . . -33.19 . . .
 
CONCLUSION: Here tcal=-.1.707 & ttab=1.96 at 5%level of significance 
and d.f. =935. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between religions (Hindu&Sikh) of a person 
as far as occurance of calsenoma/disease is concered. 
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Table-76 T-Test 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS
Hindu 936 31.81 19.432 .635
Christian 2 32.50 21.920 15.500
HYPOTHESIS Hо: There is no significance difference between religions 
(Hindu&Christian) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variance
s 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed
) 
Mean 
Differenc
e 
Std. 
Error 
Differenc
e 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
DIESEA
S 
Equal 
variance
s 
assumed 
.027 .870
-
.05
0
936 .960 -.69 13.757 -27.693 26.304
Equal 
variance
s not 
assumed 
  
-
.04
5
1.00
3 .972 -.69 15.513 
-
196.25
2
194.86
3
 
CONCLUSION: Here tcal=-.050 &ttab=1.96 at 5%level of significance 
and d.f. =936. tcal< ttab accept the hypothesis. And we conclude that there 
is no significance difference between religions of persons as far as 
occurance of calsenoma/disease is concered. 
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Table-77 T-Test 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Muslim 69 33.61 21.537 2.593
Jain 1 68.00 . .
HYPOTHESIS Hо:  There is no significance difference between religions 
(Muslim&Jain) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
. . -1.585 68 .118 -34.39 21.693 -77.679 8.896
Equal 
variances 
not 
assumed 
  . . . -34.39 . . .
 
CONCLUSION: Here tcal=-.1.585 & ttab=2.00 at 5%level of significance 
and d.f. =68. tcal< ttab accept the hypothesis. And we conclude that there is 
no significance difference between religions (Muslim&Jain) of persons as 
far as occurance of calsenoma/disease is concered. 
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Table-78 T-Test 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Muslim 69 33.61 21.537 2.593
Sikh 1 65.00 . .
HYPOTHESIS Hо: There is no significance difference between religions 
(Muslim&Sikh) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
 
Independent Samples Test  
DIESEAS 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper
 
Equal 
variances 
assumed 
. . -1.447 68 .152 -31.39 21.693 -74.679 11.896
Equal 
variances 
not 
assumed 
  . . . -31.39 . . .
 
CONCLUSION: Here tcal=-.1.447 & ttab=2.00 at 5%level of significance 
and d.f. =68. tcal< ttab accept the hypothesis. And we conclude that there is 
no significance difference between religions (Muslim&Sikh) of persons as 
far as occurance of calsenoma/disease is concered. 
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Table-79 T-Test 
 
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Muslim 69 33.61 21.537 2.593
Christian 2 32.50 21.920 15.500
HYPOTHESIS Hо: There is no significance difference between religions 
(Muslim&Christian) of persons as far as occurrence of cailsenoma/disease 
is concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality 
of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
D
IE
SE
A
S 
Equal 
variances 
assumed 
.238 .627 .072 69 .943 1.11 15.452 -29.718 31.935
Equal 
variances 
not 
assumed 
  .071 1.057 .955 1.11 15.715 -174.939 177.157
CONCLUSION: Here tcal=.702 & ttab=2.00 at 5% level of significance 
and d.f. =69. tcal< ttab accept the hypothesis. And we conclude that there is 
no significance difference between religions of persons as far as occurance 
of calsenoma/disease is concered. 
Table-80 T-Test  
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Jain 1 68.00 . .
Christian 2 32.50 21.920 15.500
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HYPOTHESIS Hо: There is no significance difference between religions 
(Jain&Christian) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
 
Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
D
IE
SE
A
S 
Equal 
variances 
assumed 
. . 1.322 1 .412 35.50 26.847 -305.621 376.621
Equal 
variances 
not 
assumed 
  . . . 35.50 . . .
CONCLUSION: Here tcal = 1.322 & ttab=12.71 at 5%level of 
significance and d.f. =1. tcal< ttab accept the hypothesis. And we conclude 
that there is no significance difference between religions (Jain&Christian) 
of persons as far as occurance of calsenoma/disease is concered. 
 
Table-81 T-Test  
Group Statistics  
 
 RELIGION N Mean Std. Deviation Std. Error Mean
DIESEAS 
Sikh 1 65.00 . .
Christian 2 32.50 21.920 15.500
HYPOTHESIS Hо: There is no significance difference between religions 
(Sikh&Christian) of persons as far as occurrence of cailsenoma/disease is 
concerned. 
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Independent Samples Test  
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
D
IE
SE
A
S 
Equal 
variances 
assumed 
. . 1.211 1 .440 32.50 26.847 -308.621 373.621
Equal 
variances 
not 
assumed 
  . . . 32.50 . . .
CONCLUSION: Here tcal =1.211 & ttab=12.71 at 5% level of 
significance and d.f. =1.tcal< ttab accept the hypothesis. And we conclude 
that there is no significance difference between religions (Sikh&Christian) 
of a person as far as occurance of calsenoma/disease is concered. 
 
Table-82 T-Test  
Group Statistics  
 
 AGE_GR2 N Mean Std. Deviation Std. Error Mean
DIESEAS 
<= 40 253 30.06 20.598 1.295
> 40 756 32.65 19.240 .700
HYPOTHESIS Hо: Average number of patients in the below and equal to 
40 age Group is same as the above 40 age Group. 
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Independent Samples Test
 
 
Levene's 
Test for 
Equality 
of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed)
Mean 
Difference
Std. Error 
Difference 
95% 
Confidence 
Interval of 
the 
Difference 
Lower Upper
D
IE
SE
A
S 
Equal 
variances 
assumed 
3.542 .060 -1.820 1007 .069 -2.59 1.423 -5.381 .203
Equal 
variances 
not 
assumed 
  -1.759 408.999 .079 -2.59 1.472 -5.482 .305
 
CONCLUSION: Here tcal =-1.82 & ttab=1.96 at 5%level of significance 
and d.f. =1007. tcal< ttab accept the hypothesis. And we conclude that 
there is no significance difference between below and equal to 40 age 
group and above 40.     
 
 General Conclusion for T-Test: 
 
     (1) Here we conculed that they have the same chances of occurance of   
          cailsenoma/diseases whether persons have below 40 & equal to 40  
          Age group and above 40 age group. 
   (2) Here we conculed that they have the same chances of occurance of   
         Cailsenoma/diseases whether persons are male or female of diseases  
        Number 11, 13, 15, 23, 33, 36, 48 & 68. 
   (3) Here we conculed that they have the different chances of occurance of   
        Cailsenoma/diseases whether persons are male or   female of diseases      
        Number 1 to 76. 
   (4)  Here we conculed that they have the same chances of occurance of      
          Calisenoma/diseases whether persons are different martial-status    
          Like unmarried, married, widowed, divoced. 
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   (5) Here we conculed that they have the same chances of occuranceof  
         Calisenoma/diseases whether persons are different mother-tongue   
         Like Gujarati, Hindi and other. 
  (6) Here we conculed that they have the same chances of occurance of  
        Calisenoma/diseases whether persons are different religions like         
       Hindu, Muslim, Jain, Christian and Sikh. 
                                                         
 
Table 83 
Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 41.732 2 .000
Bloc
k 41.732 2 .000
Mod
el 41.732 2 .000
 Model Summary 
 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 379.52
0(a) .041 .119
An Estimation terminated at iteration number 8 because parameter estimates 
changed by less than .001. 
 
 Classification Table (a) 
 
  Observed 
Predicted 
D11 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D11 .00 955 0 100.0 
1.00 54 0 .0 
Overall Percentage   94.6 
A The cut value is .500 
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Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age .022 .010 5.133 1 .023 1.022 
Male 2.450 .599 16.738 1 .000 11.588 
Const
ant -6.003 .770 60.847 1 .000 .002 
A Variable(s) entered on step 1: Age, Male. 
 
 
Logistic Regression 
 
 Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 170.373 2 .000
Bloc
k 170.373 2 .000
Mod
el 170.373 2 .000
 
 
 Model Summary 
 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 468.33
6(a) .155 .331
An Estimation terminated at iteration number 8 because parameter estimates 
changed by less than .001. 
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Classification Table (a) 
 
  Observed 
Predicted 
D13 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D13 .00 912 0 100.0 
1.00 97 0 .0 
Overall Percentage   90.4 
A The cut value is .500 
 
 Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age .004 .008 .262 1 .609 1.004 
Male -4.533 .719 39.806 1 .000 .011 
Const
ant -1.389 .417 11.127 1 .001 .249 
A Variable(s) entered on step 1: Age, Male. 
 
 
Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 157.603 2 .000
Bloc
k 157.603 2 .000
Mod
el 157.603 2 .000
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Model Summary 
 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 472.09
7(a) .145 .311
Estimation terminated at iteration number 8 because parameter estimates 
changed by less than .001. 
 
 
 Classification Table (a) 
 
  Observed 
Predicted 
D17 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D17 .00 914 0 100.0 
1.00 95 0 .0 
Overall Percentage   90.6 
A The cut value is .500 
 
 
  
Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age .004 .008 .238 1 .626 1.004 
Male -4.084 .592 47.662 1 .000 .017 
Const
ant -1.422 .418 11.589 1 .001 .241 
A Variable(s) entered on step 1: Age, Male. 
 
 
 Observed 
Predicted 
D23 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
0 
D23 .00 959 0 100.0 
1.00 50 0 .0 
Overall Percentage   95.0 
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A Constant is included in the model. 
B The cut value is .500 
  
 
 
 
 
 
Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 6.258 2 .044
Bloc
k 6.258 2 .044
Mod
el 6.258 2 .044
 
 
 Model Summary 
 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 391.69
1(a) .006 .019
Estimation terminated at iteration number 6 because parameter estimates 
changed by less than .001. 
 
 
 Classification Table (a) 
 
  Observed 
Predicted 
D23 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D23 .00 959 0 100.0 
1.00 50 0 .0 
Overall Percentage   95.0 
A The cut value is .500 
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Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age .019 .010 3.728 1 .054 1.019 
Male .409 .318 1.653 1 .199 1.505 
Const
ant -4.227 .581 53.003 1 .000 .015 
A Variable(s) entered on step 1: Age, Male. 
 
 
 
 
Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 26.452 2 .000
Bloc
k 26.452 2 .000
Mod
el 26.452 2 .000
 
 
  
Model Summary 
 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 257.38
5(a) .026 .106
Estimation terminated at iteration number 8 because parameter estimates 
changed by less than .001. 
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Classification Table (a) 
 
  Observed 
Predicted 
D33 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D33 .00 977 0 100.0 
1.00 32 0 .0 
Overall Percentage   96.8 
A The cut value is .500 
 
 Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age .031 .013 5.978 1 .014 1.031 
Male 2.254 .735 9.398 1 .002 9.524 
Const
ant -6.892 .985 48.966 1 .000 .001 
A Variable(s) entered on step 1: Age, Male. 
 
  
Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 26.762 2 .000
Bloc
k 26.762 2 .000
Mod
el 26.762 2 .000
 
 Model Summary 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 377.07
4(a) .026 .079
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Estimation terminated at iteration number 7 because parameter estimates 
changed by less than .001. 
 
 Classification Table (a) 
 
  Observed 
Predicted 
D36 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D36 .00 958 0 100.0 
1.00 51 0 .0 
Overall Percentage   94.9 
A The cut value is .500 
 
 Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age .041 .011 14.977 1 .000 1.041 
Male .921 .363 6.442 1 .011 2.511 
Const
ant -5.798 .667 75.640 1 .000 .003 
A Variable(s) entered on step 1: Age, Male. 
 
Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 29.131 2 .000
Bloc
k 29.131 2 .000
Mod
el 29.131 2 .000
 
 Model Summary 
 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 320.13
5(a) .028 .097
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Estimation terminated at iteration number 7 because parameter estimates 
changed by less than .001. 
 
 Classification Table (a) 
 
  Observed 
Predicted 
D48 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D48 .00 967 0 100.0 
1.00 42 0 .0 
Overall Percentage   95.8 
A The cut value is .500 
  
Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age .031 .011 7.864 1 .005 1.032 
Male 1.807 .532 11.537 1 .001 6.091 
Const
ant -6.216 .786 62.528 1 .000 .002 
A Variable(s) entered on step 1: Age, Male. 
 
Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 1.908 2 .385
Bloc
k 1.908 2 .385
Mod
el 1.908 2 .385
 
 Model Summary 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 347.35
9(a) .002 .006
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Estimation terminated at iteration number 6 because parameter estimates 
changed by less than .001. 
 
 
 Classification Table (a) 
 
  Observed 
Predicted 
D68 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D68 .00 967 0 100.0 
1.00 42 0 .0 
Overall Percentage   95.8 
A The cut value is .500 
 
  
Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age -.005 .010 .291 1 .589 .995 
Male .439 .341 1.656 1 .198 1.551 
Const
ant -3.150 .551 32.641 1 .000 .043 
A Variable(s) entered on step 1: Age, Male. 
 
 
Block 1: Method = Enter 
 
 Omnibus Tests of Model Coefficients 
 
    
Chi-
square df Sig. 
Step 
1 
Step 24.907 2 .000
Bloc
k 24.907 2 .000
Mod
el 24.907 2 .000
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Model Summary 
 
Ste
p 
-2 Log 
likeliho
od 
Cox & 
Snell R 
Square 
Nagelker
ke R 
Square 
1 419.02
1(a) .024 .069
Estimation terminated at iteration number 7 because parameter estimates 
changed by less than .001. 
 
 
  
Classification Table (a) 
 
  Observed 
Predicted 
D15 
Percenta
ge 
Correct 
.00 1.00 .00 
Step 
1 
D15 .00 951 0 100.0 
1.00 58 0 .0 
Overall Percentage   94.3 
A the cut value is .500 
 
 
 Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Ste
p 
1(a) 
Age -.017 .008 4.515 1 .034 .983 
Male 1.553 .387 16.066 1 .000 4.725 
Const
ant -3.093 .513 36.311 1 .000 .045 
A Variable(s) entered on step 1: Age, Male. 
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From the above table of the logiestic regression we can estimate 
proportions of the particular disease for given age & gender of the patients. 
Following models are developed: 
Disease no. 11 
Y= .002+11.588(Male) +1.022(Age) 
Disease no.13 
Y=.249+.011(Male) +1.004(Age) 
Disease no. 17 
Y=.241+.017+ (Male) +1.019(Age) 
Disease no. 23 
Y=.015+1.505(Male) +1.019(Age) 
Disease no. 33 
Y=.001+9.524(Male) +1.031(Age) 
Disease no. 36 
Y=.003+2.511(Male) +1.041(age) 
Disease no. 48 
Y=.002+6.091(Male) +1.032(Age) 
Disease no. 68 
Y=.043+1.551(Male) +.995(Age) 
Disease no. 15 
Y=.045+4.725(Male) +.983(Age) 
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CHAPTER 6 CONCLUDING REMARK AND FUTURE 
PROSPECTS: 
(6.1) Concluding Remark: 
In this thise the attempts have been made to discuss some problems in 
biomedical statistics. 
 Some importants conclusions are also derived from secondary data 
collected from Gujarat cancer research institute (GCRI) Ahmedabad 
having sample size 1009 from the year 2000-2001,2002-2003,2003-
2004,2004-2005 and 2005-2006.  
 The diseases are not depending upon the sex whether male or 
female nither the martial-status, mother-tongue whether Gujarati, 
Hindi and Other and any age-group whether below 20, 20-30, 30-
40, 40-50, 50-60, 60-70 and above 70. 
 The diseases are depending upon the religions whether Hindu, 
Muslim, Jain, Christian and Sikh. 
 Propotion of diseases are not depending upon the age group 
whether person having below & equal to 40 and age group above 
40 nither marital-status and religions whether Hindu, Muslim, 
Jain, Christian and Sikh. 
 Propotion of diseases are deponding upon the sex whether male 
or female nither mother-tongue whether Gujarati, Hindi and 
Other. 
 Cases of Brest cancer is more in year 2000,2002,2003 and 2006 
where as cases of cervix cancer is more in year 2004 and 2005. 
 Cases of Brest cancer is more in Married and divorced persons 
where as Cases of Brain cancer is more in unmarried persons and 
s Cases of Cervix cencer is more in widowed persons. 
 Cases of Cervix cancer is more in those persons who know 
Gujarati language where as Cases of Brest cancer is more in those 
persons who know non-gujarati language. 
 Cases of Base of tongue cancer are more in males where as Cases 
of Brest cancer is more in females. 
 Cases of Cervix cancer are more in Hindu and Christian persons 
where as Cases of Abdoenimal L.N. is more in Muslim persons, 
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Cases of secondary sikn cancer are more in Sikh persons and 
Cases of 68 cancers are more in Jain persons. 
 Cases of Brain cancer is more in persons in the age group below 
20 and 20-30 where as Cases of Brest cancer are more in persons 
having age-group 30-40and 40-50, Cases of Cervix cancer are 
more in persons having age-group 50-60 and Cases of Lung 
cancer are more in persons having age-group 60-70 and above 70. 
            
In this thesis we have use the following statistical methodology: 
1 discriptive statistics like mean median, mode, sd and plot histographs. 
2 test of mean (t-test).  
3 Analysis of variance 
4 independent sample t-tests 
5 Test of association and propotion (chi –square tests). 
6 Logestic regressions. 
 
There is always scope for improvement in the kind of work under taken 
in this thesis. Hence we feel that the thesis will be incomplete without a 
suggestion has to the direction in which future can be carried out. 
          The work is done for cancer problems but this kind of work can be 
carried out for many life diseases whose finding will be useful to the 
Government and Society at large. Many other aspects of cancer diseases 
van is consider such as size of the tummer and problem of the survival 
analysis etc... Thus, there is always improvement in the work carried out 
and there are aempal of future prosecpts in this area.  
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(6.2) Future Prospects of the Present Research: 
 
Using a carefully chosen set of examples, illustrating the importance and 
ubiquity of quantitative reasoning in the biomedical sciences. The examples 
range across many different levels of biomedical interventions, and problems 
addressed range from basic to apply. In addition to the overall theme that 
mathematical and statistical approaches are essential for understanding 
biomedical systems, three particular and interacting mathematical themes 
emerge. First nonlinearly is pervasive; second, inclusion of Fourier series and 
third; issues of scales are common to all applications of quantitative 
approaches. Future progress in understanding many biomedical systems and 
events will depend on continued applications and developments in the three 
areas, and on understanding how nonlinearity WFSA, and scale interact. 
        Over reliance on Null Hypothesis Significance Test (NHST) is a 
serious problem in number of disciple, including Biomedical Sciences. It 
has the potential to damage not only the progress of these sciences but also 
the objects of their study. In mid 1980s, medical sciences underwent a 
(relatively) major statistical reform.  It saw the number of p values drop 
dramatically and the rates of confidence interval reporting use 
concomitantly. In Biomedical Sciences a parallel change is yet to be 
achieved despite half a century of debate, several inventions, and even an 
American Association Task Force on Statistical Inference. Biomedical 
Sciences also lags behind substantially Improvement of software and 
research understanding of outer rate methods, it seems unlikely that the 
initiatives will achieve substantial statistical reform. 
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    It is argued that combined models may be necessary for optimally 
extracting the information from biomedical studies. Out ability to find 
depends on how & precisely and accurately are able to model the 
interrelationships. We need these newer models and methods for extracting 
the information from biomedical data, and we also need to reorient 
ourselves as to how we interpret the very information extracted. It is 
projected that path and, segregation analysis, as such in terms of combined 
models, will be useful in New futuristic research. 
     Compelling arguments for reform of statistical practices and inferences 
have been made in many disciplines in some cases over several decades, 
but achieving reform has proved difficult. Discussion of how reform has 
progressed or not progressed in Biomedical Sciences and Health Sciences 
case studies of attempts by pioneering to change statistical inferences and 
practices. Those seeking reform in Biomedical Sciences included to need to 
recognize the importance of software that give practical guidance to 
statistical researchers wishing to use the recommended statistical 
mathematical techniques. Research is required on recommended techniques 
so that statistical practice on inferences can become evidence based. Also, 
improvement in statistical practice on inferences should be encouraged 
along with improvement in a way a discipline theorizes. 
    The precautionary principle recommends preventing possible harm to 
human health. I have gained support in the international community as a 
higher-order legal principle that should guide public policy and the 
formulation of specific laws. One can argue that the value of the 
precautionary principles is that it emphasizes aspects of good decision-
making that go beyond the scope of formal decision theory, and are often 
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neglected in statistical practice. It is best conceived as providing guidelines 
for formulating a decision problem, as opposed to challenging standard 
decision rules. To this effect, the statistical principles advocate assessment 
of acts relative to feasible alternatives (in approximation) and proper 
representation of all potential outcomes (probabilistic or scientifically 
uncertain). In terms of determining or estimating suitable outcome utilities 
and burdens of proof (qualification), the precautionary statistical principles 
appeals to ideals associated with newer development. Finally outline some 
general implications of these statistical principles for decision-making in 
Biomedical Sciences. 
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CHAPTER 7  CASE STUDIES: 
 
 Case Studies in Breast Cancer in ER – PR Positivity: 
 Desai et al has done study on Hormone receptor status of breast cancer in 
India: a study of 798 tumors. The objectives of this study were to document 
the estrogen and progesterone receptor (ER & PR) status of breast cancer in 
the Indian population (as done by immunohistochemistry on paraffin 
blocks), and correlate the steroid receptor status of breast cancer with all 
relevant patient and tumor characteristics. Their current data have been 
compared with previously published data from other centers. In contrast to 
the higher rates reported in the Western literature, only 32.6% of our 
tumors were ER positive and 46.1% were PR positive. Tumors were 
separated into four categories: ER+PR+ (25%), ER+PR- (7.4%), ER-PR+ 
(21.1%) and ER-PR- (46.5%). ER and PR immunoreactivity increased with 
advancing age, and correlated with the presence of elastosis. Infiltrating 
lobular carcinoma, mucinous carcinoma, and mixed tumors were more 
frequently ER & PR positive. High-grade infiltrating duct carcinomas, pure 
comedo ductal carcinoma in situ, and medullary carcinoma were 
predominantly ER & PR negative. The presence of necrosis and 
lymphovascular invasion showed an inverse relationship with ER and PR 
reactivity. (6) 
Goyle et al analyzed retrospective data of 131 breast cancer patients 
presenting to their institute between January and December 2007. The 
patients were staged according to AJCC criteria and were divided into 3 
categories: stage I/II, stage III and stage IV. ER, PR and HER2 status was 
then compared for the 3 categories. Results: Of the 131 breast cancer 
patients, 77 (59%) presented with stage I/II disease, 45 (34%) with stage III 
disease and 9 (7%) with stage IV disease. 28 (36%) patients with stage I/II 
disease were ER/PR/HER2 negative, 11 (25%) with stage III disease were 
ER/PR/HER2 negative and 2 (22%) with stage IV disease were 
ER/PR/HER2 negative. Overall 41 (31%) patients were found to be 
ER/PR/HER2 negative, of which 28 (68%) belonged to stage I/II, 11 (27%) 
to stage III and 2 (5%) to stage IV disease. Conclusions: From our data we 
conclude that presence of ER/PR/HER2 negativity does not necessarily 
correlate with more advanced disease at presentation in our Indian 
population. (7) 
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 Rakesh Chopra did a Case study in which most patients with breast cancer 
seen at general hospitals and regional cancer centers present with advanced 
disease. The reported incidence of estrogen receptor (ER) and progesterone 
receptor (PR) status has been significantly lower than in white women. 
Navnani et al2 studied these features in women presenting with breast 
cancer to the Breach Candy Hospital in Mumbai. This is an exclusive 
hospital, and the patients present with early-stage disease, unlike those at 
regional cancer centers. The findings are presented below. 
 
Receptor Status  
ER+PR+  ER+PR-  ER-PR+  ER-PR-  
No. %  No. %  No. %  No. %  
All (N = 125) 29 23.2 24 19.2 13 10.4 59 47.2 
Grade 1 (n = 14) 5 35.7 2 14.3 2 14.3 5 35.7 
Grade 2 (n = 47) 17 36.1 8 17 7 14.9 15 32 
Grade 3 (n = 64)  8  12.5 14  21.9 4  6.3  38  59.4 
The outcome is, the incidence of ER+PR+ tumors was 23.2%; the 
incidence of ER-PR- 
A tumor was 47.2%. Factors contributing to the high incidence of ER-PR- 
tumors were high tumor grade and disease/tumor stage in the majority of 
the women and premenopause status in a large number of the women.(8) 
 Zheng et al has done a study from February to September in 1994, a total 
of 58 patients with nasopharyngeal carcinoma (NPC) were testified by 
pathology. It included 56 poorly differentiated squamous cancers, 1 poorly 
differentiated adenocarcinoma, and 1 B-cell lymphoma. Clinical staging: II 
stage 6 cases, III stage 20 cases, IV stage 24 cases, recurrence 8 cases. The 
results showed that ER and PR positive rate were 26/58 (44.8%) and 28/58 
(48.3%). The rate has not relation to the age and sex. There was a contrary 
relation between ER, PR positive rate and clinical staging and VCA-IgA. 
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When ER, PR were negative and VCA-IgA was 140 in IV stage patients, 
its accorded rate was 9/12 (75%); when only VCA-IgA was 140, 
accorded rate was 13/33 (39.4%). Total CR was 38/49 (77.6%). When both 
ER and PR were positive, CR was 79%; when both ER and PR were 
negative and VCA-IgA was 140, CR was 58.3%. We regard NPC is 
belong to high expression tumor of estrogen and progesterone, and positive 
expression can reflect tumor developing tendency and relate to recent 
prognosis. The paper suggests that it isPossible to treat NPC with the 
endocrine therapy. Examining ER, PR and VCA-IgA together can improve 
the analysis of the prognosis of NPC. (9   
Biesterfelds et al has done study on Simultaneous immunohistochemical 
and biochemical   hormone receptor assessment in breast cancer provides 
complementary prognostic information.The prognostic value of the 
biochemical and the immunohistochemical assessment of estrogen- and 
progesterone receptor (ER PR) status were tested in 111 breast cancer 
patients, mostly focusing on whether the results reveal complementary 
prognostic Information. The biochemical receptor analysis was performed 
on snap-frozen tumor tissue using a standard protocol (ER-DCC, PR-
DCC). The immunhistochemical staining was done on 4 μm thick paraffin 
sections and was evaluated semiquantitatively (ER-IHC, PR-IHC) and 
immunohistometrically by means of image analysis (ERMEAN, 
PRMEAN). 74% of the ER-DCC and 50% of the PR-DCC assays were 
interpreted as positive. The positivity rates of the immunohistochemical 
reactions ranged between 78% and 81% for ER and between 66% and 82% 
for PR, depending on the interpretation mode. The concordance rate for the 
DCC method was 68%, and ranged between 77% and 85% for the 
immunohistochemical results on paraffin sections. ER-DCC and PR-DCC 
showed a better survival for receptor-positive patients; however, this 
tendency was only statistically significant for the PR-DCC (p = 0.0294). 
Patients with immunohistochemically determined ER- or PR-positivity 
revealed a significantly better survival than receptor-negative patients, the 
effect being stronger for the progesterone receptor (ER: p = 0.0253, PR: p = 
0.0005). Combining the different methods and receptors in a multivariate 
analysis, we observed that a) ER and PR reveal complementary prognostic 
information to each other after immunohistochemical determination (p ≤ 
0.0018) and that, b) complementary prognostic information was also 
obtainable by comparing the biochemical and the immunohistochemical 
PR-analysis (p≤0.0084); slightly more significant results were obtained for 
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ERMEAN and PRMEAN compared to ER-IHC and PR-IHC. Considering 
the lymph node status and a combined receptor analysis (PR-DCC, 
ERMEAN, PRMEAN) as the two strongest prognosticators in multivariate 
Cox models, the combined receptor analysis was able to discover for each 
of the three groups of NO- and N1-patients different survival probabilities 
(p<0.0001). In conclusion the ER-DCC appears to be dispensable in all 
patients. In lymph node-negative patients, the PR-DCC has no outstanding 
merit, indicating that the necessity of this method is also controversial. In 
primary tumors of lymph node-positive patients, however all three 
remaining types of receptor analysis should be evaluated for their 
therapeutic implications. (10)  
Wang B et al has done study on .discordance of estrogen receptor (ER), 
progestin receptor (PR), and HER-2 receptor statuses between primary and 
metastatic focuses of breast cancer. Hormone and Herceptin therapy for 
metastatic breast cancer is commonly based on expression of estrogen 
receptor (ER) and progestin receptor (PR), and over-expression of HER-2 
in primary breast cancer, but studies comparing receptor statuses in primary 
and metastatic focuses of the same patient are limited. This study was 
designed to investigate discordance of ER, PR, and HER-2 statuses 
between primary and metastatic focuses of breast cancer. METHODS: 
Immunohistochemistry assay was used to detect expression of ER, PR, and 
HER-2 receptor in primary and metastatic focuses of 65 cases of breast 
cancer. RESULTS: Positive rate of ER in primary focuses was 56.9% 
(37/65), significantly higher than that in metastatic focuses (33.8%, 
22/65)(P< 0.01); while positive rates of PR and HER-2 receptor have no 
significant difference between primary and metastatic focuses. Total 
discordance rates of ER, PR, and HER-2 were 35.4%, 29.2%, and 16.9%, 
respectively.  Difference in expression level of ER between primary and 
metastatic focuses of breast cancer was significant, while differences of 
expression of PR, and HER-2 wasn't significant, but we still should think 
highly of the expression differences of ER,PR, and HER-2 in our clinical pr 
clinical practices.(11) 
GAJALAKSHMI et al has done a population-based survival study on 
female breast cancer in Madras, India. 
Breast cancer is the second most common cancer among women in Madras 
and southern India after cervix cancer. The Madras Metropolitan Tumor 
Registry (MMTR), a population-based cancer registry, collects data on the 
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outcome of cancer diagnosis by both active and passive methods. A total of 
2080 cases of invasive female breast cancer were registered in MMTR 
during 1982-89. Of these, 98 (4.7%) cases were registered on the basis of 
death certificate information only (DCO), and there was no follow-up 
information for 235 (11.3%). These were excluded, leaving 1747 (84%) for 
survival analysis. The mean follow-up time was 43 months. The overall 
Kaplan-Meier observed survival rates at 1, 3 and 5 years were 80%, 58% 
and 48% respectively; the corresponding figures for relative survival were 
81%, 61% and 51%. A multifactor analysis of prognostic factors using a 
proportional hazards model showed statistically significant differences in 
survival for subjects in different categories of age at diagnosis, marital 
status, educational level and clinical extent of disease. Increasing age at 
diagnosis was associated with decreased survival. Single women displayed 
poorer survival (37.4%) at 5 years than those married and living with 
spouses (50.0%). The survival rate among those who had more than 12 
years of education was higher (70%) at 5 years than that of illiterate 
subjects (47%). An inverse relationship was seen between survival rates 
and clinical extent of disease. The need for research to determine feasible 
public health approaches, allied to coordinated treatment facilities to 
control breast cancer in India, is emphasized. (12) 
Case studies on Survival Analysis of Cervix Cancer: 
 
             Yeole et al have done a study on Survival from breast and cervical 
cancer in Mumbai (Bombay), India. This paper is reported on the survival 
of breast and cervical cancer patients registered during 1982-86 in Bombay 
Cancer Registry. A total of 2872 breast cancer and 2354 cervical cancer 
cases were registered for survival analysis. Details on marital status, 
mother tongue, religion, education, and clinical extent of disease were 
available for these cases. Information is obtained from 168 hospitals and 
clinics in the public and private sector using a structured form. Overall, 
analytical results represent an average prognosis from breast and cervical 
cancers in the country. Age group, marital status and clinical extent of 
disease emerged as significant factors affecting survival in breast and 
cervical cancer. The clear downward gradient in survival with advanced 
disease indicates that the classification of the clinical extent of disease was 
reasonably accurate. Although Mumbai has a level of health services which 
allows patients reasonable access to diagnostic and therapeutic services, 
there is a considerable scope for improving outcome by early diagnosis and 
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treatment. It would also be prudent to consider ways of achieving this at a 
minimal cost. (13) 
Nandkumar et al have done a study on Incidence, mortality and survival in 
cervix Cancer in Banglore, India.Cancer of the cervix is the most common 
cancer among women in India constituting between one sixth to one half of 
all female cancers with an age adjusted incidence rate ranging from19.4 to 
43.5 per 100,000 in the registries under the National Cancer Registry 
Program (NCRP). (Annual reports, NCRP, ICMR).It has been estimated 
that 100,000 new cases of cancer of the cervix occur in India every year, 
and 70% or more of these are Stage-III or higher at diagnosis. However, the 
incidence of cancer of the cervix as suggested in this report appears to be 
on the decline in Banglore. Besides incidence and clinical stage at 
presentation knowledge of survival is essential to complete the picture of 
establishing baseline indicators to monitor and evaluate cancer control 
programs. Survival analysis was carried out on 2121 patients diagnosed 
during 1982-89 in Banglore, India. They observed that 5- year survival was 
34.4% and the relative survival was 38.3%. Clinical stage at presentation 
was the single most important variable in predicting survival. The 5 year 
observed survival for stage I disease was 63.3%, for stage II was 44.0%, for 
stage III was 30.3% and for stage IV was 5.7 %.( 14) 
Sriamporn et al studied on Loss-adjusted survival of cervix cancer in Khon 
Kaen, Northeast Thailand 
For incident cancers of the cervix uteri (601 cases) registered in the 
population-based cancer registry of Khon Kaen province, Northeast 
Thailand, in 1985–1990 where loss-adjusted survival probabilities were 
estimated by a logistic regression model with four prognostic factors (age 
at diagnosis, stage of disease, place of residence and treatment), and 
compared with observed survival, estimated by the actuarial method. All 
patients were followed up for a minimum of 5 years, using both passive 
and active methods. In all, 27.6% of patients were lost to follow-up within 
5 years of the index date. The overall observed survival at 5 years was 
56.8% and loss-adjusted survival was 54.7%. The difference between the 
loss-adjusted and observed survival at 5 years was small: 2.1% overall, 
varying between 0.8 and 3.5 percent units for any prognostic group. The 
assumption of independence of loss to follow-up and death in the 
calculation of survival by the actuarial method in this, and probably in 
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other, population-based series, is reasonable and leads to no material bias in 
the estimates. (15) 
 
 SANKARANARAYANAN et al further studied studied on cervical 
cancer in Kerala: a hospital registry-based study on survival and 
prognostic factors. The survival experience of 452 cervical cancer patients 
were registered during 1984 and noted in the hospital registry of the 
Regional Cancer Centre, Trivandrum, and Kerala, India. In that hospital, 
eighty per cent of the patients completed the prescribed treatment, which 
was predominantly radiotherapy. The vital status of each patient was 
established by scrutiny of case records and by reply-paid postal enquiries. 
The observed survival rates were estimated by the Kaplan-Meier method 
and prognostic factors were assessed using Cox's proportional hazards 
regression analysis. The overall 5 year observed survival rate was 47.4%.It 
has been found that the 95% of Confidence Interval was between 41.6 to 
52.9%.Next socioeconomic status, performance status and the clinical 
stage of disease emerged as independent predictors of survival. Low 
survival was associated with advanced stages of disease, low 
socioeconomic status and poor performance status. It is stressed that trends 
in survival rates may be used to evaluate cancer control programs in 
Developing countries in the absence of reliable mortality statistics and, 
even when mortality data are available, survival rates are valuable 
comparative statistics. Earlier detection by improving the awareness of the 
population and the physicians will improve survival rates, but a more 
effective and prudent approach would be to prevent invasive cervical 
cancer, and thereby reduce mortality, by implementing feasible and 
effective screening programs in India. (16) 
 
Case Study 
Case Study: Elderly patients with early non-small cell lung cancer: What 
are the benefits and harms of adjuvant platinum-based chemotherapy? 
More In Lung Cancer 
 A prospective perspective: The iTARGET trial and gefitinib therapy 
for NSCLC in patients with known mutations of the EGFR  
 Case Study: EGFR-directed therapy optimizes responses in patients 
with NSCLC harboring EGFR mutations  
 EGFR-directed therapy optimizes responses in patients with NSCLC 
harboring EGFR mutations  
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 Improving survival rates in lung cancer  
 Adjuvant therapy for early-stage non-small cell lung cancer: Recent 
reports and their implications 
Tags 
 Case Study  
 Cancer  
 Lung Cancer  
 
In August 2004, a 73-year-old Caucasian female underwent a routine chest 
x-ray because of a prolonged dry cough following a viral infection. A 4-cm 
peripheral mass in the left upper lung lobe was discovered. Further workup 
including a CT-guided transthoracic biopsy revealed a moderately 
differentiated adenocarcinoma of the lung that was highly positive for 
thyroid transcription factor 1 (TTF-1) staining on immunohistochemistry. 
A PET-CT showed avid fluorodeoxyglucose (FDG) uptake of the tumor 
and a 2-cm left hilar lymph node with no evidence of any distant 
metastases. Mediastinoscopy and MRI of the brain wasNegative. 
 
 Her past medical history was unremarkable except for a remote smoking 
history of 20 pack-years ending 35 years ago, an 8-year history of 
hypertension, and mild arthritis of her knees. Her ECOG performance 
status was 1, and she did not complain of any weight loss. She had normal 
pulmonary function tests and routine laboratory results. 
   She was considered to be an operable candidate and successfully 
underwent left upper lobectomy with hilar and mediastinal lymph node 
dissection. The pathological specimen showed a completely resected 
adenocarcinoma, 5.2-cm in size with one positive hilar lymph node (pT2 
pN1 M0 G2, stage IIB). 
 Six weeks after surgery the patient had recovered fully except for ongoing 
shortness of breath when climbing a single flight of stairs. Given her good 
recovery, she was scheduled for four cycles of adjuvant chemotherapy with 
cisplatin and vinorelbine. She experienced prolonged neutropenia during 
the first cycle, which led to the use of granulocyte colonystimulating factor 
in the following cycles. On her visit for the second cycle, she complained 
of grade 2 asthenia and intermittent mild tinnitus of the right ear but was 
willing to continue treatment. Chemotherapy was discontinued after three 
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cycles at the patient's request after an episode of diarrhea, which required 
short-term hospitalization during the third cycle. The patient continues to 
do well today, 4 years after her initial diagnosis, with no sequelae from her 
treatment.   
 
 
Case 152 -- Right Upper Quadrant Mass 
 
PATIENT HISTORY:  
A two year old white female was seen for a routine well child examination. 
On physical examination, a right upper quadrant mass was palpable. Serum 
alpha fetoprotein was 44,240 ng/mL at the time of admission.  
RADIOLOGIC FINDINGS:  
The scout film (Image 01) from the CT scan revealed a heterogeneous 
intrahepatic mass which extended through the diaphragm into the right 
lower thoracic cavity. The axial non-contrast enhanced CT scan showed a 
heterogeneous intrahepatic mass (Image 02) with areas containing 
fibroadipose tissue, soft tissue, and calcifications. At the level of the heart 
(Image 03), the CT scan showed a right sided paraspinal mass which on 
adjacent sections was in continuity with the intrahepatic mass.  
GROSS DESCRIPTION:  
 
The right lobe of the liver, gallbladder, a portion of the diaphragm, and a 
wedge resection of the right lower lobe of the lung were received, 
measuring in total 14.5 x 10.0 x 6.0 cm, 530 grams. The right lobe of the 
liver was distorted by a 10.0 x 8.5 x 5.5 cm well circumscribed mass 
covered with a thick fibrous capsule. The capsule of the mass abutted the 
capsule of the liver. A portion of the diaphragm was firmly adherent to the 
surface of the right lobe of the liver. A resected wedge of lung was 
adherent to the diaphragm. On cut section, the mass in the right lobe of the 
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liver (Image 04) was a multicystic tan-white tumor with cysts ranging up to 
3.0 cm in greatest dimension. Some cysts contained yellow, clear fluid, 
while other cysts contained mucinous tan-white material. Fragments of 
cartilage and bone (Image 05) were identified in the tan-white 
fibroconnective tissue between cysts. Some cysts contained yellow caseous 
debris and pieces of hair. Foci of black retinal pigment were present. On 
cut section, a poorly circumscribed, yellow-white, focally hemorrhagic, 
soft friable, tumor (Image 06), 4.5 x 3.5 x 3.0 cm, extended from the edge 
of the main tumor mass in the liver, through the diaphragm into the lung. 
 
 
 
MICROSCOPIC DESCRIPTION:  
The tumor in the liver was composed of cysts with varied epithelial linings, 
including ciliated respiratory epithelium, (Images 07, 08) simple squamous 
epithelium (Image 09), keratinizing stratified squamous epithelium (Image 
10), and bone were identified. Mature fibroadipose tissue and neural tissue 
(Image 11) and bone were identified. Mature fibroadipose tissue and neural 
tissue (Image 12) were present. Foci of pigmented retinal epithelium were 
seen. The tumor extending through the diaphragm into the lung showed a 
reticulated pattern (Image 13) of low cuboidal cells with some papillae 
intermixed (Images 14, 15). In cross section, these papillae with 
fibrovascular cores were lined by cuboidal cells forming Schiller-Duval 
bodies (Image 16). The cuboidal cells had large pleomorphic nuclei with 
prominent nucleoli. Some had eosinophilic hyaline globules in their 
cytoplasm. Similar foci of tumor were identified within the liver mass.  
Immunoperoxidase staining for alpha fetoprotein showed cytoplasmic 
staining in several foci of the tumor extending through the diaphragm into 
the lung (Image 17). 
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FINAL DIAGNOSIS Final Diagnosis -- Yolk Sac Carcinoma Arising in 
a Mature Teratoma of the Liver 
 
FINAL DIAGNOSIS: YOLK SAC CARCINOMA ARISING IN A 
MATURE TERATOMA OF THE LIVER.  
Contributor's note:  
arcinoma,5 "malignancies of hepatic and mesodermal components",6 and 
malignant neural elements.7 The most common germ cell malignancy 
arising in teratomas overall is the endodermal sinus tumor or yolk sac 
tumor.8 The most common malignancies arising in mature The term 
teratoma is derived from the Greek root "teratos" which means monster. 
This name is applied to neoplasms which are characterized by abnormal 
growth of a combination of tissues derived from ectodermal, mesodermal, 
and endodermal germ layers. This combination of tissues is unrelated to the 
organ in which the tumor is arising. Teratomas have been described in 
numerous anatomic sites. 1 Most commonly these tumors arise in the 
ovaries or in the sacrococcygeal region in children.1 other less common 
anatomic locations include the testes, mediastinum, and central nervous 
system. Rare teratomas arising in the gastrointestinal tract, liver, nasal 
sinuses, uterus, cervix, and thyroid2 have been reported. The biologic 
behavior of these neoplasms is also highly variable, some being entirely 
benign and others undergoing aggressive malignant transformation. Several 
hypotheses concerning the pathogenesis of these lesions have been 
suggested. The most commonly espoused hypothesis is that these tumors 
arise from primordial germ cells and primitive somatic cells which 
proliferate in an abnormal fashion due to absence of the regulatory 
influence of unidentified organizers and inducers.1 the definitive 
pathogenesis of these neoplasms has yet to be elucidated.  
Teratomas of the liver are rare neoplasms accounting for less than 1% of all 
teratomas. The tumors more commonly occur in pediatric patients but still 
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only account for less than 1% of all liver neoplasms in pediatric patients.3 
Of the 25 hepatic teratomas described in the literature, 4 only five occurred 
in adult patients. The majority of described cases were in female children 
under three years of age, most arising in the right lobe of the liver. Of these 
cases, only 4 cases had documented malignant degeneration. The reported 
malignancies arising in hepatic teratomas include squamous cell cteratomas 
of any site are squamous cell carcinoma and sarcoma. Rare cases of 
primary yolk sac tumor of the liver have been reported.9  
The patient described herein represents a unique instance of a hepatic 
teratoma with a germ cell tumor component, specifically yolk sac 
carcinoma. On presentation, this patient's serum alpha fetoprotein was 
markedly elevated and a similar elevation of serum alpha fetoprotein has 
been described in another case of primary hepatic teratoma.7 Following 
resection of the tumor and chemotherapy, the serum alpha fetoprotein has 
decreased to 4 ng/mL (most recently) and is being used as a tumor marker 
to screen for tumor recurrence in this patient. At present the patient has no 
evidence of tumor.  
 
 Molecular Diagnostics -- Abdominal Pain 
MOLECULAR DIAGNOSTICS:  
INTERPRETATION:  
B-cell lymphoma without Bcl-2 gene rearrangement.  
RESULTS:  
TESTS:  
Immunoglobulin heavy chain rearrangement  
Bcl-2 gene rearrangement  
DNA purification  
RESULTS:  
The heavy chain gene shows 2 bands of clonal gene  
Rearrangement. The Bcl-2 gene is normal at the mbr and mcr loci.  
COMMENTS:  
The lesion probably contains a single clone of  
Neoplastic B-cells with diallelic gene rearrangement. The clonal  
B-cells comprise the majority of cells in the tissue specimen.  
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The absence of Bcl-2 gene rearrangement indicates that this  
Marker cannot be used for the assessment of dissemination or  
         Residual disease.                                                                                               
 
Final Diagnosis -- Primary Hepatic Lymphoma 
                            
FINAL DIAGNOSIS:  
MALIGNANT LYMPHOMA, FOLLICULAR CENTER CELL TYPE, 
LARGE NONCLEAVED CELL PREDOMINANT, DIFFUSE  
 (WORKING FORMULATION: MALIGNANT LYMPHOMA, DIFFUSE 
LARGE CELL TYPE).  
 
CONTRIBUTOR'S NOTE: 
Immunophenotypic studies support the diagnosis of a follicular center cell 
lymphoma. Due to the lack of lymphadenopathy or other organ involement, 
this was determined to be a primary hepatic lymphoma. Genotypic studies 
performed on the liver biopsy in the Molecular Diagnostics Laboratory 
support the diagnosis of a B-cell neoplasm but do not help to further 
subclassify this lymphoma.  
Primary malignant lymphoma of the liver accounts for only 0.4% of all 
extranodal lymphomas in the US. A recent published series of cases 
revealed a median patient age of 55 years and a male-to-female ratio of 
3.1:11. The most common presenting signs and symptoms were epigastric 
and right upper quadrant pain, weight loss, fever; the histopathologic 
sections demonstrate a diffuse large noncleaved follicular center cell 
lymphoma. There is sclerosis. The flow cytometric night sweats, and 
hepatomegaly. The majority of patients had elevated liver function tests. 
All patients in the series had no elevation of either alpha-fetoprotein or 
carcinoembryonic antigen.  
While Hodgkin's disease, non-Hodgkin's lymphoma and various leukemias 
may secondarily involve the liver, virtually all primary hepatic lymphomas 
are non-Hodgkin's lymphomas. The majority (88.2%) are classified as 
Diffuse Type, with just over half (57.4%) further identified as Large Cell 
Type. Seventy-nine percent of the cases are B-cell lymphomas, 6.9% T-cell 
lymphomas, and the remainder phenotypically unclassified. The overall 
two-year survival rate is approximately 66%.  
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                                       Case 60 -- Peritonitis 
PATIENT HISTORY:  
The patient is a 70 year old male with peritonitis.  
 
GROSS DESCRIPTION:  
Received is a 25.0 cm. segment of small intestine with attached mesentery. 
The serosal surface is dull with areas of tan-white, purulent exudate. In the 
mid portion of the serosal surface, there is a 3.0 x 2.3 x 2.0 cm polypoid, 
pedunculated mass. Opening the bowel reveals a 4.5 cm. uniform 
circumference. The mucosa is tan and shows normal folds. In the mid portion 
of the mucosal surface, corresponding with the polypoid mass on the serosa, 
there is a small raised papilla with a pinpoint lumen which appears to have a 
tortuous connection with the serosal polypoid mass. The mucosa surrounding 
the papilla is slightly edematous with focal erosions. Within the wall of the 
polypoid mass, there is multiple round tan -white nodules noted.  
Additionally received is a 4.0 cm. vermiform appendix with attached 
periappendiceal fat. The serosa is dull with areas of white purulent material. 
Sectioning reveals no obvious fecalith and the lumen appears patent.  
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MICROSCOPIC DESCRIPTION:  
Sections demonstrate a large diverticulum lined by small intestinal mucosa. 
Focally, ectopic gastric mucosa is identified in the tip of the diverticulum. 
Beneath the mucosa, in the wall of the diverticulum, there are nodules of 
basophilic cells. At higher magnification, these cells are forming nests and 
cords. The nuclei are round and uniform with "salt and pepper" chromatin 
pattern. There is a moderate amount of amphophilic cytoplasm. 
Chromogranin stain is positive in these cells.  
Diagnosis Final Diagnosis -- Carcinoid tumor arising in a Meckel's 
diverticulum (Peritonitis) 
FINAL DIAGNOSIS:  
 
ILEUM, SEGMENTAL RESECTION - CARCINOID TUMOR ARISING 
IN A MECKEL'S DIVERTICULUM.  
Notes:  
 Meckel's diverticulum is one of the most common congenital anomalies 
of the gastrointestinal tract. Most Meckel's diverticuli demonstrate 
ectopic gastric mucosa. Additionally, one can see pancreatic or colonic 
mucosa. Symptoms can be related to rupture of the diverticulum, 
secretion of ectopic gastric or pancreatic hormones, or intussusception 
(with the diverticulum as the lead point).  
 A 1992 review (1) lists 104 cases of carcinoid tumor arising in Meckel's 
diverticulum reported in the world literature. Most of these showed the 
tumor present in the tip of the diverticulum. The majority of patients are 
asymptomatic. A few become symptomatic from the diverticulum 
and/or the carcinoid tumor itself. Only ten of these cases developed the 
"carcinoid syndrome". Metastasis of the carcinoid tumor is related to 
size. Those tumors greater than 2.0 cm all had metastatic foci.  
 
 
 
 
 
 
 
 
CHAPTER 8 
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Appendix  A 
 
 
 
 
 
 
In this histrograph put years in X-axis and mode of diseas in Y-axis. We 
observed that disease no 13 (Brest cancer) are more in the years 2000, 
2002, 2003 and 2006 and disease no 17(Cervix cancer) are more in the 
years 2004 & 2005. 
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Appendix B 
 
 
 
 
 
 
 
In this histrograph put Martial-Status in X-axis and mode of disease in Y-
axis. We observed that disease no 14 (Brain cancer) are more in unmarried 
persons where as disease no 13 (Brest cancer) are more in married & 
divorced persons and disease no 17(Cervix cancer) are more in widowed 
persons. 
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Appendix C 
 
 
 
In this histograph put Mother-tounge (Language) in X-axis and Mode of 
diseases in Y-axis. We observed that disease no 17 (Cervix cancer) are 
more in those persons who know Gujarati language and disease no 13(Brest 
cancer) are more in Hindi and other language. 
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Appendix D 
 
 
 
 
 
In this histograph put age-groups in X-axis and mode of disease in Y-axis. 
We observe that disease no 14(Brain cancer) are more in age-group below 
20 & 20-30 where as diseases no 13(Brest cancer) are more in age-group 
20-30 & 30-40, diseases no 17 (Cervix cancer) are more in age-group 50-
60 and diseases no 36 (Lung cancer) are more in age-group 60-70 and 
above 70. 
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Appendix E 
 
 
 
 
 
 
 
In this histograph put males and females in X-axis and mode of disease in 
Y-axis. Above graph we observe that disease no 11(Tongue cancer) are 
more in males and disease no 13(Brest cancer are more in Females. 
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Appendix F 
 
 
 
 
In this histogrph put religions in X-axis and mode of diseases in Y-axis. 
Above graph we observed that disease no 17(Cervix cancer) are more in 
Hindu and Christian persons where as disease no 10 (Abdoeminal L.N.) are 
more in Muslim persons, disease no 65 (Secondary Skin Cancer) are more 
in Sikh persons and disease no 68 (Tongue cancer) are more in Jain 
persons. 
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Appendix G 
Type of Cancer (Site)      
Sir No        
1 Anal Canal       
2 Acute Lymphoblastic Leukaemia    
3 Actue Leukaemia      
4 Actue myeloid Leukaemia     
5 Actue Promyelocytic Leukaema    
6 Adremalgland      
7 Abdomen       
8 Ampulla       
9 Axllary L.N.       
10 Abdoeminal L.N.      
11 Base of Tongue      
12 Bone        
13 Breast       
14 Brain        
15 Buccal Mucosa      
16 Bladder       
17 Cervix       
18 Chronic       
19 Colon        
20 Connestive Tissue      
21 Corpus Uteri       
22 Chronic myeloid leukaemia     
23 Esophagus       
24 Eye and Adnexa      
25 Floor of Mouth      
26 Gum        
27 Gall Bladder       
28 Hypopharnx       
29 Hodgkin`s Disease      
30 Inguinal L.N.       
31 Hodgkin`s lymphoma mixed cellularity   
32 Kidney       
 270
33 Larynx      
34 Liver        
35 Lip       
36 Lung        
37 Lymphnodes Neck     
38 Multiple Myeloma      
39 Mediastinum       
40 Maxillany sinus      
41 Non Hodgkin`s Lymphoma     
42 Nasal Cavity       
43 Nasopharynx      
44 Ovary        
45 Orpharynx       
46 Penis        
47 Pharynx       
48 Pyriform Fossa      
49 Prostate       
50 Pleura       
51 Plate        
52 Parotid aland      
53 Pancreas       
54 Rectum       
55 Retroperitoneum      
56 Rectosigmoid      
57 Skin        
58 Secondary Adrenal Gland     
59 Stomach       
60 Secondary Liver      
61 Secondary Bone      
62 Secondary BRAIN      
63 Secondary Rectroperitoneum    
34 Salivary Gland      
65 Secondary Skin    
66 Secondary Lung      
67 Testis      
 271
68 Tongue     
69 Tonsil        
70 Thyroid     
71 Upper limb       
72 Vagina  
73 Vulva        
74 Plasmacytoma      
75 Thoraxnos       
76 Intestimal tract      
         
         
 Sex 
Marital 
Status 
Mother 
Toungs Religion Site  
1 Male 
1 
Unmarried 1 Gujarati 1 Hindu 1 to 76 
2 Female 2 Married 2 Hindi 2 Muslim  
  3 Widow 3 Unknow 3 Jain   
  
4 
Divorced   4 Sikh  
      5 Christian   
         
         
        
         
        
 
